id,conversation_id,created_at,date,time,timezone,user_id,username,name,place,tweet,language,mentions,urls,photos,replies_count,retweets_count,likes_count,hashtags,cashtags,link,retweet,quote_url,video,thumbnail,near,geo,source,user_rt_id,user_rt,retweet_id,reply_to,retweet_date,translate,trans_src,trans_dest
1396805711083016194,1396805711083016194,2021-05-24 12:30:07 UTC,2021-05-24,12:30:07,+0000,59769395,niaidnews,NIAID News,,Interested in volunteering for a #COVID19 clinical study? Check out the COVID-19 Clinical Trials webpage to find a volunteer opportunity that is appropriate for you!  https://t.co/G3cClTkTAC  https://t.co/wwZwpURtnP,en,[],['https://bit.ly/3n8xhZB'],['https://pbs.twimg.com/media/E2JzY_QXIAQtqCb.jpg'],0,1,3,['covid19'],[],https://twitter.com/NIAIDNews/status/1396805711083016194,False,,1,https://pbs.twimg.com/media/E2JzY_QXIAQtqCb.jpg,,,,,,,[],,,,
1395741402852732929,1395741402852732929,2021-05-21 14:00:56 UTC,2021-05-21,14:00:56,+0000,59769395,niaidnews,NIAID News,,More than 60% of American adults have received their first #COVID19 vaccine. Do your part to help defeat this virus so we can get back to spending time with the ones we love. #WeCanDoThis üîç Search  https://t.co/8w7venotut üí¨ Text your ZIP code to 438829 üìû Call 1-800-232-0233  https://t.co/VQ0Tl7zVnC,en,[],['http://vaccines.gov'],[],1,1,4,"['covid19', 'wecandothis']",[],https://twitter.com/NIAIDNews/status/1395741402852732929,False,,1,https://pbs.twimg.com/ext_tw_video_thumb/1395741377485496326/pu/img/q9M6wiwmYkFvJPBo.jpg,,,,,,,[],,,,
1395038054541402115,1395038054541402115,2021-05-19 15:26:05 UTC,2021-05-19,15:26:05,+0000,59769395,niaidnews,NIAID News,,"Healthy adults 18 to 50 years old are needed to participate in the study of an investigational influenza (flu vaccine). To volunteer, call 1-866-833-5433 (TTY 1-866-411-1010), email vaccines@nih.gov, or visit  https://t.co/l8dV93ZWK4. Financial compensation is provided.  https://t.co/c1CNP2WrHK",en,[],['http://niaid.nih.gov/about/vrc'],['https://pbs.twimg.com/media/E1wrtKaWYAIAdH0.jpg'],2,1,7,[],[],https://twitter.com/NIAIDNews/status/1395038054541402115,False,,1,https://pbs.twimg.com/media/E1wrtKaWYAIAdH0.jpg,,,,,,,[],,,,
1392500823419199489,1392500823419199489,2021-05-12 15:24:02 UTC,2021-05-12,15:24:02,+0000,59769395,niaidnews,NIAID News,,"NIAID has updated the strategic plan for #COVID19 research which outlines research priorities critical to better understanding, treating and preventing SARS-CoV-2 &amp; COVID19. Read more:  https://t.co/zmsJk3wP0R  https://t.co/OylX0fZhRK",en,[],['https://bit.ly/3y5X5uY'],['https://pbs.twimg.com/media/E1MoHm7XMAQHKTD.png'],9,8,14,['covid19'],[],https://twitter.com/NIAIDNews/status/1392500823419199489,False,,1,https://pbs.twimg.com/media/E1MoHm7XMAQHKTD.png,,,,,,,[],,,,
1392113364206194688,1392113364206194688,2021-05-11 13:44:24 UTC,2021-05-11,13:44:24,+0000,59769395,niaidnews,NIAID News,,"NEWS: An investigational #GeneTherapy can safely restore #immune function in infants &amp; children who have the life-threatening #RareDisease #ADASCID, according to research supported in part by @NIH &amp; published today in @NEJM.  https://t.co/0UNqhw8Zlc  https://t.co/2XSalWCIyk",en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}, {'screen_name': 'nejm', 'name': 'nejm', 'id': '25950355'}]",['http://bit.ly/ADA-SCID'],['https://pbs.twimg.com/media/E1HHtB2VUAAWpJ9.jpg'],4,2,15,"['genetherapy', 'immune', 'raredisease', 'adascid']",[],https://twitter.com/NIAIDNews/status/1392113364206194688,False,,1,https://pbs.twimg.com/media/E1HHtB2VUAAWpJ9.jpg,,,,,,,[],,,,
1391857084128497668,1391857084128497668,2021-05-10 20:46:02 UTC,2021-05-10,20:46:02,+0000,59769395,niaidnews,NIAID News,,"On May 12 at 5:30 p.m. ET, join NIAID Director Anthony S. Fauci, M.D., at the #5thAnnualVPS for a Fireside Chat with the first full-time @NIH_ORWH Director, Dr. Vivian Pinn. Register at  https://t.co/PiQ0XSJfRi.  https://t.co/YzM5e0mNCQ",en,"[{'screen_name': 'nih_orwh', 'name': ""nih women's health"", 'id': '562188508'}]",['https://bit.ly/2SmnNyX'],['https://pbs.twimg.com/media/E1Deo3RXsAI9skP.jpg'],6,3,16,['5thannualvps'],[],https://twitter.com/NIAIDNews/status/1391857084128497668,False,,1,https://pbs.twimg.com/media/E1Deo3RXsAI9skP.jpg,,,,,,,[],,,,
1390699483965497349,1386722498801188864,2021-05-07 16:06:09 UTC,2021-05-07,16:06:09,+0000,59769395,niaidnews,NIAID News,,Learn more at  https://t.co/kHoOhVmWzp,en,[],['https://www.niaid.nih.gov/clinical-trials/drug-treatment-mild-covid-19-speselpis'],[],1,1,5,[],[],https://twitter.com/NIAIDNews/status/1390699483965497349,False,,0,,,,,,,,[],,,,
1390385475601403905,1390385475601403905,2021-05-06 19:18:24 UTC,2021-05-06,19:18:24,+0000,59769395,niaidnews,NIAID News,,"FLU NEWS: Tiny nanoparticles could make a huge impact in future, long-lasting #flu #vax. New research by #NIAID scientists and @UW colleagues  https://t.co/JkcgKKrB22",en,"[{'screen_name': 'uw', 'name': 'university of washington', 'id': '27103822'}]",['https://bit.ly/3vLYDbt'],[],6,15,44,"['flu', 'vax', 'niaid']",[],https://twitter.com/NIAIDNews/status/1390385475601403905,False,,0,,,,,,,,[],,,,
1390052146385616897,1390052068421894148,2021-05-05 21:13:52 UTC,2021-05-05,21:13:52,+0000,59769395,niaidnews,NIAID News,,"Results from the trial, led by @CDCgov w/ support from @NIAIDNews-funded @ACTGNetwork and first reported in Oct. 2020 at #UnionConf, will help inform future TB treatment.  https://t.co/98oNeJwJ3P",en,"[{'screen_name': 'cdcgov', 'name': 'cdc', 'id': '146569971'}, {'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'actgnetwork', 'name': 'actg network', 'id': '361405892'}]",['http://bit.ly/ShortTB'],[],0,1,8,['unionconf'],[],https://twitter.com/NIAIDNews/status/1390052146385616897,False,,0,,,,,,,,[],,,,
1390052068421894148,1390052068421894148,2021-05-05 21:13:33 UTC,2021-05-05,21:13:33,+0000,59769395,niaidnews,NIAID News,,"#TB NEWS: A new 4-month daily treatment regimen is as safe &amp; effective as the standard 6-month regimen at curing drug-susceptible #tuberculosis disease, researchers report today in @NEJM.  https://t.co/e1baG9chzM  https://t.co/zf1ZB3k5f7",en,"[{'screen_name': 'nejm', 'name': 'nejm', 'id': '25950355'}]",['http://bit.ly/S31A5349'],['https://pbs.twimg.com/media/E0p00ynVIAAhxYl.jpg'],1,6,16,"['tb', 'tuberculosis']",[],https://twitter.com/NIAIDNews/status/1390052068421894148,False,,1,https://pbs.twimg.com/media/E0p00ynVIAAhxYl.jpg,,,,,,,[],,,,
1389946915400294407,1389946915400294407,2021-05-05 14:15:43 UTC,2021-05-05,14:15:43,+0000,59769395,niaidnews,NIAID News,,"#ASTHMA NEWS: Today on #WorldAsthmaDay, @NIAIDNews, @nih_nhlbi, and @NIEHS reaffirm their commitment to research to improve the lives of people with this chronic #lung disease.  https://t.co/rnXavjLjDw  https://t.co/3bvtWFiR7E",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'nih_nhlbi', 'name': 'nih nhlbi', 'id': '68987936'}, {'screen_name': 'niehs', 'name': 'niehs', 'id': '97464922'}]",['http://bit.ly/NIHWAD2021'],['https://pbs.twimg.com/media/E0oVCRSVoAQ8p4e.jpg'],1,10,18,"['asthma', 'worldasthmaday', 'lung']",[],https://twitter.com/NIAIDNews/status/1389946915400294407,False,,1,https://pbs.twimg.com/media/E0oVCRSVoAQ8p4e.jpg,,,,,,,[],,,,
1389927860740165633,1389927860740165633,2021-05-05 13:00:00 UTC,2021-05-05,13:00:00,+0000,59769395,niaidnews,NIAID News,,NEWS: NIAID-led research in @NatureComms reveals that #ExtracellularVesicles shed by #MastCells contribute to #bone disease and #osteoporosis in people with mast cell disorders.  https://t.co/coXkbbZrBe   üì∏: NIAID  https://t.co/Nk4hOAB2zR,en,"[{'screen_name': 'naturecomms', 'name': 'nature communications', 'id': '206255645'}]",['https://go.nature.com/3ul9okP'],['https://pbs.twimg.com/media/E0n1fnYXsAUTQ_7.jpg'],0,0,2,"['extracellularvesicles', 'mastcells', 'bone', 'osteoporosis']",[],https://twitter.com/NIAIDNews/status/1389927860740165633,False,,1,https://pbs.twimg.com/media/E0n1fnYXsAUTQ_7.jpg,,,,,,,[],,,,
1387146594324074496,1387146594324074496,2021-04-27 20:48:14 UTC,2021-04-27,20:48:14,+0000,59769395,niaidnews,NIAID News,,ANTIBIOTICS NEWS: A new trial will test the existing #antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus #bacteremia. Learn more:  https://t.co/HqO444Catz  https://t.co/JOHfcIj3WI,en,[],['http://bit.ly/SAureusBacteremia'],['https://pbs.twimg.com/media/E0AibuUVgAUqsoq.jpg'],1,6,16,"['antibiotic', 'bacteremia']",[],https://twitter.com/NIAIDNews/status/1387146594324074496,False,,1,https://pbs.twimg.com/media/E0AibuUVgAUqsoq.jpg,,,,,,,[],,,,
1387087079142658050,1387087079142658050,2021-04-27 16:51:45 UTC,2021-04-27,16:51:45,+0000,59769395,niaidnews,NIAID News,,"NEWS: To help #vaccine developers identify suitable adjuvants, @NIAIDNews has established a Vaccine #Adjuvant Compendium to share characteristics and metadata on adjuvants studied by NIAID-supported researchers and other research programs.  https://t.co/UorTMPZvs1",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://vac.niaid.nih.gov/'],[],0,6,13,"['vaccine', 'adjuvant']",[],https://twitter.com/NIAIDNews/status/1387087079142658050,False,,0,,,,,,,,[],,,,
1387082403500363778,1387082403500363778,2021-04-27 16:33:10 UTC,2021-04-27,16:33:10,+0000,59769395,niaidnews,NIAID News,,Liver Disease News: NIAID scientists and colleagues identify key #LiverFibrosis gene and how it can make aging livers more prone to #cirrhosis and #HepatocellularCarcinoma. Study also could inform new therapies to reduce or prevent #HepaticFibrosis.  https://t.co/PQoeHl7Qfx,en,[],['https://bit.ly/3npspjy'],[],0,7,9,"['liverfibrosis', 'cirrhosis', 'hepatocellularcarcinoma', 'hepaticfibrosis']",[],https://twitter.com/NIAIDNews/status/1387082403500363778,False,,0,,,,,,,,[],,,,
1387078788186525701,1387078788186525701,2021-04-27 16:18:48 UTC,2021-04-27,16:18:48,+0000,59769395,niaidnews,NIAID News,,"#COVID19 NEWS: ICYMI commentary by Dr. Fauci &amp; @CatharinePaules. Key points: COVID-19 #ClinicalTrial data should guide therapeutic use, don‚Äôt extrapolate results between disease stages, design robust studies to give clinically relevant data.   https://t.co/kOQjRQGqob",en,"[{'screen_name': 'catharinepaules', 'name': 'catharine paules md', 'id': '1122668552228622337'}]",['https://www.cell.com/med/fulltext/S2666-6340(21)00164-1#%20'],[],1,3,8,"['covid19', 'clinicaltrial']",[],https://twitter.com/NIAIDNews/status/1387078788186525701,False,,0,,,,,,,,[],,,,
1386722498801188864,1386722498801188864,2021-04-26 16:43:02 UTC,2021-04-26,16:43:02,+0000,59769395,niaidnews,NIAID News,,"VOLUNTEER üôã: NIAID is seeking volunteers who are newly diagnosed with mild COVID-19 who live within 50 miles of Bethesda, Maryland. For more information, call 1-800-411-1222 (reference study #20-I-0140). TTY: 1-866-411-1010. Se habla espa√±ol.  https://t.co/axcFsnPi8S",en,[],[],['https://pbs.twimg.com/media/Ez6gwyVWYAIFJd2.jpg'],3,5,12,[],[],https://twitter.com/NIAIDNews/status/1386722498801188864,False,,1,https://pbs.twimg.com/media/Ez6gwyVWYAIFJd2.jpg,,,,,,,[],,,,
1385674290721435671,1385674290721435671,2021-04-23 19:17:50 UTC,2021-04-23,19:17:50,+0000,59769395,niaidnews,NIAID News,,COVID19 NEWS: #NIH Clinical Center study now open to assess response to #COVID19 #vaccine in people with and without #immunedeficiency disorders. #NIAID study leaders plan to enroll 500 volunteers. #clinicaltrials #piawareness  https://t.co/aGXXeZHhjL  https://t.co/D9snh4Y7hc,en,[],['https://bit.ly/32JP1BM'],['https://pbs.twimg.com/media/EzrnJHDWEAA36Ig.jpg'],3,4,15,"['nih', 'covid19', 'vaccine', 'immunedeficiency', 'niaid', 'clinicaltrials', 'piawareness']",[],https://twitter.com/NIAIDNews/status/1385674290721435671,False,,1,https://pbs.twimg.com/media/EzrnJHDWEAA36Ig.jpg,,,,,,,[],,,,
1385672353737154560,1385672353737154560,2021-04-23 19:10:08 UTC,2021-04-23,19:10:08,+0000,59769395,niaidnews,NIAID News,,ASTHMA NEWS: @NIAIDNews has established a new #ChildhoodAsthma clinical research network to conduct #pediatric #asthma research in low-income urban settings and develop new treatment and prevention strategies.  https://t.co/0EY3qbyz47  https://t.co/zyYfQaxaPd,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['http://bit.ly/CAUSEnetwork'],['https://pbs.twimg.com/media/EzrlWJUVkAQwyep.jpg'],0,3,13,"['childhoodasthma', 'pediatric', 'asthma']",[],https://twitter.com/NIAIDNews/status/1385672353737154560,False,,1,https://pbs.twimg.com/media/EzrlWJUVkAQwyep.jpg,,,,,,,[],,,,
1385256080360497166,1385256080360497166,2021-04-22 15:36:01 UTC,2021-04-22,15:36:01,+0000,59769395,niaidnews,NIAID News,,COVID-19 NEWS: A new clinical trial to test therapeutics in severely ill #COVID19 patients has begun enrolling participants. ACTIV-3 Critical Care will test Zyesami and remdesivir in patients hospitalized with severe COVID-19. Learn more:  https://t.co/fDvrN9aozm  https://t.co/q74PSz7kLm,en,[],['http://bit.ly/ACTIV3CriticalCareLaunch'],['https://pbs.twimg.com/media/Ezlq9HbXMAQ6eNE.jpg'],10,16,39,['covid19'],[],https://twitter.com/NIAIDNews/status/1385256080360497166,False,,1,https://pbs.twimg.com/media/Ezlq9HbXMAQ6eNE.jpg,,,,,,,[],,,,
1384969091123974148,1384969091123974148,2021-04-21 20:35:37 UTC,2021-04-21,20:35:37,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: A trial to test a new, high-potency fully-human #polyclonal #antibody therapeutic in people with mild or moderate cases of #COVID19 has begun enrolling participants. Learn more:  https://t.co/8mC473mKCS  https://t.co/sd9wdlgm2t",en,[],['http://bit.ly/ACTIV2SAB'],['https://pbs.twimg.com/media/Ezhl7stUYAEMcen.jpg'],3,10,26,"['polyclonal', 'antibody', 'covid19']",[],https://twitter.com/NIAIDNews/status/1384969091123974148,False,,1,https://pbs.twimg.com/media/Ezhl7stUYAEMcen.jpg,,,,,,,[],,,,
1383135584193974273,1383135584193974273,2021-04-16 19:09:55 UTC,2021-04-16,19:09:55,+0000,59769395,niaidnews,NIAID News,,"COVID NEWS: NIAID scientists find experimental antiviral for #COVID19 effective in hamster study. MK-4482, also known as #molnupiravir and EIDD-2801, originally developed to treat influenza.  https://t.co/JHcc1F9Vfh  https://t.co/VJWMYdBVBX",en,[],['https://bit.ly/3ahx0Pk'],['https://pbs.twimg.com/media/EzHiTYzVoAAahX4.jpg'],6,26,46,"['covid19', 'molnupiravir']",[],https://twitter.com/NIAIDNews/status/1383135584193974273,False,,1,https://pbs.twimg.com/media/EzHiTYzVoAAahX4.jpg,,,,,,,[],,,,
1382043064617766912,1382043064617766912,2021-04-13 18:48:38 UTC,2021-04-13,18:48:38,+0000,59769395,niaidnews,NIAID News,,"#COVID19 NEWS: @NIAIDNews has launched a #ClinicalTrial to test the safety and efficacy of an investigational monoclonal #antibody, IC14, for treating people who are hospitalized with respiratory disease and low blood oxygen due to #SARSCoV2 infection.  https://t.co/tyBoaedlNy  https://t.co/TC8hTIPaL7",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://bit.ly/3dYwjeD'],['https://pbs.twimg.com/media/Ey4Ayp3UYAADcLU.jpg'],2,19,39,"['covid19', 'clinicaltrial', 'antibody', 'sarscov2']",[],https://twitter.com/NIAIDNews/status/1382043064617766912,False,,1,https://pbs.twimg.com/media/Ey4Ayp3UYAADcLU.jpg,,,,,,,[],,,,
1381625496920682509,1381625496920682509,2021-04-12 15:09:22 UTC,2021-04-12,15:09:22,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: #SARSCoV2 activates the #immune #complement system in lung cells, @NIH scientists &amp; colleagues report in @SciImmunology. They suggest that pairing antivirals w/ drugs that block excessive complement activity could help treat severe #COVID19.  https://t.co/lnoEnALHO2",en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}, {'screen_name': 'sciimmunology', 'name': 'science immunology', 'id': '4002598402'}]",['https://bit.ly/3dc0y2Q'],[],1,10,30,"['sarscov2', 'immune', 'complement', 'covid19']",[],https://twitter.com/NIAIDNews/status/1381625496920682509,False,,0,,,,,,,,[],,,,
1380640168168800264,1380640168168800264,2021-04-09 21:54:01 UTC,2021-04-09,21:54:01,+0000,59769395,niaidnews,NIAID News,,"Volunteers needed! There are several #COVID19 clinical studies ongoing to evaluate therapies and vaccine candidates, as well as studies of people who have recovered from infection. Visit  https://t.co/G3cClTkTAC to see if there is a clinical study that you can volunteer for.  https://t.co/tWuREOdPVG",en,[],['https://bit.ly/3n8xhZB'],['https://pbs.twimg.com/media/EykE6lXXIAUX5iE.jpg'],2,9,21,['covid19'],[],https://twitter.com/NIAIDNews/status/1380640168168800264,False,,1,https://pbs.twimg.com/media/EykE6lXXIAUX5iE.jpg,,,,,,,[],,,,
1380560659503411202,1380560659503411202,2021-04-09 16:38:05 UTC,2021-04-09,16:38:05,+0000,59769395,niaidnews,NIAID News,,"PRION DISEASE NEWS: NIAID scientists are working to establish an ear punch in wild game animals as a fast, easy sample for diagnosing chronic wasting disease, a type of  #prion disease.  https://t.co/TM29f7f2x9  https://t.co/NSNeMEUTol",en,[],['https://go.nature.com/3d0srdW'],['https://pbs.twimg.com/media/Eyi8Y0oVcAAxcd-.jpg'],0,3,12,['prion'],[],https://twitter.com/NIAIDNews/status/1380560659503411202,False,,1,https://pbs.twimg.com/media/Eyi8Y0oVcAAxcd-.jpg,,,,,,,[],,,,
1380505952609308673,1380505952609308673,2021-04-09 13:00:42 UTC,2021-04-09,13:00:42,+0000,59769395,niaidnews,NIAID News,,COVID-19 NEWS: Dr. Fauci explains the story behind #COVID19 vaccines in @ScienceMagazine  https://t.co/eP6sekJJJ2  https://t.co/QRfn5dexUJ,en,"[{'screen_name': 'sciencemagazine', 'name': 'science magazine', 'id': '32372834'}]",['http://bit.ly/StoryBehindCOVID19Vaccines'],['https://pbs.twimg.com/media/EyiK2NSWYAI2Ig3.jpg'],17,47,107,['covid19'],[],https://twitter.com/NIAIDNews/status/1380505952609308673,False,,1,https://pbs.twimg.com/media/EyiK2NSWYAI2Ig3.jpg,,,,,,,[],,,,
1380207828799877120,1380207825306013696,2021-04-08 17:16:04 UTC,2021-04-08,17:16:04,+0000,59769395,niaidnews,NIAID News,,"A year ago, the same study group found that 4 common human #coronaviruses are seasonal, like flu. The coronavirus that causes #COVID19 was not examined in that study.  https://t.co/Wae5DqcHtR",en,[],['https://bit.ly/3a5xDs4'],[],0,2,5,"['coronaviruses', 'covid19']",[],https://twitter.com/NIAIDNews/status/1380207828799877120,False,,0,,,,,,,,[],,,,
1380207825306013696,1380207825306013696,2021-04-08 17:16:03 UTC,2021-04-08,17:16:03,+0000,59769395,niaidnews,NIAID News,,"NEWS: NIAID-funded #coronavirus study from University of Michigan finds that reinfections of seasonal coronaviruses are frequent, suggesting that #SARSCoV2, which causes #COVID19, also might produce reinfections.  https://t.co/WVh6eubpmb  https://t.co/1GzHPcfhQH",en,[],['https://bit.ly/39SiWeN'],['https://pbs.twimg.com/media/Eyd7bE7UcAA4BAS.jpg'],2,10,14,"['coronavirus', 'sarscov2', 'covid19']",[],https://twitter.com/NIAIDNews/status/1380207825306013696,False,,1,https://pbs.twimg.com/media/Eyd7bE7UcAA4BAS.jpg,,,,,,,[],,,,
1380162191626752000,1380162191626752000,2021-04-08 14:14:43 UTC,2021-04-08,14:14:43,+0000,59769395,niaidnews,NIAID News,,"HIV &amp; COVID-19 NEWS: Accelerated research is needed to effectively address the concurrent #HIV and #COVID19 pandemics, @NIAIDNews experts write in @IDSAInfo‚Äôs #JInfectDis.  https://t.co/4SkepgqClg  https://t.co/HJnXILnIg1",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'idsainfo', 'name': 'idsa', 'id': '76417139'}]",['http://bit.ly/JIDHIVCOVID'],['https://pbs.twimg.com/media/EydSDWjWgAQT0p3.jpg'],2,6,8,"['hiv', 'covid19', 'jinfectdis']",[],https://twitter.com/NIAIDNews/status/1380162191626752000,False,,1,https://pbs.twimg.com/media/EydSDWjWgAQT0p3.jpg,,,,,,,[],,,,
1379789077851992069,1379789077851992069,2021-04-07 13:32:06 UTC,2021-04-07,13:32:06,+0000,59769395,niaidnews,NIAID News,,"#COVID19 NEWS: A @NIAIDNews trial is underway to find out if ppl who are highly #allergic or have a #MastCellDisorder are at increased risk for an immediate, systemic allergic reaction to the @moderna_tx or @pfizer @BioNTech_Group COVID-19 #vaccines.  https://t.co/RFNc1ZIgYQ  https://t.co/fdWOC2C0uW",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'moderna_tx', 'name': 'moderna', 'id': '2227355222'}, {'screen_name': 'pfizer', 'name': 'pfizer inc.', 'id': '56488059'}, {'screen_name': 'biontech_group', 'name': 'biontech se', 'id': '1060984350995550208'}]",['https://bit.ly/3rWXkV0'],['https://pbs.twimg.com/media/EyX7Qg6VcAYNES_.jpg'],7,27,53,"['covid19', 'allergic', 'mastcelldisorder', 'vaccines']",[],https://twitter.com/NIAIDNews/status/1379789077851992069,False,,1,https://pbs.twimg.com/media/EyX7Qg6VcAYNES_.jpg,,,,,,,[],,,,
1379558541162213376,1379558541162213376,2021-04-06 22:16:01 UTC,2021-04-06,22:16:01,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: volunteers who received two doses of the @moderna_tx #COVID19 vaccine in spring 2020 as part of an #NIH-led Phase 1 trial retained high levels of antibodies 6 months after the second dose, according to new data published in @NEJM today.",en,"[{'screen_name': 'moderna_tx', 'name': 'moderna', 'id': '2227355222'}, {'screen_name': 'nejm', 'name': 'nejm', 'id': '25950355'}]",[],[],1,41,82,"['covid19', 'nih']",[],https://twitter.com/NIAIDNews/status/1379558541162213376,False,https://twitter.com/NEJM/status/1379467685944172547,0,,,,,,,,[],,,,
1378022637415194624,1378022637415194624,2021-04-02 16:32:53 UTC,2021-04-02,16:32:53,+0000,59769395,niaidnews,NIAID News,,"NEWS: NIAID study shows single dose #COVID19 nasal vaccine, ChAd-SARS-CoV-2-S, limits infection in monkeys. Trial of experimental vaccine developed by Washington University underway in India.  https://t.co/mpguXNV0SY  https://t.co/gTBtCRsXpX",en,[],['https://bit.ly/3rL0efk'],['https://pbs.twimg.com/media/Ex-4CNHVgAIw3kf.jpg'],3,17,32,['covid19'],[],https://twitter.com/NIAIDNews/status/1378022637415194624,False,,1,https://pbs.twimg.com/media/Ex-4CNHVgAIw3kf.jpg,,,,,,,[],,,,
1376945536008212480,1376945536008212480,2021-03-30 17:12:52 UTC,2021-03-30,17:12:52,+0000,59769395,niaidnews,NIAID News,,#COVID19 NEWS: #Tcells from recovered #COVID19 patients retain ability to recognize #SARSCoV2 variants. New peer-reviewed research from #NIAID and colleagues @immunoscape and @jhucovidplasma  https://t.co/w5WB0dRdzl  https://t.co/7PVSnCVLVL,en,"[{'screen_name': 'immunoscape', 'name': 'immunoscape', 'id': '996511835078590464'}, {'screen_name': 'jhucovidplasma', 'name': 'johns hopkins covid-19 blood plasma research', 'id': '1258906461536768003'}]",['https://bit.ly/3foy0EE'],['https://pbs.twimg.com/media/ExvkmS1VoAEkMuz.jpg'],4,33,52,"['covid19', 'tcells', 'covid19', 'sarscov2', 'niaid']",[],https://twitter.com/NIAIDNews/status/1376945536008212480,False,,1,https://pbs.twimg.com/media/ExvkmS1VoAEkMuz.jpg,,,,,,,[],,,,
1375564107106058246,1375564105352814594,2021-03-26 21:43:34 UTC,2021-03-26,21:43:34,+0000,59769395,niaidnews,NIAID News,,"Findings from the study will help inform science-based decisions about mask use and social distancing post-COVID-19 vaccination. The study will enroll 12,000 students across more than 20 universities. For more information, visit:  https://t.co/j3VyYOdi5t",en,[],['https://preventcovidu.org/'],[],1,8,15,[],[],https://twitter.com/NIAIDNews/status/1375564107106058246,False,,0,,,,,,,,[],,,,
1375564105352814594,1375564105352814594,2021-03-26 21:43:34 UTC,2021-03-26,21:43:34,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: College students can enroll in a study designed to determine if Moderna‚Äôs vaccine can prevent #SARSCoV2 infection, limit amount of virus in the nose &amp; reduce transmission of SARS-CoV-2 from those vaccinated to their close contacts.  https://t.co/1BZJbpzCTa",en,[],['http://bit.ly/PreventCOVIDU'],[],9,50,88,['sarscov2'],[],https://twitter.com/NIAIDNews/status/1375564105352814594,False,,0,,,,,,,,[],,,,
1375439448616235015,1375439441540476930,2021-03-26 13:28:13 UTC,2021-03-26,13:28:13,+0000,59769395,niaidnews,NIAID News,,#COVID-19 #vaccines authorized to date use the #SARSCoV2 spike protein to teach the #ImmuneSystem to recognize the virus &amp; generate strong B-cell &amp; T-cell immune responses. @gritstoneonc designed a vaccine component that includes the spike plus bits of other SARSCoV2 proteins.  https://t.co/lJDvUQuJyO,en,[],[],['https://pbs.twimg.com/media/ExaKgP0UcAIqvqY.jpg'],2,12,12,"['covid', 'vaccines', 'sarscov2', 'immunesystem']",[],https://twitter.com/NIAIDNews/status/1375439448616235015,False,,1,https://pbs.twimg.com/media/ExaKgP0UcAIqvqY.jpg,,,,,,,[],,,,
1375439441540476930,1375439441540476930,2021-03-26 13:28:11 UTC,2021-03-26,13:28:11,+0000,59769395,niaidnews,NIAID News,,#COVID19 NEWS: A clinical trial supported by @NIAIDNews in collaboration with @gritstoneonc has begun to assess the safety and tolerability of different doses of two-part investigational COVID-19 #vaccine regimens in healthy adults:  https://t.co/95cXmBlSul,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://clinicaltrials.gov/ct2/show/NCT04776317'],[],1,11,22,"['covid19', 'vaccine']",[],https://twitter.com/NIAIDNews/status/1375439441540476930,False,,0,,,,,,,,[],,,,
1374832094258597889,1374762831501922306,2021-03-24 21:14:49 UTC,2021-03-24,21:14:49,+0000,59769395,niaidnews,NIAID News,,"#WorldTBDay marks the anniversary of the announcement that the bacterium Mycobacterium tuberculosis causes #tuberculosis. As the bacteria develop resistance to common #antibiotics, #TheClockIsTicking in the fight to #EndTB.  https://t.co/nLxI1JD4mn",en,[],[],['https://pbs.twimg.com/media/ExRiVD3XEAUuqNs.jpg'],1,5,17,"['worldtbday', 'tuberculosis', 'antibiotics', 'theclockisticking', 'endtb']",[],https://twitter.com/NIAIDNews/status/1374832094258597889,False,,1,https://pbs.twimg.com/media/ExRiVD3XEAUuqNs.jpg,,,,,,,[],,,,
1374831339019571206,1374762831501922306,2021-03-24 21:11:49 UTC,2021-03-24,21:11:49,+0000,59769395,niaidnews,NIAID News,,"On #WorldTBDay, NIAID renews its commitment to fighting #tuberculosis, one of the world‚Äôs leading causes of death from an infectious disease.  https://t.co/Sf0k3dUvaH",en,[],[],['https://pbs.twimg.com/media/ExRhwNGXIAA5at6.jpg'],2,2,8,"['worldtbday', 'tuberculosis']",[],https://twitter.com/NIAIDNews/status/1374831339019571206,False,,1,https://pbs.twimg.com/media/ExRhwNGXIAA5at6.jpg,,,,,,,[],,,,
1374762831501922306,1374762831501922306,2021-03-24 16:39:35 UTC,2021-03-24,16:39:35,+0000,59769395,niaidnews,NIAID News,,"On this #WorldTBDay, #NIAID joins global partners in resolve to #EndTB. #NIAIDNow blog has more  https://t.co/YNNsH78mAj",en,[],['https://bit.ly/2QrOG3w'],[],1,13,22,"['worldtbday', 'niaid', 'endtb', 'niaidnow']",[],https://twitter.com/NIAIDNews/status/1374762831501922306,False,,0,,,,,,,,[],,,,
1374027626839379969,1374027626839379969,2021-03-22 15:58:09 UTC,2021-03-22,15:58:09,+0000,59769395,niaidnews,NIAID News,,"NEWS: A new @NIAIDNews study aims to identify #prenatal and early #childhood markers of high risk for #FoodAllergy and #eczema, as well as biological pathways that lead to these conditions.  https://t.co/dM5Co9bk26   #AtopicDermatitis #atopy  https://t.co/OrNej1zniE",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['http://bit.ly/SUNBEAMstudy'],['https://pbs.twimg.com/media/ExGGoxHVoAExgwl.jpg'],0,0,11,"['prenatal', 'childhood', 'foodallergy', 'eczema', 'atopicdermatitis', 'atopy']",[],https://twitter.com/NIAIDNews/status/1374027626839379969,False,,1,https://pbs.twimg.com/media/ExGGoxHVoAExgwl.jpg,,,,,,,[],,,,
1372294061504204806,1372293875675635712,2021-03-17 21:09:34 UTC,2021-03-17,21:09:34,+0000,59769395,niaidnews,NIAID News,,"Results from these studies, first reported in Jan. 2021 at @HIVR4Px, inform development of long-acting #antibody-based #HIVPrevention tools &amp; ultimately an #HIV #vaccine.  https://t.co/7hyYNaDKZ4 #AMPStudy",en,"[{'screen_name': 'hivr4px', 'name': 'hivr4p', 'id': '2332232390'}]",['http://bit.ly/AMPefficacy'],[],0,1,10,"['antibody', 'hivprevention', 'hiv', 'vaccine', 'ampstudy']",[],https://twitter.com/NIAIDNews/status/1372294061504204806,False,,0,,,,,,,,[],,,,
1372293875675635712,1372293875675635712,2021-03-17 21:08:50 UTC,2021-03-17,21:08:50,+0000,59769395,niaidnews,NIAID News,,"#HIV NEWS: #Antibody infusions prevented acquisition of HIV strains sensitive to the antibody, but did not significantly reduce overall HIV acquisition among participants in 2 #NIAID-sponsored studies, researchers report in @NEJM.  https://t.co/TOkusAHy2q   üì∏: @HelpEndHIV  https://t.co/PAgpZ3qDkj",en,"[{'screen_name': 'nejm', 'name': 'nejm', 'id': '25950355'}, {'screen_name': 'helpendhiv', 'name': 'hvtn', 'id': '20549304'}]",['http://bit.ly/AMP-NEJM'],['https://pbs.twimg.com/media/Ewtdty4WUAER6Fw.jpg'],1,3,9,"['hiv', 'antibody', 'niaid']",[],https://twitter.com/NIAIDNews/status/1372293875675635712,False,,1,https://pbs.twimg.com/media/Ewtdty4WUAER6Fw.jpg,,,,,,,[],,,,
1371872333439369224,1371872325973458946,2021-03-16 17:13:47 UTC,2021-03-16,17:13:47,+0000,59769395,niaidnews,NIAID News,,"Approximately 6,750 pediatric participants in the U.S. and Canada will be carefully monitored to determine the safety and effectiveness of mRNA-1273 in children.  https://t.co/byEh2fuQdW",en,[],[],['https://pbs.twimg.com/media/EwneLXEW8AM8p6a.jpg'],0,4,10,[],[],https://twitter.com/NIAIDNews/status/1371872333439369224,False,,1,https://pbs.twimg.com/media/EwneLXEW8AM8p6a.jpg,,,,,,,[],,,,
1371872327877730304,1371872325973458946,2021-03-16 17:13:45 UTC,2021-03-16,17:13:45,+0000,59769395,niaidnews,NIAID News,,"The KidCOVE study will begin by enrolling children under 12 years old. As the trial progresses, it will enroll younger children as well, including those as young as 6 months old.  https://t.co/qpftXYQF3o",en,[],[],['https://pbs.twimg.com/media/EwneCZZXIAE9mIM.jpg'],2,5,8,[],[],https://twitter.com/NIAIDNews/status/1371872327877730304,False,,1,https://pbs.twimg.com/media/EwneCZZXIAE9mIM.jpg,,,,,,,[],,,,
1371872325973458946,1371872325973458946,2021-03-16 17:13:45 UTC,2021-03-16,17:13:45,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: In collaboration with @NIAIDNews and @BARDA, Moderna is conducting a Phase 2/3 study of the mRNA-1273 #COVID19 #vaccine in healthy children:  https://t.co/MDFaicY91W",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'barda', 'name': 'barda', 'id': '855482932173168640'}]",['https://clinicaltrials.gov/ct2/show/NCT04796896'],[],4,21,40,"['covid19', 'vaccine']",[],https://twitter.com/NIAIDNews/status/1371872325973458946,False,,0,,,,,,,,[],,,,
1371582919756644352,1371582919756644352,2021-03-15 22:03:45 UTC,2021-03-15,22:03:45,+0000,59769395,niaidnews,NIAID News,,"#PHAGE NEWS: As part of its antimicrobial resistance research program, NIAID has awarded funding to #bacteriophage research initiatives at 12 institutes. Learn more:  https://t.co/8accgNiSRQ  https://t.co/fVYV1gs5oQ",en,[],['http://bit.ly/PhageAwards'],['https://pbs.twimg.com/media/EwjXUobWgBAVZEd.jpg'],0,9,19,"['phage', 'bacteriophage']",[],https://twitter.com/NIAIDNews/status/1371582919756644352,False,,1,https://pbs.twimg.com/media/EwjXUobWgBAVZEd.jpg,,,,,,,[],,,,
1371437781113827338,1371437781113827338,2021-03-15 12:27:01 UTC,2021-03-15,12:27:01,+0000,59769395,niaidnews,NIAID News,,Interested in volunteering for a #COVID19 clinical study? Check out the COVID-19 Clinical Trials webpage to find a volunteer opportunity that is appropriate for you!  https://t.co/G3cClTkTAC  https://t.co/VBGARr0Rie,en,[],['https://bit.ly/3n8xhZB'],['https://pbs.twimg.com/media/EwhTZJ2WEAEAzFi.jpg'],0,5,6,['covid19'],[],https://twitter.com/NIAIDNews/status/1371437781113827338,False,,1,https://pbs.twimg.com/media/EwhTZJ2WEAEAzFi.jpg,,,,,,,[],,,,
1370488196555890688,1370488194232295424,2021-03-12 21:33:43 UTC,2021-03-12,21:33:43,+0000,59769395,niaidnews,NIAID News,,Another study found that #casirivimab with #imdevimab prevented symptomatic #COVID19 and #SARSCoV2 infection and reduced viral load among people at risk of COVID-19 from household transmission. #CROI2021  https://t.co/7bId6OvX9l,en,[],['https://ww2.aievolution.com/cro2101/index.cfm?do=abs.viewAbs&abs=2542'],[],1,1,4,"['casirivimab', 'imdevimab', 'covid19', 'sarscov2', 'croi2021']",[],https://twitter.com/NIAIDNews/status/1370488196555890688,False,,0,,,,,,,,[],,,,
1370488195402506240,1370488194232295424,2021-03-12 21:33:42 UTC,2021-03-12,21:33:42,+0000,59769395,niaidnews,NIAID News,,One study (#BLAZE2) found that #bamlanivimab was highly effective in reducing the incidence of symptomatic #COVID19 and #SARSCoV2 infection among skilled nursing facility residents considered at high risk for development of severe COVID-19. #CROI2021  https://t.co/6NBeYwD7W1,en,[],['https://ww2.aievolution.com/cro2101/index.cfm?do=abs.viewAbs&abs=2538'],[],2,2,6,"['blaze2', 'bamlanivimab', 'covid19', 'sarscov2', 'croi2021']",[],https://twitter.com/NIAIDNews/status/1370488195402506240,False,,0,,,,,,,,[],,,,
1370488194232295424,1370488194232295424,2021-03-12 21:33:42 UTC,2021-03-12,21:33:42,+0000,59769395,niaidnews,NIAID News,,COVID-19 NEWS: 2 studies presented at #CROI2021 had encouraging results for monoclonal antibodies (#mAbs) for prevention of #COVID19. Both trials began last summer &amp; enrolled participants at @PreventCOVID_19 network sites.  https://t.co/utJlh29gl2,en,"[{'screen_name': 'preventcovid_19', 'name': 'covid-19 prevention network', 'id': '1283097735025946624'}]",['https://www.niaid.nih.gov/news-events/niaid-clinical-trials-monoclonal-antibodies-prevent-covid-19-now-enrolling'],[],3,9,12,"['croi2021', 'mabs', 'covid19']",[],https://twitter.com/NIAIDNews/status/1370488194232295424,False,,0,,,,,,,,[],,,,
1370060976448495619,1370060976448495619,2021-03-11 17:16:05 UTC,2021-03-11,17:16:05,+0000,59769395,niaidnews,NIAID News,,"Researchers at the @NIHClinicalCntr seek individuals 2 &amp; older who have a food allergy to participate in a study to learn more about how food allergies affect nutritional health. To learn more, visit  https://t.co/bm4SkWwmYx #foodallergy #dietaryrestrictions #foodallergyawareness  https://t.co/TGpcPM1qLt",en,"[{'screen_name': 'nihclinicalcntr', 'name': 'nih clinical center', 'id': '20186316'}]",['https://go.usa.gov/xQYw9'],['https://pbs.twimg.com/media/EwNvMjAWUA0feLZ.jpg'],0,3,7,"['foodallergy', 'dietaryrestrictions', 'foodallergyawareness']",[],https://twitter.com/NIAIDNews/status/1370060976448495619,False,,1,https://pbs.twimg.com/media/EwNvMjAWUA0feLZ.jpg,,,,,,,[],,,,
1369753717394665472,1369753717394665472,2021-03-10 20:55:09 UTC,2021-03-10,20:55:09,+0000,59769395,niaidnews,NIAID News,,"NEWS: NIAID scientists use human #cerebralorganoid to test drug for Creutzfeldt-Jakob disease, a deadly brain disease.  https://t.co/7I4jAdCsyO  https://t.co/fdPciaQPfx",en,[],['https://bit.ly/38suYLi'],['https://pbs.twimg.com/media/EwJXmCcVEAE3077.jpg'],0,6,14,['cerebralorganoid'],[],https://twitter.com/NIAIDNews/status/1369753717394665472,False,,1,https://pbs.twimg.com/media/EwJXmCcVEAE3077.jpg,,,,,,,[],,,,
1369651805378973697,1369651805378973697,2021-03-10 14:10:11 UTC,2021-03-10,14:10:11,+0000,59769395,niaidnews,NIAID News,,"HIV BLOG: @NIAIDNews‚Äô Dr. Carl Dieffenbach spoke with @HIVgov about #HIV &amp; #COVID19, potential new #HIVPrevention tools, and other research highlights from #CROI2021. Watch the interview &amp; read more on #NIAIDNow:  https://t.co/EJUFst4etF",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'hivgov', 'name': 'hiv.gov', 'id': '15368404'}]",['http://bit.ly/CROI2021-highlights-1'],[],1,8,12,"['hiv', 'covid19', 'hivprevention', 'croi2021', 'niaidnow']",[],https://twitter.com/NIAIDNews/status/1369651805378973697,False,,0,,,,,,,,[],,,,
1367547231956516873,1367547231956516873,2021-03-04 18:47:22 UTC,2021-03-04,18:47:22,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: Following a DSMB recommendation, enrollment has closed in two sub-studies of a trial evaluating therapeutics for #COVID19 in hospitalized people. There were no safety concerns with either therapeutic.  https://t.co/gCUuw8vCcG",en,[],['http://bit.ly/ACTIV3BriiGSKVIRClosure'],[],3,5,16,['covid19'],[],https://twitter.com/NIAIDNews/status/1367547231956516873,False,,0,,,,,,,,[],,,,
1366807219010818049,1366807219010818049,2021-03-02 17:46:49 UTC,2021-03-02,17:46:49,+0000,59769395,niaidnews,NIAID News,,"Why does #SARSCoV2 have such a wide range of effects in children, from no symptoms to severe illness? The @NIH CARING for Children with COVID effort aims to find out by supporting research on #COVID19 in kids, including #MISC &amp; other conditions.  https://t.co/JhHntu61Aq #NIHCARING  https://t.co/F5eankIUVc",en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}]",['http://CARING4KidsWithCOVID.nih.gov'],['https://pbs.twimg.com/media/EvffjWnUcAIgZeL.jpg'],4,9,19,"['sarscov2', 'covid19', 'misc', 'nihcaring']",[],https://twitter.com/NIAIDNews/status/1366807219010818049,False,,1,https://pbs.twimg.com/media/EvffjWnUcAIgZeL.jpg,,,,,,,[],,,,
1364329375487778816,1364329375487778816,2021-02-23 21:40:45 UTC,2021-02-23,21:40:45,+0000,59769395,niaidnews,NIAID News,,NIAID mouse study shows #bacteriophage therapy could fight #drugresistant #Klebsiella pneumoniae.  https://t.co/vZnRpGqhFi  https://t.co/yGdGX8e018,en,[],['https://bit.ly/3keeGud'],['https://pbs.twimg.com/media/Eu8SOJ_UUAI3FHP.jpg'],5,1,16,"['bacteriophage', 'drugresistant', 'klebsiella']",[],https://twitter.com/NIAIDNews/status/1364329375487778816,False,,1,https://pbs.twimg.com/media/Eu8SOJ_UUAI3FHP.jpg,,,,,,,[],,,,
1364324425064013825,1364324425064013825,2021-02-23 21:21:05 UTC,2021-02-23,21:21:05,+0000,59769395,niaidnews,NIAID News,,Promising results in early #NIAID-sponsored #ClinicalTrial of monoclonal antibody combination to treat or prevent #MERS #coronavirus  https://t.co/gAhjC0JiHV  https://t.co/FWl0iVpmVa,en,[],['http://bit.ly/3aMSkg7'],['https://pbs.twimg.com/media/Eu8Ntj2VIAA6myZ.jpg'],6,7,19,"['niaid', 'clinicaltrial', 'mers', 'coronavirus']",[],https://twitter.com/NIAIDNews/status/1364324425064013825,False,,1,https://pbs.twimg.com/media/Eu8Ntj2VIAA6myZ.jpg,,,,,,,[],,,,
1363935466379124736,1363935466379124736,2021-02-22 19:35:30 UTC,2021-02-22,19:35:30,+0000,59769395,niaidnews,NIAID News,,NEWS: A @NIAIDNews-funded clinical trial has found that 1 week of topical treatment with a bacterium isolated from healthy human skin safely reduces the amount of #Staph aureus inflaming the skin of people with #eczema. #AtopicDermatitis @NatureMedicine  https://t.co/x6nLmHMPyk,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'naturemedicine', 'name': 'nature medicine', 'id': '26832834'}]",['https://www.nature.com/articles/s41591-021-01256-2'],[],2,3,14,"['staph', 'eczema', 'atopicdermatitis']",[],https://twitter.com/NIAIDNews/status/1363935466379124736,False,,0,,,,,,,,[],,,,
1362767700393660419,1362767700393660419,2021-02-19 14:15:13 UTC,2021-02-19,14:15:13,+0000,59769395,niaidnews,NIAID News,,"#HIV NEWS: By overcoming barriers to implementing HIV services and addressing #HealthDisparities, an end to the U.S. #HIVEpidemic remains attainable, experts write in @TheLancet. @NIDAnews  https://t.co/pjj15E4xkP  https://t.co/3mr3tJ68uV",en,"[{'screen_name': 'thelancet', 'name': 'the lancet', 'id': '27013292'}, {'screen_name': 'nidanews', 'name': 'nidanews', 'id': '102234123'}]",['http://bit.ly/HIVUSseries'],['https://pbs.twimg.com/media/EumEtlMXcAAAwqI.jpg'],3,6,13,"['hiv', 'healthdisparities', 'hivepidemic']",[],https://twitter.com/NIAIDNews/status/1362767700393660419,False,,1,https://pbs.twimg.com/media/EumEtlMXcAAAwqI.jpg,,,,,,,[],,,,
1362765474984062985,1362765470516932611,2021-02-19 14:06:22 UTC,2021-02-19,14:06:22,+0000,59769395,niaidnews,NIAID News,,The new findings have yet to be peer-reviewed but are available online as a pre-print  https://t.co/XI3NJMrVOi,en,[],['https://www.medrxiv.org/content/10.1101/2021.02.11.21251585v1'],[],1,1,1,[],[],https://twitter.com/NIAIDNews/status/1362765474984062985,False,,0,,,,,,,,[],,,,
1362765473713070082,1362765470516932611,2021-02-19 14:06:22 UTC,2021-02-19,14:06:22,+0000,59769395,niaidnews,NIAID News,,"The team built on this research by examining SARS-CoV-2 variants #B117 #B1351 #B11248 for overlap with the identified epitopes from the prior study &amp; found that virtually all CD8+ T-cell responses should recognize the variants, which should partly mediate protection from disease.",en,[],[],[],1,1,4,"['b117', 'b1351', 'b11248']",[],https://twitter.com/NIAIDNews/status/1362765473713070082,False,,0,,,,,,,,[],,,,
1362765472710545413,1362765470516932611,2021-02-19 14:06:22 UTC,2021-02-19,14:06:22,+0000,59769395,niaidnews,NIAID News,,"The researchers found that the majority of CD8+ T cells targeted internal and non-structural sites on viral proteins (epitopes), indicating possible targets for next-generation vaccines.",en,[],[],[],2,1,2,[],[],https://twitter.com/NIAIDNews/status/1362765472710545413,False,,0,,,,,,,,[],,,,
1362765471624224774,1362765470516932611,2021-02-19 14:06:22 UTC,2021-02-19,14:06:22,+0000,59769395,niaidnews,NIAID News,,T cells are a type of white blood cell part of the immune system &amp; may allow for long-term protection against #SARSCoV2. Learning more about natural infection can help guide development of improved treatments and vaccines.,en,[],[],[],1,0,1,['sarscov2'],[],https://twitter.com/NIAIDNews/status/1362765471624224774,False,,0,,,,,,,,[],,,,
1362765470516932611,1362765470516932611,2021-02-19 14:06:21 UTC,2021-02-19,14:06:21,+0000,59769395,niaidnews,NIAID News,,NIAID investigators and collaborators at @ImmunoScape and @JHUcovidplasma recently published a study in @jclinicalinvest characterizing #Tcell responses in people who recover from #SARSCoV2 infection.  https://t.co/eiIs6UT7eP,en,"[{'screen_name': 'immunoscape', 'name': 'immunoscape', 'id': '996511835078590464'}, {'screen_name': 'jhucovidplasma', 'name': 'johns hopkins covid-19 blood plasma research', 'id': '1258906461536768003'}, {'screen_name': 'jclinicalinvest', 'name': 'journal of clinical investigation', 'id': '223605846'}]",['https://www.jci.org/articles/view/145476'],[],2,10,19,"['tcell', 'sarscov2']",[],https://twitter.com/NIAIDNews/status/1362765470516932611,False,,0,,,,,,,,[],,,,
1362416141222744067,1362416141222744067,2021-02-18 14:58:15 UTC,2021-02-18,14:58:15,+0000,59769395,niaidnews,NIAID News,,"ICYMI: Some people with #SARSCoV2 infection experience a late ‚Äúsecond wave‚Äù of #ImmuneResponses that is associated with more severe #COVID19 &amp; death, according to @NIAIDNews research reported in @CellCellPress.  https://t.co/L122N3PmJ0  https://t.co/kHyd62cENc",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'cellcellpress', 'name': 'cell', 'id': '65134016'}]",['http://bit.ly/3a9zzmZ'],['https://pbs.twimg.com/media/EuhGF6vXcAMs1rF.jpg'],1,23,31,"['sarscov2', 'immuneresponses', 'covid19']",[],https://twitter.com/NIAIDNews/status/1362416141222744067,False,,1,https://pbs.twimg.com/media/EuhGF6vXcAMs1rF.jpg,,,,,,,[],,,,
1362072230226706442,1362072230226706442,2021-02-17 16:11:40 UTC,2021-02-17,16:11:40,+0000,59769395,niaidnews,NIAID News,,#COVID19 NEWS: A new @NIH-supported study will evaluate the effects of #remdesivir in hospitalized #pregnant women who have been prescribed the drug to treat COVID-19. @NICHD_NIH @NIMHgov @IMPAACTNetwork  https://t.co/1eTH1MYoCm  https://t.co/BAob28dNlI,en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}, {'screen_name': 'nichd_nih', 'name': 'nichd_nih', 'id': '378740424'}, {'screen_name': 'nimhgov', 'name': 'mental health nimh', 'id': '39250316'}, {'screen_name': 'impaactnetwork', 'name': 'impaact network', 'id': '1161317444696367104'}]",['http://bit.ly/RemdesivirPregnancy'],['https://pbs.twimg.com/media/EucNO6gXYAAN1Hi.jpg'],1,12,23,"['covid19', 'remdesivir', 'pregnant']",[],https://twitter.com/NIAIDNews/status/1362072230226706442,False,,1,https://pbs.twimg.com/media/EucNO6gXYAAN1Hi.jpg,,,,,,,[],,,,
1360279982971342849,1360279982971342849,2021-02-12 17:29:55 UTC,2021-02-12,17:29:55,+0000,59769395,niaidnews,NIAID News,,COVID-19 NEWS: #COVID19 #ClinicalTrial for people with mild or moderate symptoms expanding to test 4 more potential therapies in #NIAID-sponsored #ACTIV2 trial.  https://t.co/ONw4TjHBbM  https://t.co/tNoUJGLrWX,en,[],['http://bit.ly/3aerU6C'],['https://pbs.twimg.com/media/EuCvOVHVoAE8Tm2.jpg'],3,2,9,"['covid19', 'clinicaltrial', 'niaid', 'activ2']",[],https://twitter.com/NIAIDNews/status/1360279982971342849,False,,1,https://pbs.twimg.com/media/EuCvOVHVoAE8Tm2.jpg,,,,,,,[],,,,
1360266623622336514,1360266623622336514,2021-02-12 16:36:50 UTC,2021-02-12,16:36:50,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: In a new editorial in @JAMA_current, NIAID experts discuss the rise of variants of SARS-CoV-2, the virus which causes #COVID19:  https://t.co/ljkMGYwFDu  https://t.co/ByRN0rMKrL",en,"[{'screen_name': 'jama_current', 'name': 'jama', 'id': '38489678'}]",['http://bit.ly/JAMAVariantsEditorial'],['https://pbs.twimg.com/media/EuCi_8cU0AMEgoM.jpg'],0,9,9,['covid19'],[],https://twitter.com/NIAIDNews/status/1360266623622336514,False,,1,https://pbs.twimg.com/media/EuCi_8cU0AMEgoM.jpg,,,,,,,[],,,,
1359907829398736896,1359907829398736896,2021-02-11 16:51:07 UTC,2021-02-11,16:51:07,+0000,59769395,niaidnews,NIAID News,,"#Ebola monoclonal therapy recently approved by #FDA was the result of long-term basic and clinical research by #NIH scientists, including Dr. Nancy Sullivan and team at #NIAID #VaccineReseachCenter.  https://t.co/QqtM4h0U8W @IRPatNIH  https://t.co/auDBf3lse2",en,"[{'screen_name': 'irpatnih', 'name': 'nih intramural', 'id': '282741996'}]",['https://irp.nih.gov/blog/post/2021/02/an-ebola-therapy-two-decades-in-the-making'],['https://pbs.twimg.com/media/Et9ct5aVoAEFrvG.jpg'],1,8,14,"['ebola', 'fda', 'nih', 'niaid', 'vaccinereseachcenter']",[],https://twitter.com/NIAIDNews/status/1359907829398736896,False,,1,https://pbs.twimg.com/media/Et9ct5aVoAEFrvG.jpg,,,,,,,[],,,,
1359520346899058700,1359520083257643015,2021-02-10 15:11:24 UTC,2021-02-10,15:11:24,+0000,59769395,niaidnews,NIAID News,,"Changes in #NaturalKiller (NK) cells linked to high levels of the cell-signaling protein IL-15 were connected with greater #COVID19 severity, suggesting a potential therapeutic target.  https://t.co/bHrZQ8iZzH",en,[],[],['https://pbs.twimg.com/media/Et38be0UcAAlcFm.jpg'],1,3,10,"['naturalkiller', 'covid19']",[],https://twitter.com/NIAIDNews/status/1359520346899058700,False,,1,https://pbs.twimg.com/media/Et38be0UcAAlcFm.jpg,,,,,,,[],,,,
1359520083257643015,1359520083257643015,2021-02-10 15:10:21 UTC,2021-02-10,15:10:21,+0000,59769395,niaidnews,NIAID News,,#COVID19 NEWS: @NIAIDNews research published in @CellCellPress finds some people experience a late ‚Äúsecond wave‚Äù of immune responses to #SARSCoV2 infection that is associated with more severe disease &amp; death.  https://t.co/xnB6QfqtNg  https://t.co/8i1m2amUFg,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'cellcellpress', 'name': 'cell', 'id': '65134016'}]",['https://bit.ly/3a9zzmZ'],['https://pbs.twimg.com/media/Et373iwVEAIyuJy.jpg'],1,30,58,"['covid19', 'sarscov2']",[],https://twitter.com/NIAIDNews/status/1359520083257643015,False,,1,https://pbs.twimg.com/media/Et373iwVEAIyuJy.jpg,,,,,,,[],,,,
1359231054142267398,1359231054142267398,2021-02-09 20:01:51 UTC,2021-02-09,20:01:51,+0000,59769395,niaidnews,NIAID News,,"BLOG: #NIAID-funded research contributed to the recent approval of romiplostim (Nplate) for #AcuteRadiationSyndrome, expanding the toolbox of #MedicalCountermeasures available if a catastrophic event exposes people to high doses of #radiation.  https://t.co/bo4YVDpxb7   üì∏ @CDCgov  https://t.co/fpEzNMcTMN",en,"[{'screen_name': 'cdcgov', 'name': 'cdc', 'id': '146569971'}]",['http://bit.ly/HARSromiplostim'],['https://pbs.twimg.com/media/Etz0_GiVIAcjYQK.jpg'],0,3,5,"['niaid', 'acuteradiationsyndrome', 'medicalcountermeasures', 'radiation']",[],https://twitter.com/NIAIDNews/status/1359231054142267398,False,,1,https://pbs.twimg.com/media/Etz0_GiVIAcjYQK.jpg,,,,,,,[],,,,
1358891006830120965,1358891006830120965,2021-02-08 21:30:37 UTC,2021-02-08,21:30:37,+0000,59769395,niaidnews,NIAID News,,COVID-19 NEWS: Participants hospitalized with #COVID19 in a large Phase 3 clinical trial may now be randomized to receive a long-acting antibody combination therapeutic from @AstraZeneca:  https://t.co/mUQDOGW1WS  https://t.co/wOFVaPI7GG,en,"[{'screen_name': 'astrazeneca', 'name': 'astrazeneca', 'id': '62465691'}]",['http://bit.ly/ACTIV3AZ'],['https://pbs.twimg.com/media/Etu__mlUcAAST3X.jpg'],3,6,11,['covid19'],[],https://twitter.com/NIAIDNews/status/1358891006830120965,False,,1,https://pbs.twimg.com/media/Etu__mlUcAAST3X.jpg,,,,,,,[],,,,
1358788962295242754,1358788962295242754,2021-02-08 14:45:08 UTC,2021-02-08,14:45:08,+0000,59769395,niaidnews,NIAID News,,"Volunteers needed! There are several #COVID19 clinical studies ongoing to evaluate therapies and vaccine candidates, as well as studies of people who have recovered from infection. Visit  https://t.co/G3cClTCusa to see if there is a clinical study that you can volunteer for.",en,[],['https://bit.ly/3n8xhZB'],[],1,20,25,['covid19'],[],https://twitter.com/NIAIDNews/status/1358788962295242754,False,,0,,,,,,,,[],,,,
1357789714301014017,1357789714301014017,2021-02-05 20:34:29 UTC,2021-02-05,20:34:29,+0000,59769395,niaidnews,NIAID News,,"ICYMI: Yesterday, Dr. Fauci took part in a Twitter Q&amp;A with the White House COVID-19 Response Team. Learn about #vaccines, #COVID19 variants, and more in this thread:",en,[],[],[],7,9,14,"['vaccines', 'covid19']",[],https://twitter.com/NIAIDNews/status/1357789714301014017,False,https://twitter.com/WHCOVIDResponse/status/1357478718718038016,0,,,,,,,,[],,,,
1355518629442449418,1355518629442449418,2021-01-30 14:10:00 UTC,2021-01-30,14:10:00,+0000,59769395,niaidnews,NIAID News,,"BLOG: January 30th is World Neglected Tropical Diseases (NTD) Day. Learn about how NIAID is helping to #EndTheNeglect of NTDs and supporting the global effort to prevent, control, and eliminate these diseases on the #NIAIDNow blog:  https://t.co/NZA2CBRCZk #WorldNTDday #BeatNTDs  https://t.co/gP4Pg3LzZV",en,[],['http://bit.ly/NTDDay2021'],['https://pbs.twimg.com/media/Es--yAcXMAEBp7f.jpg'],0,23,41,"['endtheneglect', 'niaidnow', 'worldntdday', 'beatntds']",[],https://twitter.com/NIAIDNews/status/1355518629442449418,False,,1,https://pbs.twimg.com/media/Es--yAcXMAEBp7f.jpg,,,,,,,[],,,,
1355236002734850049,1355236002734850049,2021-01-29 19:26:56 UTC,2021-01-29,19:26:56,+0000,59769395,niaidnews,NIAID News,,NEWS: NIAID scientists identify mechanism of early #prion disease in the eyes. Understanding these developments in the eye can help scientists identify ways to slow disease. These findings also could apply to human #retinitis pigmentosa.  https://t.co/xLPH048d1e  https://t.co/4iMq2vNjvj,en,[],['https://bit.ly/2MCeO9W'],['https://pbs.twimg.com/media/Es7DvqnUcAMduyi.jpg'],0,2,8,"['prion', 'retinitis']",[],https://twitter.com/NIAIDNews/status/1355236002734850049,False,,1,https://pbs.twimg.com/media/Es7DvqnUcAMduyi.jpg,,,,,,,[],,,,
1354087247365201926,1354086912097660935,2021-01-26 15:22:12 UTC,2021-01-26,15:22:12,+0000,59769395,niaidnews,NIAID News,,"Findings from the @NIAIDNews-funded @AMPStudy, reported at @HIVR4Px, lay the foundation for future development of long-acting #antibody-based #HIV prevention tools and, ultimately, an HIV #vaccine.",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'ampstudy', 'name': 'the amp study', 'id': '3731511976'}, {'screen_name': 'hivr4px', 'name': 'hivr4p', 'id': '2332232390'}]",[],[],0,2,7,"['antibody', 'hiv', 'vaccine']",[],https://twitter.com/NIAIDNews/status/1354087247365201926,False,,0,,,,,,,,[],,,,
1354086912097660935,1354086912097660935,2021-01-26 15:20:52 UTC,2021-01-26,15:20:52,+0000,59769395,niaidnews,NIAID News,,"#HIVPrevention NEWS: Infusions of an anti-HIV #antibody prevented acquisition of #HIV strains sensitive to that antibody, but did not significantly reduce overall HIV acquisition after 80 weeks among #ClinicalTrial participants.  https://t.co/7hyYNaDKZ4 #HIVR4P  https://t.co/iWRhnzNidj",en,[],['http://bit.ly/AMPefficacy'],['https://pbs.twimg.com/media/EsquWYVXEAAC0mC.jpg'],2,18,31,"['hivprevention', 'antibody', 'hiv', 'clinicaltrial', 'hivr4p']",[],https://twitter.com/NIAIDNews/status/1354086912097660935,False,,1,https://pbs.twimg.com/media/EsquWYVXEAAC0mC.jpg,,,,,,,[],,,,
1351567801551450118,1351567801551450118,2021-01-19 16:30:49 UTC,2021-01-19,16:30:49,+0000,59769395,niaidnews,NIAID News,,"Healthcare providers must be able to explain the latest data supporting safety &amp; efficacy of #COVID19 #vaccines so they can strongly encourage #vaccination when appropriate while acknowledging uncertainty &amp; unknowns remain, @NIAIDNews scientists write:  https://t.co/sTnmnPfvx3  https://t.co/oqljZ6tpJZ",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['http://bit.ly/COVIDVaxCommunication'],['https://pbs.twimg.com/media/EsG7s6rUcAIC0Sm.jpg'],4,6,13,"['covid19', 'vaccines', 'vaccination']",[],https://twitter.com/NIAIDNews/status/1351567801551450118,False,,1,https://pbs.twimg.com/media/EsG7s6rUcAIC0Sm.jpg,,,,,,,[],,,,
1350132688384978944,1350132688384978944,2021-01-15 17:28:11 UTC,2021-01-15,17:28:11,+0000,59769395,niaidnews,NIAID News,,NEWS: NIAID #microbiota study identifies nutrient that helps prevent bacterial infection; #taurine could offer treatment benefit.  https://t.co/Q0AcCocILU  https://t.co/raWIwJpiZa,en,[],['https://bit.ly/3oJf1q6'],['https://pbs.twimg.com/media/EryiTT9VcAAKvIj.jpg'],4,11,22,"['microbiota', 'taurine']",[],https://twitter.com/NIAIDNews/status/1350132688384978944,False,,1,https://pbs.twimg.com/media/EryiTT9VcAAKvIj.jpg,,,,,,,[],,,,
1350080275380924418,1350080275380924418,2021-01-15 13:59:55 UTC,2021-01-15,13:59:55,+0000,59769395,niaidnews,NIAID News,,"BLOG: How do #fungal #infections take hold? By studying the #RareDisease #APECED, NIAID researchers uncovered an unexpected #immune mechanism that promotes susceptibility to fungal infections of the mucous membranes.  https://t.co/BK8jOQgDN0 @ScienceMagazine  https://t.co/scqdlrjelE",en,"[{'screen_name': 'sciencemagazine', 'name': 'science magazine', 'id': '32372834'}]",['http://bit.ly/APECED'],['https://pbs.twimg.com/media/ErxySI6WMAMfD9e.jpg'],0,11,26,"['fungal', 'infections', 'raredisease', 'apeced', 'immune']",[],https://twitter.com/NIAIDNews/status/1350080275380924418,False,,1,https://pbs.twimg.com/media/ErxySI6WMAMfD9e.jpg,,,,,,,[],,,,
1349771381601288192,1349771381601288192,2021-01-14 17:32:29 UTC,2021-01-14,17:32:29,+0000,59769395,niaidnews,NIAID News,,NEWS: NIAID scientists reveal #SARSCoV2 infection dynamics in lungs of African green monkeys.  https://t.co/VKOSvXzSID  https://t.co/1J6eT91IzC,en,[],['https://bit.ly/3nBnQRl'],['https://pbs.twimg.com/media/ErtZYF8UcAADPuX.jpg'],3,6,20,['sarscov2'],[],https://twitter.com/NIAIDNews/status/1349771381601288192,False,,1,https://pbs.twimg.com/media/ErtZYF8UcAADPuX.jpg,,,,,,,[],,,,
1349437945586057220,1349437945586057220,2021-01-13 19:27:32 UTC,2021-01-13,19:27:32,+0000,59769395,niaidnews,NIAID News,,"NEWS: Today, January 13, the NIH Director‚Äôs Wednesday Afternoon Lecture Series (WALS) will host a virtual lecture on milestones in genomic research. The lecture, hosted by @NIAIDNews and @genome_gov, can be viewed here:  https://t.co/UlaZC5wWdG",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'genome_gov', 'name': 'national human genome research institute', 'id': '223560830'}]",['https://videocast.nih.gov/watch=40165'],[],1,2,4,[],[],https://twitter.com/NIAIDNews/status/1349437945586057220,False,,0,,,,,,,,[],,,,
1349433297005264897,1349433297005264897,2021-01-13 19:09:03 UTC,2021-01-13,19:09:03,+0000,59769395,niaidnews,NIAID News,,"NEWS: NIAID scientists study #Salmonella swimming behavior as clues to infection, identifying a potential target for developing new antibacterial treatments to hinder bacteria from infecting cells and colonizing the gut.  https://t.co/ZZvmKTk6Vd  https://t.co/Z50FWwYyCy",en,[],['https://bit.ly/3i86HO4'],['https://pbs.twimg.com/media/EromMILVgAA24Qx.jpg'],0,8,8,['salmonella'],[],https://twitter.com/NIAIDNews/status/1349433297005264897,False,,1,https://pbs.twimg.com/media/EromMILVgAA24Qx.jpg,,,,,,,[],,,,
1348616957117878278,1348616957117878278,2021-01-11 13:05:13 UTC,2021-01-11,13:05:13,+0000,59769395,niaidnews,NIAID News,,Interested in volunteering for a #COVID19 clinical study? Check out the COVID-19 Clinical Trials webpage to find a volunteer opportunity that is appropriate for you!  https://t.co/DC9XbIEUNe,en,[],['http://bit.ly/3n8xhZB'],[],3,8,16,['covid19'],[],https://twitter.com/NIAIDNews/status/1348616957117878278,False,,0,,,,,,,,[],,,,
1346865762770833411,1346865762770833411,2021-01-06 17:06:36 UTC,2021-01-06,17:06:36,+0000,59769395,niaidnews,NIAID News,,"NEWS: Most people who recover from #COVID19 develop robust #ImmuneMemory against #SARSCoV2 that lasts for at least 6 to 8 months, suggests a @NIAIDNews-funded study published in @ScienceMagazine.  https://t.co/5Ic9JKLjSs  https://t.co/ZJdcEyvjXC",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'sciencemagazine', 'name': 'science magazine', 'id': '32372834'}]",['http://bit.ly/COVIDImmuneMemory'],['https://pbs.twimg.com/media/ErEHB8QXAAAZ-Vl.jpg'],3,43,94,"['covid19', 'immunememory', 'sarscov2']",[],https://twitter.com/NIAIDNews/status/1346865762770833411,False,,1,https://pbs.twimg.com/media/ErEHB8QXAAAZ-Vl.jpg,,,,,,,[],,,,
1346528350634971136,1346528350634971136,2021-01-05 18:45:50 UTC,2021-01-05,18:45:50,+0000,59769395,niaidnews,NIAID News,,COVID-19 NEWS: A #NIAID-supported clinical trial to evaluate a combination monoclonal #antibody therapy has begun to enroll people who have mild or moderate #COVID19. The Phase 2/3 ACTIV-2 trial will test the safety and efficacy of BRII-196 and BRII-198.  https://t.co/5UHoZLm1sc  https://t.co/eoJXRHiAVI,en,[],['http://bit.ly/ACTIV2Brii'],['https://pbs.twimg.com/media/Eq_UQ-9WMAIPEss.jpg'],8,9,22,"['niaid', 'antibody', 'covid19']",[],https://twitter.com/NIAIDNews/status/1346528350634971136,False,,1,https://pbs.twimg.com/media/Eq_UQ-9WMAIPEss.jpg,,,,,,,[],,,,
1345021973571674114,1345021973571674114,2021-01-01 15:00:02 UTC,2021-01-01,15:00:02,+0000,59769395,niaidnews,NIAID News,,"#ScienceHighlights2020: #HappyNewYear! As 2021 begins, @NIAIDNews looks back at a productive 2020, with scientific research advances in #COVID19, #HIV, #tuberculosis, #eczema &amp; many other areas:  https://t.co/0XB3M9qiAZ  https://t.co/iTCwqAYhAX",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['http://bit.ly/2020NIAIDHighlights'],['https://pbs.twimg.com/tweet_video_thumb/Eqa1s7MXYAcivnt.jpg'],6,8,21,"['sciencehighlights2020', 'happynewyear', 'covid19', 'hiv', 'tuberculosis', 'eczema']",[],https://twitter.com/NIAIDNews/status/1345021973571674114,False,,1,https://pbs.twimg.com/tweet_video_thumb/Eqa1s7MXYAcivnt.jpg,,,,,,,[],,,,
1344694563181481985,1344694563181481985,2020-12-31 17:19:01 UTC,2020-12-31,17:19:01,+0000,59769395,niaidnews,NIAID News,,NEWS: NIAID scientists further validate #RTQuIC test to diagnose #Parkinson‚Äôs disease. Spinal fluid sample yields result in 1-2 days with high accuracy.  https://t.co/JkHnJm6ojc,en,[],['https://bit.ly/3pv3Jpo'],[],0,2,13,"['rtquic', 'parkinson']",[],https://twitter.com/NIAIDNews/status/1344694563181481985,False,,0,,,,,,,,[],,,,
1344691367339933697,1344691367339933697,2020-12-31 17:06:19 UTC,2020-12-31,17:06:19,+0000,59769395,niaidnews,NIAID News,,NEJM paper details mRNA-1273 vaccine's 94.1% efficacy in preventing symptomatic COVID-19 when tested in Phase 3 clinical trial. Vaccine co-developed by Moderna and NIH also effective at preventing severe COVID-19. Study findings at: DOI: 10.1056/NEJMoa2035389 (2020).,en,[],[],[],1,9,25,[],[],https://twitter.com/NIAIDNews/status/1344691367339933697,False,,0,,,,,,,,[],,,,
1344282091098259457,1344282091098259457,2020-12-30 14:00:00 UTC,2020-12-30,14:00:00,+0000,59769395,niaidnews,NIAID News,,"#ScienceHighlights2020 üî¨: This year, researchers made enormous strides in understanding, preventing &amp; treating #COVID19. Other work brought scientific advances in #HIV, #tuberculosis, #eczema &amp; many additional areas:  https://t.co/0XB3M9qiAZ  https://t.co/sfiwobsGbR",en,[],['http://bit.ly/2020NIAIDHighlights'],['https://pbs.twimg.com/tweet_video_thumb/Eqa1k2pXEAYttK-.jpg'],1,12,20,"['sciencehighlights2020', 'covid19', 'hiv', 'tuberculosis', 'eczema']",[],https://twitter.com/NIAIDNews/status/1344282091098259457,False,,1,https://pbs.twimg.com/tweet_video_thumb/Eqa1k2pXEAYttK-.jpg,,,,,,,[],,,,
1344024492306120704,1344024480926978048,2020-12-29 20:56:24 UTC,2020-12-29,20:56:24,+0000,59769395,niaidnews,NIAID News,,"#Ebanga is the 1st product discovered and developed by NIAID‚Äôs Vaccine Research Center to receive @FDA license approval and builds upon tools and experience from HIV research. VRC integrates research, process development, manufacturing, clinical testing and sample evaluation.",en,"[{'screen_name': 'fda', 'name': 'fda', 'id': '1255526396807561217'}]",[],[],0,2,6,['ebanga'],[],https://twitter.com/NIAIDNews/status/1344024492306120704,False,,0,,,,,,,,[],,,,
1344024491190435841,1344024480926978048,2020-12-29 20:56:24 UTC,2020-12-29,20:56:24,+0000,59769395,niaidnews,NIAID News,,#Ebanga was licensed to Ridgeback Biotherapeutics in Dec. 2018. Ridgeback and @BARDA partnered in September 2019 for late-stage manufacturing and regulatory activities to support licensure.  https://t.co/MC6QX6YsXd,en,"[{'screen_name': 'barda', 'name': 'barda', 'id': '855482932173168640'}]",['https://medicalcountermeasures.gov/newsroom/2020/ridgeback/'],[],1,0,1,['ebanga'],[],https://twitter.com/NIAIDNews/status/1344024491190435841,False,,0,,,,,,,,[],,,,
1344024489768615937,1344024480926978048,2020-12-29 20:56:23 UTC,2020-12-29,20:56:23,+0000,59769395,niaidnews,NIAID News,,The #PALM trial ended early (in Aug 2019) due to data showing patients receiving #Ebanga or REGN-EB3 (Inmazeb) had a greater chance of surviving Ebola virus disease. The findings were confirmed in a Nov. 2019 publication  https://t.co/8ZmMQHsyr7  https://t.co/UzDy40tpj6,en,[],['https://www.niaid.nih.gov/news-events/investigational-drugs-reduce-risk-death-ebola-virus-disease'],['https://pbs.twimg.com/media/EqbrtoKUcAAAKLr.png'],1,0,1,"['palm', 'ebanga']",[],https://twitter.com/NIAIDNews/status/1344024489768615937,False,,1,https://pbs.twimg.com/media/EqbrtoKUcAAAKLr.png,,,,,,,[],,,,
1344024487742717952,1344024480926978048,2020-12-29 20:56:23 UTC,2020-12-29,20:56:23,+0000,59769395,niaidnews,NIAID News,,"In Aug. 2018, the #DRC declared the country‚Äôs 10th outbreak of #EVD. In Nov. 2018, @inrb_kinshasa and #NIAID (with @WHO support) began a randomized, controlled trial of multiple investigational Ebola therapies, including #Ebanga, in the #DRC.  https://t.co/ZEaMzAz7dB  https://t.co/NpNKSjfyPu",en,"[{'screen_name': 'inrb_kinshasa', 'name': 'institut national de recherche biom√©dicale (inrb)', 'id': '1158376400635748352'}, {'screen_name': 'who', 'name': 'world health organization (who)', 'id': '14499829'}]",['https://www.niaid.nih.gov/news-events/clinical-trial-investigational-ebola-treatments-begins-democratic-republic-congo'],['https://pbs.twimg.com/media/EqbpJBCVQAA5jp4.jpg'],1,0,0,"['drc', 'evd', 'niaid', 'ebanga', 'drc']",[],https://twitter.com/NIAIDNews/status/1344024487742717952,False,,1,https://pbs.twimg.com/media/EqbpJBCVQAA5jp4.jpg,,,,,,,[],,,,
1344024484337000448,1344024480926978048,2020-12-29 20:56:22 UTC,2020-12-29,20:56:22,+0000,59769395,niaidnews,NIAID News,,"In May 2018, NIAID (with @DARPA support) began enrolling healthy volunteers in a Phase 1 clinical trial of #Ebanga at the @NIHClinicalCntr. Results published in Jan. 2019 showed the therapy is safe, well-tolerated, and easy to administer.  https://t.co/cSVobDBPIQ",en,"[{'screen_name': 'darpa', 'name': 'darpa', 'id': '54645160'}, {'screen_name': 'nihclinicalcntr', 'name': 'nih clinical center', 'id': '20186316'}]",['https://www.niaid.nih.gov/news-events/investigational-monoclonal-antibody-treat-ebola-safe-adults'],[],1,0,1,['ebanga'],[],https://twitter.com/NIAIDNews/status/1344024484337000448,False,,0,,,,,,,,[],,,,
1344024483124768768,1344024480926978048,2020-12-29 20:56:22 UTC,2020-12-29,20:56:22,+0000,59769395,niaidnews,NIAID News,,"Together with @MTamfum, @inrb_kinshasa &amp; the Institute for Research in Biomedicine (Switzerland), Dr. Nancy Sullivan &amp; her team at NIAID‚Äôs VRC isolated #Ebanga from a survivor of the 1995 Kikwit Ebola outbreak. Preclinical studies showed promise:  https://t.co/Aq0mYgvGZl",en,"[{'screen_name': 'mtamfum', 'name': 'muyembe tamfum', 'id': '1133327209735884801'}, {'screen_name': 'inrb_kinshasa', 'name': 'institut national de recherche biom√©dicale (inrb)', 'id': '1158376400635748352'}]",['https://www.niaid.nih.gov/news-events/experimental-ebola-antibody-protects-monkeys'],[],1,0,0,['ebanga'],[],https://twitter.com/NIAIDNews/status/1344024483124768768,False,,0,,,,,,,,[],,,,
1344024482059448321,1344024480926978048,2020-12-29 20:56:21 UTC,2020-12-29,20:56:21,+0000,59769395,niaidnews,NIAID News,,A longstanding research partnership between #NIAID scientists and their collaborators in the Democratic Republic of the Congo (#DRC) made this significant achievement possible.,en,[],[],[],1,0,0,"['niaid', 'drc']",[],https://twitter.com/NIAIDNews/status/1344024482059448321,False,,0,,,,,,,,[],,,,
1344024480926978048,1344024480926978048,2020-12-29 20:56:21 UTC,2020-12-29,20:56:21,+0000,59769395,niaidnews,NIAID News,,"#EBOLA NEWS: Last week, @FDA approved a single human monoclonal antibody now known as #Ebanga (Ansuvimab-zykl, #mAb114), for the treatment for Zaire ebolavirus (Ebolavirus) infection in adults and children.   https://t.co/VZiH1Rrq0y",en,"[{'screen_name': 'fda', 'name': 'fda', 'id': '1255526396807561217'}]",['https://www.fda.gov/drugs/drug-safety-and-availability/fda-approves-treatment-ebola-virus'],[],5,4,19,"['ebola', 'ebanga', 'mab114']",[],https://twitter.com/NIAIDNews/status/1344024480926978048,False,,0,,,,,,,,[],,,,
1341744766287970305,1341744766287970305,2020-12-23 13:57:35 UTC,2020-12-23,13:57:35,+0000,59769395,niaidnews,NIAID News,,COVID-19 NEWS: now published in @NEJM: results of a clinical trial testing LY-CoV555 in hospitalized #COVID19 patients showed that it did not provide clinical benefit compared to placebo in that patient population.  https://t.co/y3z6NLTdaU  https://t.co/ESj8Fb5Qvm,en,"[{'screen_name': 'nejm', 'name': 'nejm', 'id': '25950355'}]",['http://bit.ly/38wv2Je'],['https://pbs.twimg.com/media/Ep7Vp5OUwAA8kxr.jpg'],8,15,22,['covid19'],[],https://twitter.com/NIAIDNews/status/1341744766287970305,False,,1,https://pbs.twimg.com/media/Ep7Vp5OUwAA8kxr.jpg,,,,,,,[],,,,
1341135816584798208,1341134969712861189,2020-12-21 21:37:50 UTC,2020-12-21,21:37:50,+0000,59769395,niaidnews,NIAID News,,.@NIAIDNews scientists demonstrate deep phenotyping of human tissues using IBEX and commercially available antibodies by visualizing #immune interactions in a mesenteric #LymphNode with #GerminalCenters:  https://t.co/Lq1MM5omAl,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",[],[],0,2,7,"['immune', 'lymphnode', 'germinalcenters']",[],https://twitter.com/NIAIDNews/status/1341135816584798208,False,,1,https://pbs.twimg.com/ext_tw_video_thumb/1341135734565167104/pu/img/Db4r4SK1YSElWRUm.jpg,,,,,,,[],,,,
1341135313553534976,1341134969712861189,2020-12-21 21:35:50 UTC,2020-12-21,21:35:50,+0000,59769395,niaidnews,NIAID News,,"IBEX can be applied to capture ultra-high content data from human tissues, as @NIAIDNews scientists demonstrate by visualizing #tumor-#immune interactions in a pancreatic #LymphNode with #metastatic lesions:  https://t.co/UlkhNBnM2L",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",[],['https://pbs.twimg.com/media/EpyrYTlW4AEGxDY.jpg'],2,2,7,"['tumor', 'immune', 'lymphnode', 'metastatic']",[],https://twitter.com/NIAIDNews/status/1341135313553534976,False,,1,https://pbs.twimg.com/media/EpyrYTlW4AEGxDY.jpg,,,,,,,[],,,,
1341134969712861189,1341134969712861189,2020-12-21 21:34:28 UTC,2020-12-21,21:34:28,+0000,59769395,niaidnews,NIAID News,,"NEWS: @NIAIDNews researchers have developed a new #OpenSource method for highly #multiplex tissue imaging, called IBEX, that can be integrated into most current lab workflows. Read more in @PNASNews:  https://t.co/YBuqq7eSzL  https://t.co/B698gpDMAM",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'pnasnews', 'name': 'pnasnews', 'id': '258847118'}]",['http://bit.ly/IBEX-PNAS'],['https://pbs.twimg.com/media/EpyrCLIWwAMwWnZ.jpg'],3,25,36,"['opensource', 'multiplex']",[],https://twitter.com/NIAIDNews/status/1341134969712861189,False,,1,https://pbs.twimg.com/media/EpyrCLIWwAMwWnZ.jpg,,,,,,,[],,,,
1341116712519757824,1341116712519757824,2020-12-21 20:21:55 UTC,2020-12-21,20:21:55,+0000,59769395,niaidnews,NIAID News,,"NIAID Director, Dr. Anthony Fauci will be rolling up his sleeve tomorrow to get @moderna_tx #COVID19 vaccine alongside @SecAzar, @NIHDirector, and several @NIHClinicalCntr frontline workers to build confidence in the vaccine, which is the best hope against this pandemic.  https://t.co/q8uu6vMs1E",en,"[{'screen_name': 'moderna_tx', 'name': 'moderna', 'id': '2227355222'}, {'screen_name': 'secazar', 'name': 'alex azar', 'id': '956283913835614208'}, {'screen_name': 'nihdirector', 'name': 'francis s. collins', 'id': '124237063'}, {'screen_name': 'nihclinicalcntr', 'name': 'nih clinical center', 'id': '20186316'}]",[],['https://pbs.twimg.com/media/EpyZbjhUUAIkTXx.jpg'],62,202,974,['covid19'],[],https://twitter.com/NIAIDNews/status/1341116712519757824,False,,1,https://pbs.twimg.com/media/EpyZbjhUUAIkTXx.jpg,,,,,,,[],,,,
1341114742060929025,1341114742060929025,2020-12-21 20:14:05 UTC,2020-12-21,20:14:05,+0000,59769395,niaidnews,NIAID News,,"NEWS: NIAID scientists suggest #Reston #ebolavirus be considered a livestock pathogen with potential to affect other mammals, including people, based on a new study of pigs.  https://t.co/zu07sOgyzD  https://t.co/gJqj1BOmxy",en,[],['https://bit.ly/3h7SEHM'],['https://pbs.twimg.com/media/EpyYni1VgAAGbjS.png'],1,10,19,"['reston', 'ebolavirus']",[],https://twitter.com/NIAIDNews/status/1341114742060929025,False,,1,https://pbs.twimg.com/media/EpyYni1VgAAGbjS.png,,,,,,,[],,,,
1339671063844667392,1339671063844667392,2020-12-17 20:37:26 UTC,2020-12-17,20:37:26,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: Today, two Phase 3 trials to test potential therapeutics for #COVID19 began enrolling participants. The two trials, part of the ACTIV-3 master protocol, will test monoclonal #antibody therapeutics in hospitalized participants.  https://t.co/iWgSCbSnCC  https://t.co/oCJEiI2ONp",en,[],['http://bit.ly/ACTIV3-GSK-VIR-Brii'],['https://pbs.twimg.com/media/Epd2qg-VEAELFLS.jpg'],1,19,46,"['covid19', 'antibody']",[],https://twitter.com/NIAIDNews/status/1339671063844667392,False,,1,https://pbs.twimg.com/media/Epd2qg-VEAELFLS.jpg,,,,,,,[],,,,
1339308308977618947,1339308308977618947,2020-12-16 20:35:58 UTC,2020-12-16,20:35:58,+0000,59769395,niaidnews,NIAID News,,"#COVID19 NEWS: @NIAIDNews has launched a study to evaluate short- and long-term health outcomes of #SARSCoV2 infection in #children, including MIS-C, and to characterize immunologic pathways associated with different disease presentations and outcomes.  https://t.co/vnz0ivYn9E  https://t.co/34O90CRA5S",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['http://bit.ly/SARSCoV2inKids'],['https://pbs.twimg.com/media/EpYtnoMVoAADqZt.jpg'],0,14,13,"['covid19', 'sarscov2', 'children']",[],https://twitter.com/NIAIDNews/status/1339308308977618947,False,,1,https://pbs.twimg.com/media/EpYtnoMVoAADqZt.jpg,,,,,,,[],,,,
1337460023807643648,1337460023807643648,2020-12-11 18:11:33 UTC,2020-12-11,18:11:33,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: Today, a #NIAID study of #baricitinib and #remdesivir for people hospitalized with #COVID19 published in @NEJM. Participants who received the combination did better than those who received remdesivir alone.  https://t.co/CxnUNNROy5  https://t.co/G98q7KsVsV",en,"[{'screen_name': 'nejm', 'name': 'nejm', 'id': '25950355'}]",['http://bit.ly/ACTT2NEJM'],['https://pbs.twimg.com/media/Eo-cq4BXUAAcHjr.jpg'],4,27,49,"['niaid', 'baricitinib', 'remdesivir', 'covid19']",[],https://twitter.com/NIAIDNews/status/1337460023807643648,False,,1,https://pbs.twimg.com/media/Eo-cq4BXUAAcHjr.jpg,,,,,,,[],,,,
1334603847973679104,1334603841883566082,2020-12-03 21:02:07 UTC,2020-12-03,21:02:07,+0000,59769395,niaidnews,NIAID News,,Natural infection with SARS-CoV-2 does not always lead to durable immunity to the virus. These results suggest that the mRNA-1273 vaccine could provide long-term protection.  https://t.co/oCGhEHkWEz,en,[],[],['https://pbs.twimg.com/media/EoV2tqnXUAwFuOM.jpg'],2,17,41,[],[],https://twitter.com/NIAIDNews/status/1334603847973679104,False,,1,https://pbs.twimg.com/media/EoV2tqnXUAwFuOM.jpg,,,,,,,[],,,,
1334603845993979906,1334603841883566082,2020-12-03 21:02:07 UTC,2020-12-03,21:02:07,+0000,59769395,niaidnews,NIAID News,,"Participants had sustained, elevated levels of #antibodies against the virus which causes #COVID19, despite some decline in antibody titers over time. This suggests that the vaccine could provide durable humoral immunity against the virus.",en,[],[],[],1,4,15,"['antibodies', 'covid19']",[],https://twitter.com/NIAIDNews/status/1334603845993979906,False,,0,,,,,,,,[],,,,
1334603843649331203,1334603841883566082,2020-12-03 21:02:06 UTC,2020-12-03,21:02:06,+0000,59769395,niaidnews,NIAID News,,"The study tracked participants for 119 days after receiving their first dose of the vaccine; three months after the second dose. Blood tests were used to track the levels of antibodies against SARS-CoV-2, the virus which causes #COVID19, in their blood.  https://t.co/JWLxLupGcU",en,[],[],['https://pbs.twimg.com/media/EoV2bQFXYAM2HJy.jpg'],1,1,5,['covid19'],[],https://twitter.com/NIAIDNews/status/1334603843649331203,False,,1,https://pbs.twimg.com/media/EoV2bQFXYAM2HJy.jpg,,,,,,,[],,,,
1334603841883566082,1334603841883566082,2020-12-03 21:02:06 UTC,2020-12-03,21:02:06,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: In a letter published in @NEJM today, researchers from #NIAID and partners describe the long-term immunogenicity results from a phase 1 trial of the mRNA-1273 #COVID19 #vaccine:  https://t.co/CKWoz07Npd",en,"[{'screen_name': 'nejm', 'name': 'nejm', 'id': '25950355'}]",['https://www.nejm.org/doi/full/10.1056/NEJMc2032195?query=featured_home'],[],8,20,37,"['niaid', 'covid19', 'vaccine']",[],https://twitter.com/NIAIDNews/status/1334603841883566082,False,,0,,,,,,,,[],,,,
1333778025855528960,1333778025855528960,2020-12-01 14:20:36 UTC,2020-12-01,14:20:36,+0000,59769395,niaidnews,NIAID News,,"On #WorldAIDSDay, @NIH reflects on both the remarkable progress that has been made against #HIV &amp; the considerable challenges that remain. Read a statement from @NIAIDNews Director Dr. Fauci &amp; @NIH_OAR Director Dr. Goodenow:  https://t.co/z2zvEeUbLI  https://t.co/uduqTGysoI",en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}, {'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'nih_oar', 'name': 'nih oar', 'id': '918210614090256385'}]",['https://bit.ly/NIHWAD2020'],['https://pbs.twimg.com/media/EoKH0ewXcAAx6DV.jpg'],1,19,45,"['worldaidsday', 'hiv']",[],https://twitter.com/NIAIDNews/status/1333778025855528960,False,,1,https://pbs.twimg.com/media/EoKH0ewXcAAx6DV.jpg,,,,,,,[],,,,
1333507438063083523,1333507438063083523,2020-11-30 20:25:23 UTC,2020-11-30,20:25:23,+0000,59769395,niaidnews,NIAID News,,#HIV NEWS: @NIAIDNews today announced the investigators &amp; institutions that will lead 4 @NIH HIV #ClinicalTrials networks over the next 7 years. NIAID also awarded grants to 35 institutions selected as HIV clinical trials units.  https://t.co/5ztbXPSrgR  https://t.co/OTDbLyZgkp,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}]",['https://bit.ly/HIVnetworks'],['https://pbs.twimg.com/media/EoGR5f9XEAgTkwN.jpg'],3,10,21,"['hiv', 'clinicaltrials']",[],https://twitter.com/NIAIDNews/status/1333507438063083523,False,,1,https://pbs.twimg.com/media/EoGR5f9XEAgTkwN.jpg,,,,,,,[],,,,
1333493097745956864,1333493097745956864,2020-11-30 19:28:24 UTC,2020-11-30,19:28:24,+0000,59769395,niaidnews,NIAID News,,#PeanutAllergy NEWS: @NIAIDNews is supporting a study to improve #pediatric clinicians‚Äô adherence to the Addendum Guidelines for the Prevention of #Peanut #Allergy using an education module and a new tool in the Electronic Health Record.  https://t.co/iRXqvnjCOG  https://t.co/QKF2EoP44a,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://clinicaltrials.gov/ct2/show/NCT04604431'],['https://pbs.twimg.com/media/EoGEzxLVQAE7_eh.jpg'],1,3,9,"['peanutallergy', 'pediatric', 'peanut', 'allergy']",[],https://twitter.com/NIAIDNews/status/1333493097745956864,False,,1,https://pbs.twimg.com/media/EoGEzxLVQAE7_eh.jpg,,,,,,,[],,,,
1333476599367307269,1333476599367307269,2020-11-30 18:22:50 UTC,2020-11-30,18:22:50,+0000,59769395,niaidnews,NIAID News,,NEWS: An experimental vaccine developed in Europe to prevent infection by #Crimean Congo hemorrhagic fever virus has protected cynomolgus macaques in a new NIAID collaborative study.  https://t.co/SrGKY3mwac  https://t.co/g67JhUPUvR,en,[],['https://bit.ly/3o9F1dv'],['https://pbs.twimg.com/media/EoF1xQCVcAA-U_N.jpg'],0,4,12,['crimean'],[],https://twitter.com/NIAIDNews/status/1333476599367307269,False,,1,https://pbs.twimg.com/media/EoF1xQCVcAA-U_N.jpg,,,,,,,[],,,,
1331645560323969026,1331645560323969026,2020-11-25 17:06:57 UTC,2020-11-25,17:06:57,+0000,59769395,niaidnews,NIAID News,,"NEWS: Spatial organization of #ImmuneCells in the liver is induced &amp; sustained by interactions w/ the #microbiome &amp; #endothelium and plays a critical role in protection against blood-borne pathogens, @NIAIDNews scientists report in @nature.  https://t.co/jE6CJrtavg",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'nature', 'name': 'nature', 'id': '15862891'}]",['https://go.nature.com/378OsD9'],[],2,0,9,"['immunecells', 'microbiome', 'endothelium']",[],https://twitter.com/NIAIDNews/status/1331645560323969026,False,,0,,,,,,,,[],,,,
1329863740452429826,1329863588320833541,2020-11-20 19:06:38 UTC,2020-11-20,19:06:38,+0000,59769395,niaidnews,NIAID News,,"The study, which was conducted by members of the @ARLGnetwork, also suggests that IV minocycline may need to be paired with other drugs in these critically-ill patients. #WAAW",en,"[{'screen_name': 'arlgnetwork', 'name': 'antibacterial resistance leadership group', 'id': '1177311688434966528'}]",[],[],1,2,6,['waaw'],[],https://twitter.com/NIAIDNews/status/1329863740452429826,False,,0,,,,,,,,[],,,,
1329863588320833541,1329863588320833541,2020-11-20 19:06:01 UTC,2020-11-20,19:06:01,+0000,59769395,niaidnews,NIAID News,,"NEWS: Multi-drug resistant #bacteria, such as A. baumannii, can cause #infections which are sometimes treated with IV minocycline. A study supported by #NIAID suggests that this #antibiotic may not reach needed blood levels in critically-ill patients:  https://t.co/rqjeTyWGWH",en,[],['https://pubmed.ncbi.nlm.nih.gov/33168615/'],[],2,14,28,"['bacteria', 'infections', 'niaid', 'antibiotic']",[],https://twitter.com/NIAIDNews/status/1329863588320833541,False,,0,,,,,,,,[],,,,
1329487559806763010,1329487559806763010,2020-11-19 18:11:49 UTC,2020-11-19,18:11:49,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: NIAID-supported study by scientists at @StJude shows that TNF-Œ± and IFN-Œ≥ synergistically drive inflammatory cell death, tissue damage and mortality in #COVID19 and other #cytokine shock syndromes:  https://t.co/B0luCQUjNv",en,"[{'screen_name': 'stjude', 'name': 'st. jude', 'id': '9624042'}]",['https://www.cell.com/cell/fulltext/S0092-8674(20)31542-7'],[],3,9,21,"['covid19', 'cytokine']",[],https://twitter.com/NIAIDNews/status/1329487559806763010,False,,0,,,,,,,,[],,,,
1328700793101320192,1328700793101320192,2020-11-17 14:05:29 UTC,2020-11-17,14:05:29,+0000,59769395,niaidnews,NIAID News,,NEWS: A ‚Äúminimal monitoring‚Äù approach to delivering #hepatitisC treatment is safe &amp; results in similarly high cure rates as standard approaches. The approach could facilitate #HepC treatment implementation in resource-limited areas. @ACTGNetwork #TLMDx  https://t.co/17IJHe8wrb,en,"[{'screen_name': 'actgnetwork', 'name': 'actg network', 'id': '361405892'}]",['https://bit.ly/MinmonStudy'],[],0,4,7,"['hepatitisc', 'hepc', 'tlmdx']",[],https://twitter.com/NIAIDNews/status/1328700793101320192,False,,0,,,,,,,,[],,,,
1328326243733753856,1326185693408763904,2020-11-16 13:17:10 UTC,2020-11-16,13:17:10,+0000,59769395,niaidnews,NIAID News,,@NIH NIAID also offers AccessClinicalData@NIAID for reports and data sets from NIAID COVID-19 and other sponsored clinical trials for the basic and clinical research community.  https://t.co/bHdJxWVvGz,en,[],['http://bit.ly/AccessClinicalData'],[],1,2,7,[],[],https://twitter.com/NIAIDNews/status/1328326243733753856,False,,0,,,,,,,,"[{'screen_name': 'NIH', 'name': 'NIH', 'id': '15134240'}]",,,,
1327325992357044225,1327325992357044225,2020-11-13 19:02:31 UTC,2020-11-13,19:02:31,+0000,59769395,niaidnews,NIAID News,,"NEWS: Over 3 months, 39% of #HIV-vulnerable men &amp; trans people who have sex w men reported inhalant use; 13% reported methamphetamine use. Geographic, socio-economic factors influenced type, rate of #SubstanceUse.  https://t.co/gOvfJpAOdH  @CUNYSPH #LGBTHealth",en,"[{'screen_name': 'cunysph', 'name': 'cuny grad school of public health & health policy', 'id': '277659827'}]",['http://doi.org/10.1080/10826084.2020.1843057'],[],3,8,10,"['hiv', 'substanceuse', 'lgbthealth']",[],https://twitter.com/NIAIDNews/status/1327325992357044225,False,,0,,,,,,,,[],,,,
1326583862407831552,1326583862407831552,2020-11-11 17:53:34 UTC,2020-11-11,17:53:34,+0000,59769395,niaidnews,NIAID News,,NEWS: Dr. #Fauci and NIAID colleagues encourage #COVID19 research exploring treatment for people with early #SARSCoV2 infection.  https://t.co/aoXsmsZ5Zw  https://t.co/fR9jV31l0L,en,[],['https://bit.ly/2IplExH'],['https://pbs.twimg.com/media/Emj41G9VkAAlQWd.jpg'],6,10,29,"['fauci', 'covid19', 'sarscov2']",[],https://twitter.com/NIAIDNews/status/1326583862407831552,False,,1,https://pbs.twimg.com/media/Emj41G9VkAAlQWd.jpg,,,,,,,[],,,,
1326191729121222657,1326191729121222657,2020-11-10 15:55:22 UTC,2020-11-10,15:55:22,+0000,59769395,niaidnews,NIAID News,,"Recovered #COVID19 patients, have you wondered whether your immune system changed? We need healthy volunteers 18 years of age or older who have recovered from COVID-19 to participate in a study. Learn more about this research study and how to volunteer:  https://t.co/f95zoV0VAC  https://t.co/mwffQESekV",en,[],['https://bit.ly/35dXdfr'],['https://pbs.twimg.com/media/EmeUUEkVcAU5iVt.jpg'],1,8,17,['covid19'],[],https://twitter.com/NIAIDNews/status/1326191729121222657,False,,1,https://pbs.twimg.com/media/EmeUUEkVcAU5iVt.jpg,,,,,,,[],,,,
1325820014285344769,1325820014285344769,2020-11-09 15:18:18 UTC,2020-11-09,15:18:18,+0000,59769395,niaidnews,NIAID News,,"#HIV NEWS: Long-acting injectable #cabotegravir prevents HIV acquisition among cisgender women, @NIAIDNews-sponsored study finds. The long-acting #PrEP regimen was safe &amp; more effective than daily oral PrEP among African women.  https://t.co/kjBAf79ylZ  https://t.co/lolZ2UAXON",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['http://bit.ly/CABLAwomen'],['https://pbs.twimg.com/media/EmZCHGeU0AI2dMK.jpg'],1,61,104,"['hiv', 'cabotegravir', 'prep']",[],https://twitter.com/NIAIDNews/status/1325820014285344769,False,,1,https://pbs.twimg.com/media/EmZCHGeU0AI2dMK.jpg,,,,,,,[],,,,
1324809839650824193,1324809839650824193,2020-11-06 20:24:14 UTC,2020-11-06,20:24:14,+0000,59769395,niaidnews,NIAID News,,"BLOG: Discovery of #hepatitis C virus led to safer donor blood supplies, powerful antiviral therapies, and the 2020 Nobel Prize in Medicine. NIAID Now has the story, including #NIAID role in supporting research by one of this year‚Äôs winners.  https://t.co/gj4nYoiYzB  https://t.co/ZPtJaUT7g7",en,[],['https://bit.ly/2U04JV1'],['https://pbs.twimg.com/media/EmKrfkYVMAI12J8.jpg'],0,0,8,"['hepatitis', 'niaid']",[],https://twitter.com/NIAIDNews/status/1324809839650824193,False,,1,https://pbs.twimg.com/media/EmKrfkYVMAI12J8.jpg,,,,,,,[],,,,
1324760136229875712,1324760136229875712,2020-11-06 17:06:43 UTC,2020-11-06,17:06:43,+0000,59769395,niaidnews,NIAID News,,"NEWS: A single #COVID19 patient with a weakened immune system shed #SARSCoV2 up to 70 days, much longer than typically seen, NIAID scientists and colleagues report.  https://t.co/XyxpysKFFP  https://t.co/tkmDKKX2sm",en,[],['https://bit.ly/38gvZH8'],['https://pbs.twimg.com/media/EmJ-TFbVkAAQPqf.jpg'],17,17,29,"['covid19', 'sarscov2']",[],https://twitter.com/NIAIDNews/status/1324760136229875712,False,,1,https://pbs.twimg.com/media/EmJ-TFbVkAAQPqf.jpg,,,,,,,[],,,,
1323724734131920896,1323724734131920896,2020-11-03 20:32:24 UTC,2020-11-03,20:32:24,+0000,59769395,niaidnews,NIAID News,,NEWS: Keeping it all together ‚Äì NIAID scientists and colleagues reveal new tethering mechanism in a #Gram-negative cell envelope.  https://t.co/DQ80NKxI7a  https://t.co/sekSegPWGb,en,[],['https://go.nature.com/34UwVid'],['https://pbs.twimg.com/media/El7QK6BU8AAf7kn.jpg'],0,1,5,['gram'],[],https://twitter.com/NIAIDNews/status/1323724734131920896,False,,1,https://pbs.twimg.com/media/El7QK6BU8AAf7kn.jpg,,,,,,,[],,,,
1320753910055759873,1320753765872353281,2020-10-26 15:47:25 UTC,2020-10-26,15:47:25,+0000,59769395,niaidnews,NIAID News,,The authors explain that these ‚Äúlow-tech‚Äù modalities will still be needed after a #COVID19 vaccine is initially available as it will take at least several months for enough people to be vaccinated to confer herd immunity.,en,[],[],[],2,4,12,['covid19'],[],https://twitter.com/NIAIDNews/status/1320753910055759873,False,,0,,,,,,,,[],,,,
1320753765872353281,1320753765872353281,2020-10-26 15:46:50 UTC,2020-10-26,15:46:50,+0000,59769395,niaidnews,NIAID News,,"NEWS: Dr. Fauci &amp; colleagues note in @JAMA_current: a return to normalcy will require widespread adoption of masks &amp; other interventions to prevent #SARSCoV2 spread (distancing; hand hygiene; testing, isolation &amp; contact tracing; limiting crowds):  https://t.co/bGHUHhQm1V",en,"[{'screen_name': 'jama_current', 'name': 'jama', 'id': '38489678'}]",['https://jamanetwork.com/journals/jama/fullarticle/2772459'],[],3,28,53,['sarscov2'],[],https://twitter.com/NIAIDNews/status/1320753765872353281,False,,0,,,,,,,,[],,,,
1319714548719366144,1319714548719366144,2020-10-23 18:57:22 UTC,2020-10-23,18:57:22,+0000,59769395,niaidnews,NIAID News,,NEWS: NIAID-sponsored #ARLG childhood pneumonia study presented at @IDWeek2020 shows 5-day course of antibiotics superior to standard 10. #IDWeek2020  https://t.co/JhFO8lBwH6  https://t.co/4OhtOvgiw9,en,[],['https://bit.ly/34okc7l'],['https://pbs.twimg.com/media/ElCRNIAVMAAdA_V.jpg'],2,2,14,"['arlg', 'idweek2020']",[],https://twitter.com/NIAIDNews/status/1319714548719366144,False,,1,https://pbs.twimg.com/media/ElCRNIAVMAAdA_V.jpg,,,,,,,[],,,,
1318939174339190784,1318939174339190784,2020-10-21 15:36:18 UTC,2020-10-21,15:36:18,+0000,59769395,niaidnews,NIAID News,,"#TB NEWS: A new 4-month daily treatment regimen is as safe &amp; effective as the standard 6-month regimen at curing drug-susceptible #tuberculosis disease, finds study led by @CDCgov w/ collaboration from @NIAIDNews @ACTGNetwork. #UnionConf  https://t.co/98oNeJwJ3P  https://t.co/3oxZNz5qUP",en,"[{'screen_name': 'cdcgov', 'name': 'cdc', 'id': '146569971'}, {'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'actgnetwork', 'name': 'actg network', 'id': '361405892'}]",['http://bit.ly/ShortTB'],['https://pbs.twimg.com/media/Ek3P-etVkAcfKj9.jpg'],4,61,122,"['tb', 'tuberculosis', 'unionconf']",[],https://twitter.com/NIAIDNews/status/1318939174339190784,False,,1,https://pbs.twimg.com/media/Ek3P-etVkAcfKj9.jpg,,,,,,,[],,,,
1318548266888384519,1318548266888384519,2020-10-20 13:42:58 UTC,2020-10-20,13:42:58,+0000,59769395,niaidnews,NIAID News,,#HIV BLOG: A @NIAIDNews-supported study in which HIV reverse transcription and integration happen outside a cell for the first time clarifies that reverse transcription must take place inside a largely intact capsid:  https://t.co/mufag2WnPT #NIH  https://t.co/YrzI68CPjZ,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://bit.ly/2TaAcU0'],['https://pbs.twimg.com/media/EkxsktnX0AE7P1K.jpg'],0,15,23,"['hiv', 'nih']",[],https://twitter.com/NIAIDNews/status/1318548266888384519,False,,1,https://pbs.twimg.com/media/EkxsktnX0AE7P1K.jpg,,,,,,,[],,,,
1316500317811302402,1316500317811302402,2020-10-14 22:05:09 UTC,2020-10-14,22:05:09,+0000,59769395,niaidnews,NIAID News,,NIAID-funded study determines swine unlikely to carry #SARS-CoV-2 and unsuitable model to study #COVID-19.  https://t.co/gCRtK8oXqV  https://t.co/k43F3BDY1z,en,[],['https://bit.ly/312lEdp'],['https://pbs.twimg.com/media/EkUlwAjU8AEY2Lh.jpg'],1,4,11,"['sars', 'covid']",[],https://twitter.com/NIAIDNews/status/1316500317811302402,False,,1,https://pbs.twimg.com/media/EkUlwAjU8AEY2Lh.jpg,,,,,,,[],,,,
1314314211682521088,1314314205055467520,2020-10-08 21:18:21 UTC,2020-10-08,21:18:21,+0000,59769395,niaidnews,NIAID News,,A reminder that you can follow @NIHCOVIDTxGuide for the latest updates from the COVID-19 Treatment Guidelines panel  https://t.co/AT7vFIOy7W,en,"[{'screen_name': 'nihcovidtxguide', 'name': 'nih covid-19 treatment guidelines', 'id': '1263541525205659648'}]",['https://www.covid19treatmentguidelines.nih.gov/'],[],1,4,6,[],[],https://twitter.com/NIAIDNews/status/1314314211682521088,False,,0,,,,,,,,[],,,,
1314314210537431041,1314314205055467520,2020-10-08 21:18:21 UTC,2020-10-08,21:18:21,+0000,59769395,niaidnews,NIAID News,,"NIAID has made #ACTT1 datasets available to the research community through the AccessClinicalData@NIAID secure clinical trials data repository. To access and download datasets, visit:  https://t.co/HnaptdiIJv.",en,[],['https://accessclinicaldata.niaid.nih.gov/'],[],2,1,5,['actt1'],[],https://twitter.com/NIAIDNews/status/1314314210537431041,False,,0,,,,,,,,[],,,,
1314314209472073728,1314314205055467520,2020-10-08 21:18:20 UTC,2020-10-08,21:18:20,+0000,59769395,niaidnews,NIAID News,,"The authors note, ‚ÄúCumulatively, these findings suggest that treatment with remdesivir may not only reduce the disease burden but may also decrease the use of scarce health care resources during this pandemic.‚Äù",en,[],[],[],1,1,3,[],[],https://twitter.com/NIAIDNews/status/1314314209472073728,False,,0,,,,,,,,[],,,,
1314314208490659842,1314314205055467520,2020-10-08 21:18:20 UTC,2020-10-08,21:18:20,+0000,59769395,niaidnews,NIAID News,,"The final report shows the remdesivir group had a shorter length of initial hospital stay; remdesivir may have prevented progression to more severe disease &amp; remdesivir was associated with fewer days of oxygen use, mechanical ventilation &amp; ECMO",en,[],[],[],1,2,3,[],[],https://twitter.com/NIAIDNews/status/1314314208490659842,False,,0,,,,,,,,[],,,,
1314314207454588928,1314314205055467520,2020-10-08 21:18:20 UTC,2020-10-08,21:18:20,+0000,59769395,niaidnews,NIAID News,,The trial‚Äôs key finding remains unchanged in the final report: #remdesivir reduces time to recovery. The final report also confirms those receiving remdesivir were more likely to have improved clinical status at day 15.,en,[],[],[],1,2,5,['remdesivir'],[],https://twitter.com/NIAIDNews/status/1314314207454588928,False,,0,,,,,,,,[],,,,
1314314206271823872,1314314205055467520,2020-10-08 21:18:20 UTC,2020-10-08,21:18:20,+0000,59769395,niaidnews,NIAID News,,#ACTT1 began in Feb 2020. An interim report published in May showed that patients who received #remdesivir had a shorter time to recovery than those who received placebo.  https://t.co/aZGRL1gV6Q,en,[],['https://www.niaid.nih.gov/news-events/peer-reviewed-data-shows-remdesivir-covid-19-improves-time-recovery'],[],2,1,3,"['actt1', 'remdesivir']",[],https://twitter.com/NIAIDNews/status/1314314206271823872,False,,0,,,,,,,,[],,,,
1314314205055467520,1314314205055467520,2020-10-08 21:18:19 UTC,2020-10-08,21:18:19,+0000,59769395,niaidnews,NIAID News,,COVID-19 NEWS: Today @NEJM published a final report on NIAID‚Äôs Adaptive COVID-19 Treatment Trial (#ACTT1) evaluating the antiviral #remdesivir (@Gileadsciences) for the treatment of people hospitalized with #COVID19  https://t.co/QfuacjovvB,en,"[{'screen_name': 'nejm', 'name': 'nejm', 'id': '25950355'}, {'screen_name': 'gileadsciences', 'name': 'gilead sciences', 'id': '309728693'}]",['https://www.nejm.org/doi/full/10.1056/NEJMoa2007764?query=featured_home'],[],6,13,24,"['actt1', 'remdesivir', 'covid19']",[],https://twitter.com/NIAIDNews/status/1314314205055467520,False,,0,,,,,,,,[],,,,
1314272486356217856,1314272480245161984,2020-10-08 18:32:33 UTC,2020-10-08,18:32:33,+0000,59769395,niaidnews,NIAID News,,Additional details are available in a news release from @LillyPad:  https://t.co/lInPCcV5x2,en,"[{'screen_name': 'lillypad', 'name': 'eli lilly and company', 'id': '172496840'}]",['https://investor.lilly.com/news-releases/news-release-details/baricitinib-has-significant-effect-recovery-time-most-impactful'],[],0,1,3,[],[],https://twitter.com/NIAIDNews/status/1314272486356217856,False,,0,,,,,,,,[],,,,
1314272484636594176,1314272480245161984,2020-10-08 18:32:32 UTC,2020-10-08,18:32:32,+0000,59769395,niaidnews,NIAID News,,The presentation expanded on results announced earlier this year: the combination of remdesivir and baricitinib reduced time to recovery in hospitalized patients and improved their condition by Day 15 of their participation in the trial.  https://t.co/9u2ybPm95y,en,[],[],['https://pbs.twimg.com/media/Ej07p-_VoAAQGar.jpg'],2,3,8,[],[],https://twitter.com/NIAIDNews/status/1314272484636594176,False,,1,https://pbs.twimg.com/media/Ej07p-_VoAAQGar.jpg,,,,,,,[],,,,
1314272480245161984,1314272480245161984,2020-10-08 18:32:31 UTC,2020-10-08,18:32:31,+0000,59769395,niaidnews,NIAID News,,COVID-19 NEWS: New data from a trial examining the safety and efficacy of #remdsivir and #baricitinib for hospitalized #COVID19 patients (#ACTT2) were presented today by #NIAID at a virtual @isirvAVG conference.  https://t.co/wSYXAoAtC5,en,"[{'screen_name': 'isirvavg', 'name': 'isirv antiviral', 'id': '562973000'}]",[],['https://pbs.twimg.com/media/Ej07Q1PVgAAsEaG.jpg'],1,15,24,"['remdsivir', 'baricitinib', 'covid19', 'actt2', 'niaid']",[],https://twitter.com/NIAIDNews/status/1314272480245161984,False,,1,https://pbs.twimg.com/media/Ej07Q1PVgAAsEaG.jpg,,,,,,,[],,,,
1314248337948725254,1314248337948725254,2020-10-08 16:56:35 UTC,2020-10-08,16:56:35,+0000,59769395,niaidnews,NIAID News,,COVID-19 NEWS: @NIAIDNews launches phase 3 #ClinicalTrial in #COVID19 patients in 18 countries to determine if a highly concentrated solution of #antibodies that neutralize #SARSCoV2 can help the immune system suppress the virus before disease advances.  https://t.co/9tar62roWd  https://t.co/84w98SaHQT,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['http://bit.ly/SARSCoV2-hIVIG'],['https://pbs.twimg.com/media/Ej0l2-2U8AAR3hq.jpg'],2,18,27,"['clinicaltrial', 'covid19', 'antibodies', 'sarscov2']",[],https://twitter.com/NIAIDNews/status/1314248337948725254,False,,1,https://pbs.twimg.com/media/Ej0l2-2U8AAR3hq.jpg,,,,,,,[],,,,
1311059083818983425,1311059083818983425,2020-09-29 21:43:38 UTC,2020-09-29,21:43:38,+0000,59769395,niaidnews,NIAID News,,#COVID19 NEWS: A new paper published today in @NEJM describes some results of a Phase 1 trial of the mRNA-1273 candidate #vaccine for COVID-19 in older adults. The vaccine appears to be well-tolerated and generates a strong immune response.  https://t.co/B6R8lqKxlh  https://t.co/rDJm4SOtno,en,"[{'screen_name': 'nejm', 'name': 'nejm', 'id': '25950355'}]",['http://bit.ly/VaccineInOlderAdults'],['https://pbs.twimg.com/media/EjHRB9PVkAMxmuH.jpg'],1,11,26,"['covid19', 'vaccine']",[],https://twitter.com/NIAIDNews/status/1311059083818983425,False,,1,https://pbs.twimg.com/media/EjHRB9PVkAMxmuH.jpg,,,,,,,[],,,,
1310643405559484419,1310643405559484419,2020-09-28 18:11:53 UTC,2020-09-28,18:11:53,+0000,59769395,niaidnews,NIAID News,,"Join experts from @NIAIDNews, @ChildrensNatl &amp; elsewhere tomorrow for the #CNNIAIDSymposium highlighting #COVID19 research! Free registration is required:  https://t.co/GXU7GSU7DS  https://t.co/cDNjiGeZtP",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'childrensnatl', 'name': ""children's national hospital üè•"", 'id': '17547367'}]",['https://ctsicn.org/cn-niaid'],['https://pbs.twimg.com/media/EjBW_6LUwAAPeI6.jpg'],0,9,13,"['cnniaidsymposium', 'covid19']",[],https://twitter.com/NIAIDNews/status/1310643405559484419,False,,1,https://pbs.twimg.com/media/EjBW_6LUwAAPeI6.jpg,,,,,,,[],,,,
1309227726772080640,1309227726772080640,2020-09-24 20:26:28 UTC,2020-09-24,20:26:28,+0000,59769395,niaidnews,NIAID News,,"#HIV BLOG: New @NIH awards support HIV implementation science research in US communities to advance the goals of the #EndingTheHIVEpidemic initiative, which aims to reduce new HIV diagnoses in the US by at least 90% by 2030.  https://t.co/n5Tv2h5Okt  https://t.co/fqJykrcOQX",en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}]",['http://bit.ly/NIHEHE2020'],['https://pbs.twimg.com/media/EitPS8BX0AAUEvi.jpg'],2,4,7,"['hiv', 'endingthehivepidemic']",[],https://twitter.com/NIAIDNews/status/1309227726772080640,False,,1,https://pbs.twimg.com/media/EitPS8BX0AAUEvi.jpg,,,,,,,[],,,,
1309192075989008386,1309192075989008386,2020-09-24 18:04:49 UTC,2020-09-24,18:04:49,+0000,59769395,niaidnews,NIAID News,,#COVID19 NEWS: New findings by @NIAIDNews scientists and their collaborators help explain why some people with COVID-19 develop severe disease. The findings also may provide the first molecular explanation for why more men than women die from COVID-19.  https://t.co/PsxrVEXc4h  https://t.co/5M4EoTAscb,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://bit.ly/3mRKINi'],['https://pbs.twimg.com/media/EisvF2sVgAEfPkm.jpg'],1,24,28,['covid19'],[],https://twitter.com/NIAIDNews/status/1309192075989008386,False,,1,https://pbs.twimg.com/media/EisvF2sVgAEfPkm.jpg,,,,,,,[],,,,
1308841388537270272,1308841388537270272,2020-09-23 18:51:18 UTC,2020-09-23,18:51:18,+0000,59769395,niaidnews,NIAID News,,"BLOG: Valley fever, common in the southwestern US, is a #fungal disease that can be hard to diagnose and treat. Learn about NIAID-funded research on #ValleyFever on the #NIAIDNow blog. #FungalWeek  https://t.co/Mj9ER25kMk  https://t.co/PnLiMkLXCu",en,[],['https://bit.ly/2RS6gv5'],['https://pbs.twimg.com/media/EinwRtxUMAAMlAy.jpg'],0,1,10,"['fungal', 'valleyfever', 'niaidnow', 'fungalweek']",[],https://twitter.com/NIAIDNews/status/1308841388537270272,False,,1,https://pbs.twimg.com/media/EinwRtxUMAAMlAy.jpg,,,,,,,[],,,,
1308747890773250055,1308747885559734274,2020-09-23 12:39:47 UTC,2020-09-23,12:39:47,+0000,59769395,niaidnews,NIAID News,,An independent Data and Safety Monitoring Board is overseeing the trial. Phase 3 clinical trials of candidate vaccines supported through #OperationWarpSpeed are overseen by a common DSMB developed in consultation with ACTIV.  https://t.co/Q8EFRYHXZC,en,[],['https://www.nih.gov/research-training/medical-research-initiatives/activ'],[],0,1,2,['operationwarpspeed'],[],https://twitter.com/NIAIDNews/status/1308747890773250055,False,,0,,,,,,,,[],,,,
1308747889577844736,1308747885559734274,2020-09-23 12:39:46 UTC,2020-09-23,12:39:46,+0000,59769395,niaidnews,NIAID News,,Positive interim results (due to be published online imminently) from a Phase 1/2a clinical trial of the Janssen vaccine candidate demonstrated that the safety profile and immunogenicity after a single vaccination were supportive of further development.,en,[],[],[],1,0,2,[],[],https://twitter.com/NIAIDNews/status/1308747889577844736,False,,0,,,,,,,,[],,,,
1308747888118300673,1308747885559734274,2020-09-23 12:39:46 UTC,2020-09-23,12:39:46,+0000,59769395,niaidnews,NIAID News,,The investigational #Janssen #COVID19 vaccine is a recombinant vector vaccine that uses a human adenovirus to express the #SARSCoV2 spike protein in cells. The candidate showed promise in #NIAID-supported preclinical research  https://t.co/sTFozCNTlF.,en,[],['https://www.nature.com/articles/s41586-020-2607-z'],[],1,0,0,"['janssen', 'covid19', 'sarscov2', 'niaid']",[],https://twitter.com/NIAIDNews/status/1308747888118300673,False,,0,,,,,,,,[],,,,
1308747886826409984,1308747885559734274,2020-09-23 12:39:46 UTC,2020-09-23,12:39:46,+0000,59769395,niaidnews,NIAID News,,"The trial will enroll up to 60,000 volunteers at up to about 215 trial sites in the U.S. &amp; internationally. Sites part of the #NIAID-supported #COVID19 Prevention Network will participate in the trial. #CoVPN  https://t.co/rUM858qB23",en,[],['http://preventCOVID.org'],[],1,0,1,"['niaid', 'covid19', 'covpn']",[],https://twitter.com/NIAIDNews/status/1308747886826409984,False,,0,,,,,,,,[],,,,
1308747885559734274,1308747885559734274,2020-09-23 12:39:45 UTC,2020-09-23,12:39:45,+0000,59769395,niaidnews,NIAID News,,#COVID19 NEWS: A 4th Phase 3 clinical trial of a COVID-19 vaccine candidate has begun enrolling adult volunteers. The trial will evaluate if the investigational @JanssenUS vaccine can prevent symptomatic COVID-19 after a single dose  https://t.co/tiCgVmwZzK,en,"[{'screen_name': 'janssenus', 'name': 'janssenus', 'id': '256182836'}]",['http://bit.ly/JnJPh3'],[],1,8,20,['covid19'],[],https://twitter.com/NIAIDNews/status/1308747885559734274,False,,0,,,,,,,,[],,,,
1308423680289054720,1308423680289054720,2020-09-22 15:11:29 UTC,2020-09-22,15:11:29,+0000,59769395,niaidnews,NIAID News,,NEWS: @NIAIDNews-funded study in @CellRepMed illustrates how combination #vaccine #adjuvants induce #Tcell immunity in the respiratory tract. The findings may aid development of vaccines against respiratory pathogens like #influenza.  https://t.co/j04TY0XD3X,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'cellrepmed', 'name': 'cell reports medicine', 'id': '1181623999152963584'}]",['http://bit.ly/AdjuvantsTcells'],[],0,4,3,"['vaccine', 'adjuvants', 'tcell', 'influenza']",[],https://twitter.com/NIAIDNews/status/1308423680289054720,False,,0,,,,,,,,[],,,,
1308387683060903936,1308387683060903936,2020-09-22 12:48:26 UTC,2020-09-22,12:48:26,+0000,59769395,niaidnews,NIAID News,,"Next Tues., Sept. 29, join experts from @NIAIDNews, @ChildrensNatl, @ncats_nih_gov &amp; elsewhere at the #CNNIAIDSymposium highlighting #COVID19 research, with a focus on #pediatrics. Register now:  https://t.co/GXU7GSCwMk  https://t.co/0AUiLcSRZy",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'childrensnatl', 'name': ""children's national hospital üè•"", 'id': '17547367'}, {'screen_name': 'ncats_nih_gov', 'name': 'ncats', 'id': '461242546'}]",['https://ctsicn.org/cn-niaid'],['https://pbs.twimg.com/media/EihTMaPWoAEmzGL.jpg'],1,9,12,"['cnniaidsymposium', 'covid19', 'pediatrics']",[],https://twitter.com/NIAIDNews/status/1308387683060903936,False,,1,https://pbs.twimg.com/media/EihTMaPWoAEmzGL.jpg,,,,,,,[],,,,
1306222179797872640,1306222179797872640,2020-09-16 13:23:30 UTC,2020-09-16,13:23:30,+0000,59769395,niaidnews,NIAID News,,EVENT: Interested in the latest research on #COVID19 &amp; its impact on children? Attend the virtual #CNNIAIDSymposium on Sept. 29! View the full agenda &amp; register for this free event:  https://t.co/GXU7GSCwMk  https://t.co/GXMU44l03Z,en,[],['https://ctsicn.org/cn-niaid'],['https://pbs.twimg.com/media/EiCh0oBXYAAv9TI.jpg'],1,7,10,"['covid19', 'cnniaidsymposium']",[],https://twitter.com/NIAIDNews/status/1306222179797872640,False,,1,https://pbs.twimg.com/media/EiCh0oBXYAAv9TI.jpg,,,,,,,[],,,,
1303761142930706438,1303761142930706438,2020-09-09 18:24:13 UTC,2020-09-09,18:24:13,+0000,59769395,niaidnews,NIAID News,,"#ECZEMA NEWS: An experimental treatment that aims to modify the skin #microbiome safely reduced eczema severity &amp; increased quality of life for children as young as age 3, @NIAIDNews researchers report in @ScienceTM.  https://t.co/IJVpeTDZS2  https://t.co/XrVR5CU7Q4",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'sciencetm', 'name': 'science translational medicine', 'id': '248897605'}]",['http://bit.ly/RmucosaEczema'],['https://pbs.twimg.com/media/EhfjkygX0AArh_d.jpg'],1,10,15,"['eczema', 'microbiome']",[],https://twitter.com/NIAIDNews/status/1303761142930706438,False,,1,https://pbs.twimg.com/media/EhfjkygX0AArh_d.jpg,,,,,,,[],,,,
1300556087846825984,1300556083786702849,2020-08-31 22:08:29 UTC,2020-08-31,22:08:29,+0000,59769395,niaidnews,NIAID News,,"#AZD1222 was developed by @UniofOxford and @JennerInstitute and licensed to @AstraZeneca for further development. #NIAID scientists at Rocky Mountain Laboratories in MT conducted preclinical research on the candidate vaccine, published in @Nature in July  https://t.co/kfR3KXDPZm",en,"[{'screen_name': 'uniofoxford', 'name': 'university of oxford', 'id': '48289662'}, {'screen_name': 'jennerinstitute', 'name': 'jenner institute', 'id': '3364000629'}, {'screen_name': 'astrazeneca', 'name': 'astrazeneca', 'id': '62465691'}, {'screen_name': 'nature', 'name': 'nature', 'id': '15862891'}]",['http://bit.ly/3hG6tgd'],[],2,7,9,"['azd1222', 'niaid']",[],https://twitter.com/NIAIDNews/status/1300556087846825984,False,,0,,,,,,,,[],,,,
1300556086118764544,1300556083786702849,2020-08-31 22:08:28 UTC,2020-08-31,22:08:28,+0000,59769395,niaidnews,NIAID News,,#NIAID-supported COVID-19 Prevention Network sites are enrolling volunteer participants in the Phase 3 clinical trial. #CoVPN  https://t.co/iRmpm65IVR,en,[],['https://coronaviruspreventionnetwork.org/'],[],1,4,5,"['niaid', 'covpn']",[],https://twitter.com/NIAIDNews/status/1300556086118764544,False,,0,,,,,,,,[],,,,
1300556083786702849,1300556083786702849,2020-08-31 22:08:28 UTC,2020-08-31,22:08:28,+0000,59769395,niaidnews,NIAID News,,"#COVID19 NEWS: A Phase 3 clinical trial evaluating the investigational #SARSCoV2 #vaccine #AZD1222 has begun. The trial aims to enroll ~30,000 adult volunteers in the U.S. to evaluate if the vaccine can prevent symptomatic COVID-19.  https://t.co/nXdHcwo4OB  https://t.co/OecxDi9kp4",en,[],['http://bit.ly/AZPhase3'],['https://pbs.twimg.com/media/Egx_7-fU8AAq9fH.jpg'],6,25,29,"['covid19', 'sarscov2', 'vaccine', 'azd1222']",[],https://twitter.com/NIAIDNews/status/1300556083786702849,False,,1,https://pbs.twimg.com/media/Egx_7-fU8AAq9fH.jpg,,,,,,,[],,,,
1300454901571563520,1300454901571563520,2020-08-31 15:26:24 UTC,2020-08-31,15:26:24,+0000,59769395,niaidnews,NIAID News,,"#COVID19 NEWS: @NIAIDNews-funded study in @CellCellPress offers potential explanation for why #antibody responses to #SARSCoV2 can be short-lived: people w/ severe disease lack #GerminalCenters, which normally produce long-lived antibody-generating cells.  https://t.co/2oOYRz8u6w",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'cellcellpress', 'name': 'cell', 'id': '65134016'}]",['http://bit.ly/TFHCOVID19'],[],0,10,9,"['covid19', 'antibody', 'sarscov2', 'germinalcenters']",[],https://twitter.com/NIAIDNews/status/1300454901571563520,False,,0,,,,,,,,[],,,,
1299458815449063425,1299458815449063425,2020-08-28 21:28:19 UTC,2020-08-28,21:28:19,+0000,59769395,niaidnews,NIAID News,,"MALARIA NEWS: In a new study, NIAID researchers and colleagues describe the first detailed ‚Äúatlas‚Äù of #mosquito immune cells. This could lead to new ways to keep mosquitoes from transmitting #malaria parasites to people.  https://t.co/Pn5Mq5eRbh  https://t.co/JXfkqTQZyb",en,[],['http://bit.ly/MosquitoAtlas'],['https://pbs.twimg.com/media/Egia16EXsAEVh7t.jpg'],0,13,25,"['mosquito', 'malaria']",[],https://twitter.com/NIAIDNews/status/1299458815449063425,False,,1,https://pbs.twimg.com/media/Egia16EXsAEVh7t.jpg,,,,,,,[],,,,
1299034008991522823,1299034008991522823,2020-08-27 17:20:17 UTC,2020-08-27,17:20:17,+0000,59769395,niaidnews,NIAID News,,NEWS: #NIAID funds new global research network to study emerging #InfectiousDiseases including #COVID19.  https://t.co/gcT9EPHSCc,en,[],['http://bit.ly/CREIDNetwork'],[],2,23,60,"['niaid', 'infectiousdiseases', 'covid19']",[],https://twitter.com/NIAIDNews/status/1299034008991522823,False,,0,,,,,,,,[],,,,
1297924321873027074,1297924321873027074,2020-08-24 15:50:47 UTC,2020-08-24,15:50:47,+0000,59769395,niaidnews,NIAID News,,"Register now for the virtual #CNNIAIDSymposium on Sept. 29! Experts from @NIAIDNews, @ChildrensNatl &amp; other institutions will share advances in #COVID19 research.  https://t.co/GXU7GSU7DS  https://t.co/cboQIcHMF4",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'childrensnatl', 'name': ""children's national hospital üè•"", 'id': '17547367'}]",['https://ctsicn.org/cn-niaid'],['https://pbs.twimg.com/media/EgMnCGUU4AIhC_e.jpg'],2,4,9,"['cnniaidsymposium', 'covid19']",[],https://twitter.com/NIAIDNews/status/1297924321873027074,False,,1,https://pbs.twimg.com/media/EgMnCGUU4AIhC_e.jpg,,,,,,,[],,,,
1294313754000326657,1294313754000326657,2020-08-14 16:43:40 UTC,2020-08-14,16:43:40,+0000,59769395,niaidnews,NIAID News,,#HIV BLOG: Initial data from the @NIH-supported @reprievetrial offer a detailed look at the health status of people #AgingWithHIV around the world. Read more:  https://t.co/LdYacF3vZG,en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}, {'screen_name': 'reprievetrial', 'name': 'reprieve trial', 'id': '2863910194'}]",['https://bit.ly/REPRIEVEbaseline'],[],3,2,6,"['hiv', 'agingwithhiv']",[],https://twitter.com/NIAIDNews/status/1294313754000326657,False,,0,,,,,,,,[],,,,
1294257008992952321,1294257008992952321,2020-08-14 12:58:11 UTC,2020-08-14,12:58:11,+0000,59769395,niaidnews,NIAID News,,NEWS: New @NIH-supported research published in @NatureComms demonstrates how two common genetic variations cause #eczema. This finding could lead to #genetic tests that identify infants at risk for the disease.  https://t.co/aI9Q0CRkjw  #AtopicDermatitis #genetictest  https://t.co/W2XaSuyR7E,en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}, {'screen_name': 'naturecomms', 'name': 'nature communications', 'id': '206255645'}]",['https://bit.ly/EczemaSNPs'],['https://pbs.twimg.com/media/EfYf2IaVoAU_dcq.jpg'],1,4,6,"['eczema', 'genetic', 'atopicdermatitis', 'genetictest']",[],https://twitter.com/NIAIDNews/status/1294257008992952321,False,,1,https://pbs.twimg.com/media/EfYf2IaVoAU_dcq.jpg,,,,,,,[],,,,
1293996932122075136,1293996932122075136,2020-08-13 19:44:44 UTC,2020-08-13,19:44:44,+0000,59769395,niaidnews,NIAID News,,"#FLU NEWS: Levels of #immune cells that produce anti-#influenza #antibodies decline within a year after seasonal flu #vaccination, a @NIAIDNews-funded study in @ScienceMagazine reveals. Insights from the research may aid #UniversalFluVax development.  https://t.co/XYo37nVxNd",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'sciencemagazine', 'name': 'science magazine', 'id': '32372834'}]",['https://bit.ly/Flu-BMPCs'],[],2,6,9,"['flu', 'immune', 'influenza', 'antibodies', 'vaccination', 'universalfluvax']",[],https://twitter.com/NIAIDNews/status/1293996932122075136,False,,0,,,,,,,,[],,,,
1293884961901035520,1293884961901035520,2020-08-13 12:19:48 UTC,2020-08-13,12:19:48,+0000,59769395,niaidnews,NIAID News,,Please join us live on NIAID‚Äôs Instagram at 6:30 pm EST as NIAID Director Dr. Anthony Fauci speaks with Matthew McConaughey about #COVID19. #NOCOVID  https://t.co/sR3IyiOM8d  https://t.co/MTrQHQjznf,en,[],['https://www.instagram.com/niaid/'],['https://pbs.twimg.com/media/EfTNZTZUMAUc1Pg.png'],3,18,38,"['covid19', 'nocovid']",[],https://twitter.com/NIAIDNews/status/1293884961901035520,False,,1,https://pbs.twimg.com/media/EfTNZTZUMAUc1Pg.png,,,,,,,[],,,,
1293258730268549120,1293258730268549120,2020-08-11 18:51:23 UTC,2020-08-11,18:51:23,+0000,59769395,niaidnews,NIAID News,,Mask up! We can all do our part to prevent the spread of #COVID19!  Thanks to our friends at @USSoccer for these great masks made from national team jerseys! @uswnt @usmnt @AbbyWambach @CobiJones @kammarmanMNT @GeorgeChiampas  https://t.co/eR4pi9F510,en,"[{'screen_name': 'ussoccer', 'name': 'u.s. soccer', 'id': '932672630028689408'}, {'screen_name': 'uswnt', 'name': 'u.s. soccer wnt', 'id': '133448051'}, {'screen_name': 'usmnt', 'name': 'u.s. soccer mnt', 'id': '7563792'}, {'screen_name': 'abbywambach', 'name': 'abby wambach', 'id': '336124836'}, {'screen_name': 'cobijones', 'name': 'cobi jones', 'id': '20249664'}, {'screen_name': 'kammarmanmnt', 'name': 'michael kammarman', 'id': '357516139'}, {'screen_name': 'georgechiampas', 'name': 'george chiampas', 'id': '2383058023'}]",[],"['https://pbs.twimg.com/media/EfKSlm7U8AAkkxa.jpg', 'https://pbs.twimg.com/media/EfKSm6RUMAEsYsx.jpg']",24,145,911,['covid19'],[],https://twitter.com/NIAIDNews/status/1293258730268549120,False,,1,https://pbs.twimg.com/media/EfKSlm7U8AAkkxa.jpg,,,,,,,[],,,,
1293182247835586560,1293182247835586560,2020-08-11 13:47:28 UTC,2020-08-11,13:47:28,+0000,59769395,niaidnews,NIAID News,,"Save the date! Join @NIAIDNews &amp; @ChildrensNatl on Sept. 29 for the 3rd annual #CNNIAIDSymposium. This year‚Äôs virtual event will highlight #COVID19 research, with a focus on #pediatrics.  https://t.co/gcPWprTeCO  https://t.co/6SZKes6cLI",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'childrensnatl', 'name': ""children's national hospital üè•"", 'id': '17547367'}]",['https://ctsicn.org/CN-NIAID'],['https://pbs.twimg.com/media/EfJOJXXUwAAnTad.jpg'],0,5,13,"['cnniaidsymposium', 'covid19', 'pediatrics']",[],https://twitter.com/NIAIDNews/status/1293182247835586560,False,,1,https://pbs.twimg.com/media/EfJOJXXUwAAnTad.jpg,,,,,,,[],,,,
1292926063077552128,1292926063077552128,2020-08-10 20:49:29 UTC,2020-08-10,20:49:29,+0000,59769395,niaidnews,NIAID News,,COVID19 NEWS: #ClinicalTrials testing monoclonal antibodies to prevent #COVID19 now enrolling adults at sites in #NIAID supported #Coronavirus Prevention Network.  https://t.co/6GIHAI5N2I,en,[],['https://bit.ly/31Eu61L'],[],0,13,37,"['clinicaltrials', 'covid19', 'niaid', 'coronavirus']",[],https://twitter.com/NIAIDNews/status/1292926063077552128,False,,0,,,,,,,,[],,,,
1291096634583953408,1291096634583953408,2020-08-05 19:39:59 UTC,2020-08-05,19:39:59,+0000,59769395,niaidnews,NIAID News,,#COVID19 NEWS: A @NIAIDNews clinical trial testing #remdesivir plus subcutaneous #InterferonBeta1a for COVID-19 treatment has begun. The study is called the Adaptive COVID-19 Treatment Trial 3 (ACTT 3).  https://t.co/VtgQNNYX5h   #SARSCoV2 #NIH  https://t.co/1tU9jVgc2d,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://bit.ly/ACTT3_Launch'],['https://pbs.twimg.com/media/EerlhWIUMAEBcz5.jpg'],3,9,23,"['covid19', 'remdesivir', 'interferonbeta1a', 'sarscov2', 'nih']",[],https://twitter.com/NIAIDNews/status/1291096634583953408,False,,1,https://pbs.twimg.com/media/EerlhWIUMAEBcz5.jpg,,,,,,,[],,,,
1291039529797685249,1291039529797685249,2020-08-05 15:53:04 UTC,2020-08-05,15:53:04,+0000,59769395,niaidnews,NIAID News,,¬øEst√°s interesado en ser un voluntario para un Estudio Cl√≠nico del #COVID19? Visita el sitio en internet de la Red de Prevenci√≥n COVID-19 (CoVPN) para llenar el Formulario de Registro de Voluntarios:  https://t.co/J3UbPRrwZm  https://t.co/POQeENIHkw,es,[],['https://bit.ly/33AzF3Q'],['https://pbs.twimg.com/media/EeqxmSKUYAAfRO9.png'],0,3,3,['covid19'],[],https://twitter.com/NIAIDNews/status/1291039529797685249,False,,1,https://pbs.twimg.com/media/EeqxmSKUYAAfRO9.png,,,,,,,[],,,,
1290704950192820224,1290704847931453440,2020-08-04 17:43:34 UTC,2020-08-04,17:43:34,+0000,59769395,niaidnews,NIAID News,,The investigators suggest that this reactivity against #SARSCoV2 may be due to previous exposure to common-cold strains of #coronavirus.,en,[],[],[],0,7,18,"['sarscov2', 'coronavirus']",[],https://twitter.com/NIAIDNews/status/1290704950192820224,False,,0,,,,,,,,[],,,,
1290704847931453440,1290704847931453440,2020-08-04 17:43:10 UTC,2020-08-04,17:43:10,+0000,59769395,niaidnews,NIAID News,,"#COVID19 News: A @NIAIDNews-funded study published in @ScienceMagazine has found that memory T cells are the source of pre-existing reactivity against #SARSCoV2, explaining how some people who have never been exposed to the virus have reactivity to it.  https://t.co/iVXtT9tTPH",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'sciencemagazine', 'name': 'science magazine', 'id': '32372834'}]",['https://science.sciencemag.org/lookup/doi/10.1126/science.abd3871'],[],5,77,129,"['covid19', 'sarscov2']",[],https://twitter.com/NIAIDNews/status/1290704847931453440,False,,0,,,,,,,,[],,,,
1290681722246434822,1290681712943521793,2020-08-04 16:11:16 UTC,2020-08-04,16:11:16,+0000,59769395,niaidnews,NIAID News,,"Another trial, ACTIV-3, will begin by testing monoclonal #antibodies in hospitalized #COVID19 patients. Additional therapeutics may be tested in the trial later:  https://t.co/2A9jDHLDuN  https://t.co/FeOrymy2UL",en,[],['http://bit.ly/ACTIV-3'],['https://pbs.twimg.com/media/EelqSoXXYAAlbkY.jpg'],0,2,8,"['antibodies', 'covid19']",[],https://twitter.com/NIAIDNews/status/1290681722246434822,False,,1,https://pbs.twimg.com/media/EelqSoXXYAAlbkY.jpg,,,,,,,[],,,,
1290681717292969984,1290681712943521793,2020-08-04 16:11:15 UTC,2020-08-04,16:11:15,+0000,59769395,niaidnews,NIAID News,,"One trial, ACTIV-2, will begin by testing monoclonal #antibodies in volunteers with mild to moderate disease:  https://t.co/wHTHhdxecn  https://t.co/XC949r4VuD",en,[],['http://bit.ly/ACTIV-2'],['https://pbs.twimg.com/media/EelqKVcXgAgOK83.jpg'],2,2,9,['antibodies'],[],https://twitter.com/NIAIDNews/status/1290681717292969984,False,,1,https://pbs.twimg.com/media/EelqKVcXgAgOK83.jpg,,,,,,,[],,,,
1290681712943521793,1290681712943521793,2020-08-04 16:11:14 UTC,2020-08-04,16:11:14,+0000,59769395,niaidnews,NIAID News,,NEWS: A set of studies sponsored by NIAID is now testing therapeutics for #COVID19. NIH‚Äôs Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) is a public-private partnership program instituted to speed development of the most promising #treatments and #vaccines.  https://t.co/bslaMiGko7,en,[],[],['https://pbs.twimg.com/media/EelpmaTX0AE0LwZ.jpg'],3,17,34,"['covid19', 'treatments', 'vaccines']",[],https://twitter.com/NIAIDNews/status/1290681712943521793,False,,1,https://pbs.twimg.com/media/EelpmaTX0AE0LwZ.jpg,,,,,,,[],,,,
1289290992382668800,1289290992382668800,2020-07-31 20:05:01 UTC,2020-07-31,20:05:01,+0000,59769395,niaidnews,NIAID News,,"NEWS: Nature study highlights pre-clinical development of #ChAdOx1nCoV19, an investigational #SARSCoV2 vaccine. NIAID‚Äôs early studies in macaques led to clinical trials in an unprecedented timeframe.  https://t.co/OeWT1jOpRW  https://t.co/1MDT16hC6I",en,[],['https://go.nature.com/39H2SLw'],['https://pbs.twimg.com/media/EeR7FloUwAAfk2-.jpg'],5,9,17,"['chadox1ncov19', 'sarscov2']",[],https://twitter.com/NIAIDNews/status/1289290992382668800,False,,1,https://pbs.twimg.com/media/EeR7FloUwAAfk2-.jpg,,,,,,,[],,,,
1288955342064250881,1288955342064250881,2020-07-30 21:51:15 UTC,2020-07-30,21:51:15,+0000,59769395,niaidnews,NIAID News,,"NEWS: NIAID-funded scientists find two-pronged #Ebola virus treatment approach that works well in rhesus macaques: #rVSV ZEBOV when healthy, followed by experimental monoclonal antibody #MIL177 after infection.  https://t.co/axzcl3LYEV  https://t.co/PNiH042ebV",en,[],['https://go.nature.com/3jO8uZ8'],['https://pbs.twimg.com/media/EeNJ1YCU4AIq1cy.jpg'],3,3,17,"['ebola', 'rvsv', 'mil177']",[],https://twitter.com/NIAIDNews/status/1288955342064250881,False,,1,https://pbs.twimg.com/media/EeNJ1YCU4AIq1cy.jpg,,,,,,,[],,,,
1288203186986053633,1288203186986053633,2020-07-28 20:02:28 UTC,2020-07-28,20:02:28,+0000,59769395,niaidnews,NIAID News,,#COVID19 NEWS: Experimental NIH/Moderna #vaccine to prevent #COVID19 induced robust immune responses and rapidly controlled #coronavirus in upper and lower airways of nonhuman primates. Research by #NIAID scientists online today in @NEJM.  https://t.co/JHK1ACOZwh,en,"[{'screen_name': 'nejm', 'name': 'nejm', 'id': '25950355'}]",['https://bit.ly/2CVllYY'],[],14,20,36,"['covid19', 'vaccine', 'covid19', 'coronavirus', 'niaid']",[],https://twitter.com/NIAIDNews/status/1288203186986053633,False,,0,,,,,,,,[],,,,
1287707120607981570,1287707116564697088,2020-07-27 11:11:16 UTC,2020-07-27,11:11:16,+0000,59769395,niaidnews,NIAID News,,Additional details about the Phase 3 clinical trial of mRNA-1273 and a full list of study locations are available on  https://t.co/K4OiZl9wYy.  https://t.co/rAp6lUvCkc. #COVID19 #SARSCoV2,en,[],"['http://ClinicalTrials.gov', 'https://bit.ly/3hBwblA']",[],2,5,7,"['covid19', 'sarscov2']",[],https://twitter.com/NIAIDNews/status/1287707120607981570,False,,0,,,,,,,,[],,,,
1287707119454531585,1287707116564697088,2020-07-27 11:11:16 UTC,2020-07-27,11:11:16,+0000,59769395,niaidnews,NIAID News,,The #NIH #COVID19 Prevention Network will participate in conducting the trial. Learn more‚Äîincluding how to volunteer to be a participant in a COVID-19 prevention trial‚Äîat  https://t.co/14TJUmLDDy.,en,[],['https://www.coronaviruspreventionnetwork.org/'],[],2,5,6,"['nih', 'covid19']",[],https://twitter.com/NIAIDNews/status/1287707119454531585,False,,0,,,,,,,,[],,,,
1287707118330499072,1287707116564697088,2020-07-27 11:11:16 UTC,2020-07-27,11:11:16,+0000,59769395,niaidnews,NIAID News,,The Phase 3 clinical trial aims to determine if the vaccine can prevent #COVID19. mRNA-1273 has shown promise in early-stage clinical testing led by #NIAID. The vaccine is generally well tolerated and prompted an immune response in healthy adults.  https://t.co/GTOcSu0NN3,en,[],['https://bit.ly/30dz1Gr'],[],1,4,7,"['covid19', 'niaid']",[],https://twitter.com/NIAIDNews/status/1287707118330499072,False,,0,,,,,,,,[],,,,
1287707116564697088,1287707116564697088,2020-07-27 11:11:15 UTC,2020-07-27,11:11:15,+0000,59769395,niaidnews,NIAID News,,"A Phase 3 clinical trial of the investigational mRNA-1273 vaccine for #COVID19 has begun. The vaccine was co-developed by @moderna_tx and #NIAID scientists. The trial will enroll 30,000 adult volunteers at nearly 90 sites in the US  https://t.co/xlIPsXRJVM  https://t.co/1gOXqWl9qF",en,"[{'screen_name': 'moderna_tx', 'name': 'moderna', 'id': '2227355222'}]",['https://bit.ly/3g7qgoa'],['https://pbs.twimg.com/media/Ed7ZfWSUMAA-2Qe.jpg'],3,38,72,"['covid19', 'niaid']",[],https://twitter.com/NIAIDNews/status/1287707116564697088,False,,1,https://pbs.twimg.com/media/Ed7ZfWSUMAA-2Qe.jpg,,,,,,,[],,,,
1286694155821998087,1286693868931555328,2020-07-24 16:06:07 UTC,2020-07-24,16:06:07,+0000,59769395,niaidnews,NIAID News,,Learn more about hereditary alpha tryptasemia and the related syndrome on the @NIAIDNews website:  https://t.co/aemY4fq8hh,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://bit.ly/HaTFAQ'],[],0,0,1,[],[],https://twitter.com/NIAIDNews/status/1286694155821998087,False,,0,,,,,,,,[],,,,
1286694009382084611,1286693868931555328,2020-07-24 16:05:32 UTC,2020-07-24,16:05:32,+0000,59769395,niaidnews,NIAID News,,.@NIAIDNews researchers originally identified and described the #genetic trait now known as hereditary alpha tryptasemia in 2016:  https://t.co/39F6P0tWfi,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://bit.ly/AlphaTryptase'],[],2,0,1,['genetic'],[],https://twitter.com/NIAIDNews/status/1286694009382084611,False,,0,,,,,,,,[],,,,
1286693868931555328,1286693868931555328,2020-07-24 16:04:58 UTC,2020-07-24,16:04:58,+0000,59769395,niaidnews,NIAID News,,"#ALLERGY NEWS: @NIAIDNews scientists &amp; colleagues identify the first #heritable risk factor for severe #anaphylaxis. People with hereditary alpha tryptasemia may have higher anaphylaxis risk, researchers report in @jacionline:  https://t.co/RedBp3wGB3",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'jacionline', 'name': 'journal of allergy and clinical immunology', 'id': '133749511'}]",['https://bit.ly/HaTanaphylaxis'],[],2,5,8,"['allergy', 'heritable', 'anaphylaxis']",[],https://twitter.com/NIAIDNews/status/1286693868931555328,False,,0,,,,,,,,[],,,,
1286644939367931904,1286644325485441024,2020-07-24 12:50:32 UTC,2020-07-24,12:50:32,+0000,59769395,niaidnews,NIAID News,,"@EMA_News @NIAIDNews thanks and congratulates everyone who led, conducted and participated in the research that led to the positive opinion, especially our partners @IPMicrobicides and @HIVMTN.  #DapivirineRing #WomensHealth #HIV #HIVprevention",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'ipmicrobicides', 'name': 'ipm', 'id': '512018538'}, {'screen_name': 'hivmtn', 'name': 'mtn', 'id': '2338701852'}]",[],[],2,5,17,"['dapivirinering', 'womenshealth', 'hiv', 'hivprevention']",[],https://twitter.com/NIAIDNews/status/1286644939367931904,False,,0,,,,,,,,"[{'screen_name': 'EMA_News', 'name': 'EU Medicines Agency', 'id': '116716199'}]",,,,
1286644325485441024,1286644325485441024,2020-07-24 12:48:06 UTC,2020-07-24,12:48:06,+0000,59769395,niaidnews,NIAID News,,HIV NEWS: A vaginal ring for #HIV prevention has received a positive opinion from @EMA_News for use by cisgender women in developing countries! @NIAIDNews celebrates this pivotal step toward expanding #HIVprevention choices for women.  https://t.co/CcdD0rkqj1   #WomensHealth  https://t.co/x7rSlvboBW,en,"[{'screen_name': 'ema_news', 'name': 'eu medicines agency', 'id': '116716199'}, {'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://bit.ly/EMA_dapivirine_ring'],['https://pbs.twimg.com/media/EdsUK8gUMAAJ_be.jpg'],5,41,62,"['hiv', 'hivprevention', 'womenshealth']",[],https://twitter.com/NIAIDNews/status/1286644325485441024,False,,1,https://pbs.twimg.com/media/EdsUK8gUMAAJ_be.jpg,,,,,,,[],,,,
1286301109422665728,1286301109422665728,2020-07-23 14:04:17 UTC,2020-07-23,14:04:17,+0000,59769395,niaidnews,NIAID News,,"HIV NEWS: #Kidney #transplantation between people with HIV is safe, a @NIAIDNews-supported HOPE Act study has found. This expands the pool of available kidneys for people with #HIV, making more kidneys available for all who are awaiting a #transplant.  https://t.co/MTn5PEvqHy  https://t.co/ShydAW3EKu",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://bit.ly/HIVKidneyTransplant'],['https://pbs.twimg.com/media/EdnY7u-U0AAiq1k.jpg'],0,30,46,"['kidney', 'transplantation', 'hiv', 'transplant']",[],https://twitter.com/NIAIDNews/status/1286301109422665728,False,,1,https://pbs.twimg.com/media/EdnY7u-U0AAiq1k.jpg,,,,,,,[],,,,
1285212376300650497,1285212376300650497,2020-07-20 13:58:03 UTC,2020-07-20,13:58:03,+0000,59769395,niaidnews,NIAID News,,"#HIV BLOG: @NIAIDNews, @IAVI &amp; collaborators will combine their expertise to develop combinations of broadly neutralizing #antibodies (#bNAbs) for #HIVPrevention &amp; possibly treatment.  https://t.co/HKWWpoJveL",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'iavi', 'name': 'iavi', 'id': '128586415'}]",['https://bit.ly/HIVcombobNAbs'],[],3,20,22,"['hiv', 'antibodies', 'bnabs', 'hivprevention']",[],https://twitter.com/NIAIDNews/status/1285212376300650497,False,,0,,,,,,,,[],,,,
1283471892846792704,1283471892846792704,2020-07-15 18:41:59 UTC,2020-07-15,18:41:59,+0000,59769395,niaidnews,NIAID News,,"#COVID19 NEWS: @NIAIDNews-funded research identifies potent #antibodies against #SARSCoV2 that are protective in animal models, providing insights for development of #vaccines &amp; antibody-based prevention for COVID-19. Read more in @nature:  https://t.co/WqXZppL0oN",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'nature', 'name': 'nature', 'id': '15862891'}]",['https://go.nature.com/2DCc1cn'],[],1,7,20,"['covid19', 'antibodies', 'sarscov2', 'vaccines']",[],https://twitter.com/NIAIDNews/status/1283471892846792704,False,,0,,,,,,,,[],,,,
1283459680447029248,1283459680447029248,2020-07-15 17:53:28 UTC,2020-07-15,17:53:28,+0000,59769395,niaidnews,NIAID News,,"#FoodAllergy NEWS: A @NIAIDNews-supported survey of U.S. pediatricians found nearly all are aware of, and 29% are fully implementing, the peanut allergy prevention guidelines. Overcoming the identified barriers to implementation may reduce #peanutallergy:  https://t.co/qdWGzk9wyD  https://t.co/rzH2Uboi7a",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://bit.ly/PeanutSurvey1'],['https://pbs.twimg.com/media/Ec_Dq2kUYAEfQ-L.jpg'],0,1,4,"['foodallergy', 'peanutallergy']",[],https://twitter.com/NIAIDNews/status/1283459680447029248,False,,1,https://pbs.twimg.com/media/Ec_Dq2kUYAEfQ-L.jpg,,,,,,,[],,,,
1283148826723807232,1283148826723807232,2020-07-14 21:18:14 UTC,2020-07-14,21:18:14,+0000,59769395,niaidnews,NIAID News,,COVID19 NEWS: Early results of #NIAID-sponsored ph1 trial of experimental #SARSCOV2 vaccine mRNA-1273: two doses generally well tolerated and prompted a robust immune response in healthy adults.  https://t.co/GTOcSu0NN3  https://t.co/fpYDH4AFfM,en,[],['https://bit.ly/30dz1Gr'],['https://pbs.twimg.com/media/Ec6ozCmVcAAYYrY.jpg'],3,65,124,"['niaid', 'sarscov2']",[],https://twitter.com/NIAIDNews/status/1283148826723807232,False,,1,https://pbs.twimg.com/media/Ec6ozCmVcAAYYrY.jpg,,,,,,,[],,,,
1282763665939116033,1282763665939116033,2020-07-13 19:47:45 UTC,2020-07-13,19:47:45,+0000,59769395,niaidnews,NIAID News,,#FLU NEWS: @NIAIDNews-funded study illustrates effect of #adjuvant in enhancing #antibody responses to H5N1 #influenza #vaccine. Findings reported in @PNASNews may aid development of a #UniversalFluVaccine.  https://t.co/TDF86f6SZa,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'pnasnews', 'name': 'pnasnews', 'id': '258847118'}]",['https://bit.ly/3j2gq8C'],[],4,8,33,"['flu', 'adjuvant', 'antibody', 'influenza', 'vaccine', 'universalfluvaccine']",[],https://twitter.com/NIAIDNews/status/1282763665939116033,False,,0,,,,,,,,[],,,,
1281640651784765443,1281640651784765443,2020-07-10 17:25:17 UTC,2020-07-10,17:25:17,+0000,59769395,niaidnews,NIAID News,,Initial data from the @NIH-funded @reprievetrial on #HIV &amp; ‚ù§Ô∏è disease highlight the impact and prevalence of other comorbidities in a global population #AgingWithHIV.,en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}, {'screen_name': 'reprievetrial', 'name': 'reprieve trial', 'id': '2863910194'}]",[],[],5,7,12,"['hiv', 'agingwithhiv']",[],https://twitter.com/NIAIDNews/status/1281640651784765443,False,https://twitter.com/reprievetrial/status/1281633241103921152,0,,,,,,,,[],,,,
1281581313733136385,1281581313733136385,2020-07-10 13:29:30 UTC,2020-07-10,13:29:30,+0000,59769395,niaidnews,NIAID News,,ICYMI: @NIAIDNews' Dr. Carl Dieffenbach spoke with  @HIVgov about highlights in #HIV treatment research from #AIDS2020Virtual. Watch the interview üìΩÔ∏è &amp; read more on #NIAIDNow:  https://t.co/fcQ91B77Rv,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'hivgov', 'name': 'hiv.gov', 'id': '15368404'}]",['https://bit.ly/AIDS2020-day-2'],[],3,0,9,"['hiv', 'aids2020virtual', 'niaidnow']",[],https://twitter.com/NIAIDNews/status/1281581313733136385,False,,0,,,,,,,,[],,,,
1281333152129011718,1281333152129011718,2020-07-09 21:03:24 UTC,2020-07-09,21:03:24,+0000,59769395,niaidnews,NIAID News,,Our final daily #AIDS2020Virtual update with @NIAIDnews‚Äô Dr. Carl Dieffenbach begins now! Join us to hear highlights from the 23rd International AIDS Conference.,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",[],[],5,1,10,['aids2020virtual'],[],https://twitter.com/NIAIDNews/status/1281333152129011718,False,https://twitter.com/HIVGov/status/1281332286588252160,0,,,,,,,,[],,,,
1281317198204555264,1281317198204555264,2020-07-09 20:00:00 UTC,2020-07-09,20:00:00,+0000,59769395,niaidnews,NIAID News,,Join us in just one hour for the final #AIDS2020Virtual interview with @NIAIDnews‚Äô Dr. Carl Dieffenbach to hear about the latest #HIV research advances. #EndHIVEpidemic  https://t.co/2Kdsye8cq7,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",[],['https://pbs.twimg.com/media/Ecf2CShUwAYU05i.jpg'],0,0,5,"['aids2020virtual', 'hiv', 'endhivepidemic']",[],https://twitter.com/NIAIDNews/status/1281317198204555264,False,,1,https://pbs.twimg.com/media/Ecf2CShUwAYU05i.jpg,,,,,,,[],,,,
1281233684285157377,1281233684285157377,2020-07-09 14:28:09 UTC,2020-07-09,14:28:09,+0000,59769395,niaidnews,NIAID News,,Join us today at 5 pm EDT for the final #AIDS2020Virtual interview with @NIAIDnews‚Äô Dr. Carl Dieffenbach to hear about the latest progress in #HIV research. #EndHIVEpidemic  https://t.co/Qxv8CUXmZs,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",[],['https://pbs.twimg.com/media/EcfbIGuVAAANLT_.jpg'],0,0,3,"['aids2020virtual', 'hiv', 'endhivepidemic']",[],https://twitter.com/NIAIDNews/status/1281233684285157377,False,,1,https://pbs.twimg.com/media/EcfbIGuVAAANLT_.jpg,,,,,,,[],,,,
1280969910882111489,1280969910882111489,2020-07-08 21:00:00 UTC,2020-07-08,21:00:00,+0000,59769395,niaidnews,NIAID News,,Join us in just one hour for the next #AIDS2020Virtual interview with @NIAIDnews‚Äô Dr. Carl Dieffenbach to hear about key #HIV research advances from the 23rd International AIDS Conference. #EndHIVEpidemic  https://t.co/OMwh5h7aUa,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",[],['https://pbs.twimg.com/media/Eca2LPEVAAAUYVW.jpg'],0,0,4,"['aids2020virtual', 'hiv', 'endhivepidemic']",[],https://twitter.com/NIAIDNews/status/1280969910882111489,False,,1,https://pbs.twimg.com/media/Eca2LPEVAAAUYVW.jpg,,,,,,,[],,,,
1280959986294648833,1280959986294648833,2020-07-08 20:20:34 UTC,2020-07-08,20:20:34,+0000,59769395,niaidnews,NIAID News,,BLOGüìΩÔ∏è: Missed yesterday's update from #AIDS2020Virtual with @NIAIDNews' Dr. Carl Dieffenbach and @HIVgov? Watch the video and read highlights on #NIAIDNow:  https://t.co/XrUhCG1fPC,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'hivgov', 'name': 'hiv.gov', 'id': '15368404'}]",['https://bit.ly/AIDS2020day1'],[],0,1,3,"['aids2020virtual', 'niaidnow']",[],https://twitter.com/NIAIDNews/status/1280959986294648833,False,,0,,,,,,,,[],,,,
1280898174236966918,1280898174236966918,2020-07-08 16:14:57 UTC,2020-07-08,16:14:57,+0000,59769395,niaidnews,NIAID News,,"NEWS: @NIAIDNews study finds #autoantibodies are prevalent in people with the #RareDisease idiopathic CD4 lymphopenia (#ICL) &amp; may contribute to disease progression, suggesting potential for new ICL therapies. Read more in @jclinicalinvest:  https://t.co/JXh95MFhLx",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'jclinicalinvest', 'name': 'journal of clinical investigation', 'id': '223605846'}]",['https://www.jci.org/articles/view/136254'],[],0,1,5,"['autoantibodies', 'raredisease', 'icl']",[],https://twitter.com/NIAIDNews/status/1280898174236966918,False,,0,,,,,,,,[],,,,
1280879686453792768,1280879686453792768,2020-07-08 15:01:29 UTC,2020-07-08,15:01:29,+0000,59769395,niaidnews,NIAID News,,"#COVID19 News: A large new clinical trials network, launched by @NIH and NIAID, will enable researchers to enroll thousands of volunteers in tests of #vaccines and other prevention tools for COVID-19.  https://t.co/Rr5dFv8TEV  https://t.co/y4weozgONb",en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}]",['https://bit.ly/COVPNLaunch'],['https://pbs.twimg.com/media/EcaYEy0XQAAY7wZ.jpg'],5,30,28,"['covid19', 'vaccines']",[],https://twitter.com/NIAIDNews/status/1280879686453792768,False,,1,https://pbs.twimg.com/media/EcaYEy0XQAAY7wZ.jpg,,,,,,,[],,,,
1280867372727857152,1280867372727857152,2020-07-08 14:12:33 UTC,2020-07-08,14:12:33,+0000,59769395,niaidnews,NIAID News,,Are you interested in volunteering for a #COVID19 Clinical Study? Visit the COVID-19 Prevention Network (CoVPN) website to take the questionnaire and join the CoVPN Volunteer Screening Registry. You may be contacted if trials open up in your area:  https://t.co/jXh29Fj3b4  https://t.co/px9Qe6Hm8k,en,[],['https://bit.ly/3gC8YiI'],['https://pbs.twimg.com/media/EcaODpGU0AMku89.jpg'],1,29,24,['covid19'],[],https://twitter.com/NIAIDNews/status/1280867372727857152,False,,1,https://pbs.twimg.com/media/EcaODpGU0AMku89.jpg,,,,,,,[],,,,
1280867281581400064,1280867281581400064,2020-07-08 14:12:11 UTC,2020-07-08,14:12:11,+0000,59769395,niaidnews,NIAID News,,"Join us today at 6 PM EDT for the next daily #AIDS2020Virtual interview with @NIAIDnews‚Äôs Dr. Carl Dieffenbach, when he‚Äôll share pivotal #HIV research advances from the international conference. #EndHIVEpidemic  https://t.co/b3XE5hqXJa",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",[],['https://pbs.twimg.com/media/EcaN-ulUYAAOuIv.jpg'],0,5,9,"['aids2020virtual', 'hiv', 'endhivepidemic']",[],https://twitter.com/NIAIDNews/status/1280867281581400064,False,,1,https://pbs.twimg.com/media/EcaN-ulUYAAOuIv.jpg,,,,,,,[],,,,
1280500553957748739,1280500553957748739,2020-07-07 13:54:57 UTC,2020-07-07,13:54:57,+0000,59769395,niaidnews,NIAID News,,"#HIV NEWS: Long-acting injectable form of HIV #PrEP outperforms daily pill in @NIAIDNews study. Both methods were highly effective at preventing HIV among MSM and TGW, @HIVptn scientists report at #AIDS2020.  https://t.co/INjcaCUaTi  https://t.co/GS0udbkJJ1",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'hivptn', 'name': 'hptn', 'id': '79056447'}]",['https://bit.ly/LAPrEP-AIDS2020'],['https://pbs.twimg.com/media/EcVAQExXYAEJREU.jpg'],5,36,49,"['hiv', 'prep', 'aids2020']",[],https://twitter.com/NIAIDNews/status/1280500553957748739,False,,1,https://pbs.twimg.com/media/EcVAQExXYAEJREU.jpg,,,,,,,[],,,,
1278791421168934932,1278791421168934932,2020-07-02 20:43:28 UTC,2020-07-02,20:43:28,+0000,59769395,niaidnews,NIAID News,,#HIV NEWS: @NIAIDNews Director Dr. Anthony S. Fauci &amp; his colleague Dr. H. Clifford Lane review four decades of progress in #HIV research and highlight future priorities an in @NEJM perspective:  https://t.co/BS4IgpkWyJ,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'nejm', 'name': 'nejm', 'id': '25950355'}]",['https://bit.ly/4decadesHIV'],[],3,11,24,"['hiv', 'hiv']",[],https://twitter.com/NIAIDNews/status/1278791421168934932,False,,0,,,,,,,,[],,,,
1275918225323069441,1275918225323069441,2020-06-24 22:26:24 UTC,2020-06-24,22:26:24,+0000,59769395,niaidnews,NIAID News,,NEWS: NIAID investigators hope CD47 study leads to broad-spectrum infectious diseases immunotherapy.  https://t.co/KT90kFhEDA #COVID19  https://t.co/TBYqgquwwQ,en,[],['https://bit.ly/3evPtYk'],['https://pbs.twimg.com/media/EbT4hRPU8AM8kPO.jpg'],2,13,31,['covid19'],[],https://twitter.com/NIAIDNews/status/1275918225323069441,False,,1,https://pbs.twimg.com/media/EbT4hRPU8AM8kPO.jpg,,,,,,,[],,,,
1275418282183372806,1275418282183372806,2020-06-23 13:19:49 UTC,2020-06-23,13:19:49,+0000,59769395,niaidnews,NIAID News,,"#COVID19 NEWS: Experts from @NIAIDNews &amp; beyond identify steps to expand and improve #SARSCoV2 antibody tests in pandemic response efforts. The report, out today in @ImmunityCP, highlights capabilities, limits of #serology testing:  https://t.co/ZNHZ9eejWQ  https://t.co/TLAVGqXuXl",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'immunitycp', 'name': 'immunity', 'id': '295993800'}]",['https://bit.ly/SARSCoV2-Ab-tests'],['https://pbs.twimg.com/media/EbMxioaUwAE_yB8.png'],8,13,27,"['covid19', 'sarscov2', 'serology']",[],https://twitter.com/NIAIDNews/status/1275418282183372806,False,,1,https://pbs.twimg.com/media/EbMxioaUwAE_yB8.png,,,,,,,[],,,,
1275112082740875265,1275112082740875265,2020-06-22 17:03:05 UTC,2020-06-22,17:03:05,+0000,59769395,niaidnews,NIAID News,,"NEWS: NIAID study provides framework for health care workers to assess and plan for spread of coronaviruses among patients and staff.  https://t.co/JGZesDqYNE #COVID19, #MERS, #SARS  https://t.co/YK8rk2vJMv",en,[],['https://bit.ly/2YibIv6'],['https://pbs.twimg.com/media/EbIbMrVU8AAXhz2.jpg'],0,9,11,"['covid19', 'mers', 'sars']",[],https://twitter.com/NIAIDNews/status/1275112082740875265,False,,1,https://pbs.twimg.com/media/EbIbMrVU8AAXhz2.jpg,,,,,,,[],,,,
1271558435142803457,1271558435142803457,2020-06-12 21:42:10 UTC,2020-06-12,21:42:10,+0000,59769395,niaidnews,NIAID News,,"VACCINE NEWS: An early trial of a ‚Äúmosquito #vaccine,‚Äù which could someday provide broad protection against #mosquito-borne diseases, showed promising results in a new study in @TheLancet.  https://t.co/oroDdkc6MC  https://t.co/1seTulWQnF",en,"[{'screen_name': 'thelancet', 'name': 'the lancet', 'id': '27013292'}]",['https://bit.ly/MosquitoVaccine'],['https://pbs.twimg.com/media/EaV7ejyXQAAVptt.jpg'],1,13,34,"['vaccine', 'mosquito']",[],https://twitter.com/NIAIDNews/status/1271558435142803457,False,,1,https://pbs.twimg.com/media/EaV7ejyXQAAVptt.jpg,,,,,,,[],,,,
1271438885361516544,1271438885361516544,2020-06-12 13:47:07 UTC,2020-06-12,13:47:07,+0000,59769395,niaidnews,NIAID News,,"NEWS: New data shows mRNA-1273, an investigational vaccine developed by #NIAID and @moderna_tx, protects mice from infection with #SARSCoV2. The findings are available on the preprint server bioRxiv and are not yet peer-reviewed.  https://t.co/BATSl9HiIN  https://t.co/3kKOeS6daY",en,"[{'screen_name': 'moderna_tx', 'name': 'moderna', 'id': '2227355222'}]",['http://bit.ly/mRNA-1273Preprint'],['https://pbs.twimg.com/media/EaUOu7QXsAAqIAG.jpg'],10,78,183,"['niaid', 'sarscov2']",[],https://twitter.com/NIAIDNews/status/1271438885361516544,False,,1,https://pbs.twimg.com/media/EaUOu7QXsAAqIAG.jpg,,,,,,,[],,,,
1267854783915982848,1267854783915982848,2020-06-02 16:25:10 UTC,2020-06-02,16:25:10,+0000,59769395,niaidnews,NIAID News,,"HIV NEWS: In pursuit of an #HIVCure, NIAID scientists update analytical treatment interruption data to accommodate modern #HIV drugs. Read more:  https://t.co/TyixnvEa7D #NIAIDNow  https://t.co/VPVyi3S8GV",en,[],['http://bit.ly/HIVTreatmentInterruption'],['https://pbs.twimg.com/media/EZhTHhOX0AI-VP7.jpg'],0,9,26,"['hivcure', 'hiv', 'niaidnow']",[],https://twitter.com/NIAIDNews/status/1267854783915982848,False,,1,https://pbs.twimg.com/media/EZhTHhOX0AI-VP7.jpg,,,,,,,[],,,,
1263960589979828224,1263960589979828224,2020-05-22 22:31:02 UTC,2020-05-22,22:31:02,+0000,59769395,niaidnews,NIAID News,,"NEWS: #Remdesivir improves time to recovery for people hospitalized with #COVID19, according to a peer-reviewed preliminary analysis published today in @NEJM. The results are from the #NIH randomized, placebo-controlled trial that began on Feb. 21  https://t.co/aZGRL1ywvq  https://t.co/vV2jQ6w4CC",en,"[{'screen_name': 'nejm', 'name': 'nejm', 'id': '25950355'}]",['https://www.niaid.nih.gov/news-events/peer-reviewed-data-shows-remdesivir-covid-19-improves-time-recovery'],['https://pbs.twimg.com/media/EYp9MyVXYAEZ6bc.jpg'],5,67,107,"['remdesivir', 'covid19', 'nih']",[],https://twitter.com/NIAIDNews/status/1263960589979828224,False,,1,https://pbs.twimg.com/media/EYp9MyVXYAEZ6bc.jpg,,,,,,,[],,,,
1262417140688306184,1262417140688306184,2020-05-18 16:17:55 UTC,2020-05-18,16:17:55,+0000,59769395,niaidnews,NIAID News,,HIV NEWS: Long-acting injectable cabotegravir prevents #HIV among men who have sex with men &amp; transgender women. @NIAIDNews study is first large trial to find long-acting HIV prevention highly effective.  https://t.co/ykuW0YwVOt #PrEP  https://t.co/mRp9dNXOG0,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://bit.ly/LAPrEP'],['https://pbs.twimg.com/media/EYUBc-kXgAA4kFV.jpg'],1,22,38,"['hiv', 'prep']",[],https://twitter.com/NIAIDNews/status/1262417140688306184,False,,1,https://pbs.twimg.com/media/EYUBc-kXgAA4kFV.jpg,,,,,,,[],,,,
1261386815413641223,1261386815413641223,2020-05-15 20:03:46 UTC,2020-05-15,20:03:46,+0000,59769395,niaidnews,NIAID News,,"NEWS: Recurring #BacterialVaginosis can be prevented with a treatment of live beneficial #bacteria, say NIAID-funded researchers in a new @NEJM study:  https://t.co/AVUq0zkJ5o  https://t.co/ZgBVwWfI8L",en,"[{'screen_name': 'nejm', 'name': 'nejm', 'id': '25950355'}]",['https://bit.ly/LACTIN-V'],['https://pbs.twimg.com/media/EYFXlgEWoAEeDJ9.jpg'],1,2,10,"['bacterialvaginosis', 'bacteria']",[],https://twitter.com/NIAIDNews/status/1261386815413641223,False,,1,https://pbs.twimg.com/media/EYFXlgEWoAEeDJ9.jpg,,,,,,,[],,,,
1261301208507015171,1261301155675516928,2020-05-15 14:23:36 UTC,2020-05-15,14:23:36,+0000,59769395,niaidnews,NIAID News,,"@ljiresearch @NIH @CellPress Such T cell responses suggest infection or a vaccine may induce immunity. Researchers also found that blood samples from those not exposed to #SARSCoV2 also produced some T cell responses, possibly explained by exposure to related coronaviruses that cause the common cold.",en,[],[],[],3,14,34,['sarscov2'],[],https://twitter.com/NIAIDNews/status/1261301208507015171,False,,0,,,,,,,,"[{'screen_name': 'ljiresearch', 'name': 'La Jolla Institute', 'id': '158539834'}, {'screen_name': 'NIH', 'name': 'NIH', 'id': '15134240'}, {'screen_name': 'CellPress', 'name': 'Cell Press', 'id': '151619213'}]",,,,
1261301155675516928,1261301155675516928,2020-05-15 14:23:24 UTC,2020-05-15,14:23:24,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: @LJIResearch scientists have identified robust T cell responses to #SARSCoV2 in people who have recovered from #COVID19, according to @NIH-supported research published today in @CellPress:  https://t.co/HB8Hy2ozNS  https://t.co/YetDAPAP62",en,"[{'screen_name': 'ljiresearch', 'name': 'la jolla institute', 'id': '158539834'}, {'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}, {'screen_name': 'cellpress', 'name': 'cell press', 'id': '151619213'}]",['http://bit.ly/COVID19Tcells'],['https://pbs.twimg.com/media/EYEKcgDVAAEBPzA.jpg'],11,87,161,"['sarscov2', 'covid19']",[],https://twitter.com/NIAIDNews/status/1261301155675516928,False,,1,https://pbs.twimg.com/media/EYEKcgDVAAEBPzA.jpg,,,,,,,[],,,,
1261291670718603266,1261291670718603266,2020-05-15 13:45:42 UTC,2020-05-15,13:45:42,+0000,59769395,niaidnews,NIAID News,,HIV NEWS: Scientists at NIAID &amp; @amsterdamumc report distinct differences in the gut #microbiomes ü¶† of people w #HIV &amp; HIV-negative peers in @NatureComms. The HIV-related microbiome may increase inflammation &amp; exacerbate complications like ‚ô•Ô∏è disease:  https://t.co/sdqMMuv2go  https://t.co/ORn5H6j85j,en,"[{'screen_name': 'amsterdamumc', 'name': 'amsterdam umc', 'id': '43339294'}, {'screen_name': 'naturecomms', 'name': 'nature communications', 'id': '206255645'}]",['http://bit.ly/HIVDysbiosis'],['https://pbs.twimg.com/media/EYECBD9XQAAhf49.jpg'],0,12,29,"['microbiomes', 'hiv']",[],https://twitter.com/NIAIDNews/status/1261291670718603266,False,,1,https://pbs.twimg.com/media/EYECBD9XQAAhf49.jpg,,,,,,,[],,,,
1260998851957272580,1260998851957272580,2020-05-14 18:22:09 UTC,2020-05-14,18:22:09,+0000,59769395,niaidnews,NIAID News,,"NEWS: @NIAIDNews has begun a #ClinicalTrial to evaluate whether hydroxychloroquine and azithromycin can prevent hospitalization and death from #COVID19. The study will enroll ~2,000 adults at @ACTGNetwork sites across the U.S.  https://t.co/ZWuTBOmGnD  https://t.co/N0MRFFczDc",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'actgnetwork', 'name': 'actg network', 'id': '361405892'}]",['https://bit.ly/HCQAzithro'],['https://pbs.twimg.com/media/EX_3uAdX0AE9Pbv.jpg'],10,30,34,"['clinicaltrial', 'covid19']",[],https://twitter.com/NIAIDNews/status/1260998851957272580,False,,1,https://pbs.twimg.com/media/EX_3uAdX0AE9Pbv.jpg,,,,,,,[],,,,
1260294268662345728,1260294268662345728,2020-05-12 19:42:23 UTC,2020-05-12,19:42:23,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: With NIAID support, @IcahnMountSinai researchers report a new lab test to identify antibodies to #SARSCoV2 (the virus that causes #COVID19) in @NatureMedicine. The test has been authorized for emergency use by the @US_FDA:  https://t.co/tlZFfbeUhE  https://t.co/kIETTluC1j",en,"[{'screen_name': 'icahnmountsinai', 'name': 'icahn school of medicine at mount sinai', 'id': '1268038951'}, {'screen_name': 'naturemedicine', 'name': 'nature medicine', 'id': '26832834'}, {'screen_name': 'us_fda', 'name': 'u.s. fda', 'id': '208120290'}]",['http://bit.ly/NatMedSARSCoV2'],['https://pbs.twimg.com/media/EX10u3dU4AAlqnk.jpg'],4,17,29,"['sarscov2', 'covid19']",[],https://twitter.com/NIAIDNews/status/1260294268662345728,False,,1,https://pbs.twimg.com/media/EX10u3dU4AAlqnk.jpg,,,,,,,[],,,,
1259860370098880513,1259860370098880513,2020-05-11 14:58:13 UTC,2020-05-11,14:58:13,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: To successfully develop vaccines for #COVID19, experts from @NIH and @FredHutch write in @ScienceMagazine, public and private sectors will need to collaborate strategically on vaccine research and development.  https://t.co/5V2otP61hg  https://t.co/e0YGMnPnFf",en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}, {'screen_name': 'fredhutch', 'name': 'fred hutch', 'id': '16645335'}, {'screen_name': 'sciencemagazine', 'name': 'science magazine', 'id': '32372834'}]",['http://bit.ly/VaccineDevelopmentCoordination'],['https://pbs.twimg.com/media/EXvsGD1XQAAYBNy.jpg'],12,17,27,['covid19'],[],https://twitter.com/NIAIDNews/status/1259860370098880513,False,,1,https://pbs.twimg.com/media/EXvsGD1XQAAYBNy.jpg,,,,,,,[],,,,
1258817812623220737,1258817812623220737,2020-05-08 17:55:28 UTC,2020-05-08,17:55:28,+0000,59769395,niaidnews,NIAID News,,"NEWS: NIAID begins a randomized, controlled clinical trial testing the antiviral #remdesivir plus the anti-inflammatory drug #baricitinib for the treatment of people hospitalized with #COVID19.  https://t.co/yEJbeCfwzq  https://t.co/3xwWrRYAaf",en,[],['http://bit.ly/ACTT_2'],['https://pbs.twimg.com/media/EXg3dAxXQAAGlwP.jpg'],2,26,32,"['remdesivir', 'baricitinib', 'covid19']",[],https://twitter.com/NIAIDNews/status/1258817812623220737,False,,1,https://pbs.twimg.com/media/EXg3dAxXQAAGlwP.jpg,,,,,,,[],,,,
1258128186451177472,1258128039071760384,2020-05-06 20:15:09 UTC,2020-05-06,20:15:09,+0000,59769395,niaidnews,NIAID News,,@CellPressNews published the findings on May 5:  https://t.co/ewSMCeabvx  #COVID19 #SARSCoV2,en,"[{'screen_name': 'cellpressnews', 'name': 'cell press', 'id': '18477428'}]",['http://bit.ly/2xCfN2O'],[],0,7,5,"['covid19', 'sarscov2']",[],https://twitter.com/NIAIDNews/status/1258128186451177472,False,,0,,,,,,,,[],,,,
1258128039071760384,1258128039071760384,2020-05-06 20:14:34 UTC,2020-05-06,20:14:34,+0000,59769395,niaidnews,NIAID News,,"NEWS: An engineered antibody derived from llama antibodies may neutralize #SARSCoV2, the virus that causes #COVID19, report researchers at NIAID, @TexasScience &amp; @ResearchUGent ü¶ôFurther research into these proteins may help scientists find new treatments:  https://t.co/THvei99UTb  https://t.co/FA0a097kPN",en,"[{'screen_name': 'texasscience', 'name': 'naturalsciences @ ut', 'id': '52425323'}, {'screen_name': 'researchugent', 'name': 'ghent university research', 'id': '381935216'}]",['http://bit.ly/2WBMaak'],['https://pbs.twimg.com/media/EXXEwizUYAABZn0.jpg'],18,70,135,"['sarscov2', 'covid19']",[],https://twitter.com/NIAIDNews/status/1258128039071760384,False,,1,https://pbs.twimg.com/media/EXXEwizUYAABZn0.jpg,,,,,,,[],,,,
1257662542018641920,1257662542018641920,2020-05-05 13:24:50 UTC,2020-05-05,13:24:50,+0000,59769395,niaidnews,NIAID News,,"On #WorldAsthmaDayüóìÔ∏è, @NIAIDNews, @NIEHS &amp; @nih_nhlbi raise awareness about #asthma, the people it affects, and biomedical research to improve its prevention and treatment.  https://t.co/Vm3y6ex5rw  https://t.co/jA36QpovQi",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'niehs', 'name': 'niehs', 'id': '97464922'}, {'screen_name': 'nih_nhlbi', 'name': 'nih nhlbi', 'id': '68987936'}]",['https://bit.ly/AsthmaDay2020'],['https://pbs.twimg.com/media/EXQdPJLXkAAUIcO.jpg'],2,23,27,"['worldasthmaday', 'asthma']",[],https://twitter.com/NIAIDNews/status/1257662542018641920,False,,1,https://pbs.twimg.com/media/EXQdPJLXkAAUIcO.jpg,,,,,,,[],,,,
1257297361254019074,1257297361254019074,2020-05-04 13:13:45 UTC,2020-05-04,13:13:45,+0000,59769395,niaidnews,NIAID News,,#COVID19 NEWS: An #NIH-funded study on the incidence of novel #coronavirus infection in U.S. children has begun. The study also will examine whether infection rates differ between children who do &amp; do not have #asthma or other #allergic conditions.  https://t.co/kenWsScmb5  https://t.co/hlLTfhX5IS,en,[],['https://bit.ly/coronavirus-in-kids'],['https://pbs.twimg.com/media/EXLRKqxUEAAL8ZV.jpg'],11,153,248,"['covid19', 'nih', 'coronavirus', 'asthma', 'allergic']",[],https://twitter.com/NIAIDNews/status/1257297361254019074,False,,1,https://pbs.twimg.com/media/EXLRKqxUEAAL8ZV.jpg,,,,,,,[],,,,
1256253505951563777,1256253505951563777,2020-05-01 16:05:50 UTC,2020-05-01,16:05:50,+0000,59769395,niaidnews,NIAID News,,"#COVID19 NEWS:  Newly launched IMPACC study examines #immune responses in people hospitalized with COVID-19. Data collected will help inform recommendations for care, may help identify new targets &amp; optimal timing for experimental treatments. Read more:  https://t.co/cpuJn05B3s  https://t.co/XmZPFzI6nw",en,[],['http://bit.ly/IMPACC'],['https://pbs.twimg.com/media/EW8bu6ZU8AILR3y.jpg'],6,25,41,"['covid19', 'immune']",[],https://twitter.com/NIAIDNews/status/1256253505951563777,False,,1,https://pbs.twimg.com/media/EW8bu6ZU8AILR3y.jpg,,,,,,,[],,,,
1255561419682009089,1255561419682009089,2020-04-29 18:15:44 UTC,2020-04-29,18:15:44,+0000,59769395,niaidnews,NIAID News,,COVID-19 NEWS: A preliminary data analysis from #NIH clinical trial shows hospitalized patients w/ advanced #COVID19 and lung involvement who received the investigational antiviral #remdesivir recovered faster than similar patients who received placebo:  https://t.co/E3igQRZidH  https://t.co/svVL3pwNvF,en,[],['http://bit.ly/NIAIDRemdesivir'],['https://pbs.twimg.com/media/EWymRnuUMAA6fce.jpg'],63,591,951,"['nih', 'covid19', 'remdesivir']",[],https://twitter.com/NIAIDNews/status/1255561419682009089,False,,1,https://pbs.twimg.com/media/EWymRnuUMAA6fce.jpg,,,,,,,[],,,,
1253758445049667584,1253758445049667584,2020-04-24 18:51:21 UTC,2020-04-24,18:51:21,+0000,59769395,niaidnews,NIAID News,,NIAID marks #WorldMalariaDay on the #NIAIDNow blog. See how we are supporting Zero Malaria Starts with Me. #EndMalaria  https://t.co/VmOycYI14B  https://t.co/EyCTEGLsnM,en,[],['https://bit.ly/2VWgSuE'],['https://pbs.twimg.com/media/EWY-ZwMVAAEFPfS.jpg'],0,9,10,"['worldmalariaday', 'niaidnow', 'endmalaria']",[],https://twitter.com/NIAIDNews/status/1253758445049667584,False,,1,https://pbs.twimg.com/media/EWY-ZwMVAAEFPfS.jpg,,,,,,,[],,,,
1251256724742451200,1251256724742451200,2020-04-17 21:10:25 UTC,2020-04-17,21:10:25,+0000,59769395,niaidnews,NIAID News,,"CHIKUNGUNYA NEWS: In a Phase 2 trial, NIAID researchers found that a new #vaccine for the #chikungunya virus is safe and shows promise for future trials:  https://t.co/Dtti1awIzw  https://t.co/wWqVTIQ17l",en,[],['http://bit.ly/CHIKV_VLP'],['https://pbs.twimg.com/media/EV1YogDWAAAR5BJ.jpg'],3,40,105,"['vaccine', 'chikungunya']",[],https://twitter.com/NIAIDNews/status/1251256724742451200,False,,1,https://pbs.twimg.com/media/EV1YogDWAAAR5BJ.jpg,,,,,,,[],,,,
1251217980660215809,1251217980660215809,2020-04-17 18:36:27 UTC,2020-04-17,18:36:27,+0000,59769395,niaidnews,NIAID News,,NEWS: NIAID study shows antiviral #remdesivir prevents disease progression in monkeys with #COVID19.  https://t.co/jAPXyjOpwd  https://t.co/VXpDHqJB23,en,[],['https://bit.ly/2za22ZK'],['https://pbs.twimg.com/media/EV031IBUEAEKFDG.jpg'],15,118,233,"['remdesivir', 'covid19']",[],https://twitter.com/NIAIDNews/status/1251217980660215809,False,,1,https://pbs.twimg.com/media/EV031IBUEAEKFDG.jpg,,,,,,,[],,,,
1251189516687167489,1251189516687167489,2020-04-17 16:43:21 UTC,2020-04-17,16:43:21,+0000,59769395,niaidnews,NIAID News,,NEWS: NIAID scientists show investigational chimp adenovirus #MERSCoV vaccine protects monkeys; #COVID19 study under way.  https://t.co/ASiglhOpB9  https://t.co/YxnmGfu7cQ,en,[],['https://bit.ly/3ctPNW2'],['https://pbs.twimg.com/media/EV0eC_eUEAEVoyd.jpg'],4,32,76,"['merscov', 'covid19']",[],https://twitter.com/NIAIDNews/status/1251189516687167489,False,,1,https://pbs.twimg.com/media/EV0eC_eUEAEVoyd.jpg,,,,,,,[],,,,
1250477333183528960,1250477333183528960,2020-04-15 17:33:23 UTC,2020-04-15,17:33:23,+0000,59769395,niaidnews,NIAID News,,NIAID study validates 3 decontamination methods for limited re-use of N95 respirators. #COVID19  https://t.co/eSymNqqMOk  https://t.co/IO3DAUbptM,en,[],['https://bit.ly/3abkVIr'],['https://pbs.twimg.com/media/EVqWTbRU8AAq1_M.jpg'],4,22,33,['covid19'],[],https://twitter.com/NIAIDNews/status/1250477333183528960,False,,1,https://pbs.twimg.com/media/EVqWTbRU8AAq1_M.jpg,,,,,,,[],,,,
1250156137661505536,1250156137661505536,2020-04-14 20:17:04 UTC,2020-04-14,20:17:04,+0000,59769395,niaidnews,NIAID News,,"Today, NIAID joins in recognizing the first #WorldChagasDiseaseDay. #ChagasDisease, an insect-borne disease, causes around 10,000 deaths each year.",en,[],[],[],1,12,9,"['worldchagasdiseaseday', 'chagasdisease']",[],https://twitter.com/NIAIDNews/status/1250156137661505536,False,https://twitter.com/WHO/status/1249952713623945217,0,,,,,,,,[],,,,
1249714706857615363,1249714706857615363,2020-04-13 15:02:59 UTC,2020-04-13,15:02:59,+0000,59769395,niaidnews,NIAID News,,"NIAID-funded Michigan study shows 4 common human #coronaviruses are seasonal, like flu. The coronavirus that causes #COVID19 was not examined in this study.  https://t.co/Wae5DqcHtR  https://t.co/3wnHfY3YST",en,[],['https://bit.ly/3a5xDs4'],['https://pbs.twimg.com/media/EVfgnXJUwAAZaFO.jpg'],7,11,22,"['coronaviruses', 'covid19']",[],https://twitter.com/NIAIDNews/status/1249714706857615363,False,,1,https://pbs.twimg.com/media/EVfgnXJUwAAZaFO.jpg,,,,,,,[],,,,
1248704977750515717,1248704977750515717,2020-04-10 20:10:41 UTC,2020-04-10,20:10:41,+0000,59769395,niaidnews,NIAID News,,#COVID19 NEWS: @NIH begins study to quantify undetected cases of #coronavirus infection. Blood samples from healthy volunteers are needed to inform public health decision making. Read more:  https://t.co/rzGtHqobru  üì∏: @NIBIBgov  https://t.co/QZQzIzjZY8,en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}, {'screen_name': 'nibibgov', 'name': 'nibib', 'id': '1603605517'}]",['http://bit.ly/NIHCOVID19SeroSurvey'],['https://pbs.twimg.com/media/EVQ4kvwUEAA0WHp.jpg'],15,128,171,"['covid19', 'coronavirus']",[],https://twitter.com/NIAIDNews/status/1248704977750515717,False,,1,https://pbs.twimg.com/media/EVQ4kvwUEAA0WHp.jpg,,,,,,,[],,,,
1246208930503512064,1246208930503512064,2020-04-03 22:52:17 UTC,2020-04-03,22:52:17,+0000,59769395,niaidnews,NIAID News,,Up close and personal: How NIAID scientists visualize microscopic enemies. #COVID19 #coronavirus  https://t.co/LtceEo3Cnm  https://t.co/FsxTXLHvz1,en,[],['https://bit.ly/2R5qqlw'],['https://pbs.twimg.com/media/EUtr_LUUUAAABJc.jpg'],22,20,37,"['covid19', 'coronavirus']",[],https://twitter.com/NIAIDNews/status/1246208930503512064,False,,1,https://pbs.twimg.com/media/EUtr_LUUUAAABJc.jpg,,,,,,,[],,,,
1246111920563732481,1246111920563732481,2020-04-03 16:26:48 UTC,2020-04-03,16:26:48,+0000,59769395,niaidnews,NIAID News,,#CORONAVIRUS BLOG: Experimental #coronavirus vaccine delivered by a microneedle patch shows promise in early animal study. #NIAIDNow blog has more  https://t.co/VaoBQPnknY  https://t.co/KUlQNIH0dY,en,[],['https://bit.ly/2UYJ2EL'],['https://pbs.twimg.com/media/EUsUFTFUYAA-35r.jpg'],37,59,113,"['coronavirus', 'coronavirus', 'niaidnow']",[],https://twitter.com/NIAIDNews/status/1246111920563732481,False,,1,https://pbs.twimg.com/media/EUsUFTFUYAA-35r.jpg,,,,,,,[],,,,
1243597725523992576,1243597725523992576,2020-03-27 17:56:17 UTC,2020-03-27,17:56:17,+0000,59769395,niaidnews,NIAID News,,NEWS: @EmoryUniversity in Atlanta will begin enrolling healthy adult volunteers in a Phase 1 clinical trial of a vaccine designed to prevent #coronavirus disease. The trial began in Seattle last week &amp; will enroll a total of 45 people across the 2 sites:  https://t.co/mxSNJjm7mq  https://t.co/1yf5BettP1,en,"[{'screen_name': 'emoryuniversity', 'name': 'emory university', 'id': '16438655'}]",['http://bit.ly/COVIDVaxAtlantaNIAID'],['https://pbs.twimg.com/media/EUIk14DWkAMZOWc.jpg'],14,281,406,['coronavirus'],[],https://twitter.com/NIAIDNews/status/1243597725523992576,False,,1,https://pbs.twimg.com/media/EUIk14DWkAMZOWc.jpg,,,,,,,[],,,,
1243224569147584512,1243224569147584512,2020-03-26 17:13:29 UTC,2020-03-26,17:13:29,+0000,59769395,niaidnews,NIAID News,,It‚Äôs starting now!  https://t.co/sR3IyiOM8d #coronavirus #COVID19 #SCASKSFAUCI @stephencurry30,en,"[{'screen_name': 'stephencurry30', 'name': 'stephen curry', 'id': '42562446'}]",['https://www.instagram.com/niaid/'],[],24,17,67,"['coronavirus', 'covid19', 'scasksfauci']",[],https://twitter.com/NIAIDNews/status/1243224569147584512,False,https://twitter.com/NIAIDNews/status/1243158522063249411,0,,,,,,,,[],,,,
1243158522063249411,1243158522063249411,2020-03-26 12:51:03 UTC,2020-03-26,12:51:03,+0000,59769395,niaidnews,NIAID News,,"LIVE at 1PM ET (3/26): On @Instagram Live, #NIH‚Äôs @NIAIDNews Director #DrFauci talks with @StephenCurry30 about #COVID19 and how to #StaySafe! Check out the NIAID Instagram for more info:  https://t.co/sR3IyiOM8d #coronavirus #SCASKSFAUCI  https://t.co/0Af9tyuz2w",en,"[{'screen_name': 'instagram', 'name': 'instagram', 'id': '180505807'}, {'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'stephencurry30', 'name': 'stephen curry', 'id': '42562446'}]",['https://www.instagram.com/niaid/'],['https://pbs.twimg.com/media/EUCV79pUwAMWQqu.png'],14,73,123,"['nih', 'drfauci', 'covid19', 'staysafe', 'coronavirus', 'scasksfauci']",[],https://twitter.com/NIAIDNews/status/1243158522063249411,False,,1,https://pbs.twimg.com/media/EUCV79pUwAMWQqu.png,,,,,,,[],,,,
1242893371523207168,1242893371523207168,2020-03-25 19:17:26 UTC,2020-03-25,19:17:26,+0000,59769395,niaidnews,NIAID News,,"LIVE Tomorrow (3/26): On @Instagram Live, #NIH‚Äôs @NIAIDNews Director #DrFauci talks with @StephenCurry30 about #COVID19 and how to #StaySafe! Check out the NIAID Instagram for more info:  https://t.co/AYjzahINVu #coronavirus #SCASKSFAUCI",en,"[{'screen_name': 'instagram', 'name': 'instagram', 'id': '180505807'}, {'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'stephencurry30', 'name': 'stephen curry', 'id': '42562446'}]",['https://www.instagram.com/p/B-KvT6ppeZN/'],[],8,65,117,"['nih', 'drfauci', 'covid19', 'staysafe', 'coronavirus', 'scasksfauci']",[],https://twitter.com/NIAIDNews/status/1242893371523207168,False,,0,,,,,,,,[],,,,
1242465636212600833,1242465636212600833,2020-03-24 14:57:46 UTC,2020-03-24,14:57:46,+0000,59769395,niaidnews,NIAID News,,"TUBERCULOSIS BLOG: To mark #WorldTBDay, NIAID joins the world in declaring ‚ÄúIt‚Äôs Time‚Äù to #EndTB. Learn more on the #NIAIDNow blog:  https://t.co/TQEUpVWIgK  https://t.co/eENtaKUGzN",en,[],['http://bit.ly/TBDay2020'],['https://pbs.twimg.com/media/ET4fCcUU4AE6JHN.jpg'],2,8,20,"['worldtbday', 'endtb', 'niaidnow']",[],https://twitter.com/NIAIDNews/status/1242465636212600833,False,,1,https://pbs.twimg.com/media/ET4fCcUU4AE6JHN.jpg,,,,,,,[],,,,
1240268612297830402,1240268612297830402,2020-03-18 13:27:34 UTC,2020-03-18,13:27:34,+0000,59769395,niaidnews,NIAID News,,"VOLUNTEERS NEEDED: The NIH Vaccine Research Center is looking for volunteers to donate blood for studies on the immune system. Participants will be compensated for their time and convenience. To volunteer, call 1-866-833-5433 (TTY 1-866-411-1010) or email vaccines@nih.gov.  https://t.co/D71SgYNBZY",en,[],[],['https://pbs.twimg.com/media/ETZRlxyUwAAWtSu.png'],11,388,359,[],[],https://twitter.com/NIAIDNews/status/1240268612297830402,False,,1,https://pbs.twimg.com/media/ETZRlxyUwAAWtSu.png,,,,,,,[],,,,
1239953798405095424,1239953798405095424,2020-03-17 16:36:37 UTC,2020-03-17,16:36:37,+0000,59769395,niaidnews,NIAID News,,FLU BLOG: #NIAID #influenza researchers publish promising results of efficacy #trial of candidate universal #FluVaccine.   https://t.co/5qITXPybXq  https://t.co/rXKIoz3BYl,en,[],['http://bit.ly/2WmYiO2'],['https://pbs.twimg.com/media/ETUzYXGUcAAX9eB.jpg'],3,21,41,"['niaid', 'influenza', 'trial', 'fluvaccine']",[],https://twitter.com/NIAIDNews/status/1239953798405095424,False,,1,https://pbs.twimg.com/media/ETUzYXGUcAAX9eB.jpg,,,,,,,[],,,,
1237772842940248064,1237772842940248064,2020-03-11 16:10:17 UTC,2020-03-11,16:10:17,+0000,59769395,niaidnews,NIAID News,,"HIV NEWS: A newer #ART regimen may be the safest, most effective #HIV treatment currently available during pregnancy, @UNC_SOM researchers announced today at #CROI2020. The study of 643 pregnant women was supported by NIAID, @NICHD_NIH &amp; @NIMHgov:  https://t.co/x8kyYbZTpq  https://t.co/XIqzgLfqqi",en,"[{'screen_name': 'unc_som', 'name': 'unc school of medicine', 'id': '3031291433'}, {'screen_name': 'nichd_nih', 'name': 'nichd_nih', 'id': '378740424'}, {'screen_name': 'nimhgov', 'name': 'mental health nimh', 'id': '39250316'}]",['http://bit.ly/IMPAACT2010'],['https://pbs.twimg.com/media/ES1zb2uUYAAf7ie.jpg'],4,25,35,"['art', 'hiv', 'croi2020']",[],https://twitter.com/NIAIDNews/status/1237772842940248064,False,,1,https://pbs.twimg.com/media/ES1zb2uUYAAf7ie.jpg,,,,,,,[],,,,
1237412664642375680,1237048668064120834,2020-03-10 16:19:03 UTC,2020-03-10,16:19:03,+0000,59769395,niaidnews,NIAID News,,"@Savaik10208995 Thanks for your question. While daily antiretroviral therapy makes it possible for people w/ HIV to live long &amp; healthy lives, it does not cure HIV. Learn more about the challenges of developing an HIV cure &amp; scientific progress in this area:  https://t.co/XboRcpeIXA",en,[],['http://youtu.be/kQ_RXBAFjoI'],[],0,0,0,[],[],https://twitter.com/NIAIDNews/status/1237412664642375680,False,,0,,,,,,,,"[{'screen_name': 'Savaik10208995', 'name': 'BARI≈û', 'id': '1154711824316686336'}]",,,,
1237086272583110656,1237086272583110656,2020-03-09 18:42:05 UTC,2020-03-09,18:42:05,+0000,59769395,niaidnews,NIAID News,,"NEWS: @NIH study finds substantially lower concentration of #PrEP drug in African young women during #pregnancy than #postpartum. Strict adherence to daily PrEP is critical in pregnancy, researchers conclude.  https://t.co/hv4uE5eob6  #HIVprevention #HIV #CROI2020",en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}]",['http://bit.ly/IMPAACT2009PK'],[],2,7,19,"['prep', 'pregnancy', 'postpartum', 'hivprevention', 'hiv', 'croi2020']",[],https://twitter.com/NIAIDNews/status/1237086272583110656,False,,0,,,,,,,,[],,,,
1237059027286163461,1237048668064120834,2020-03-09 16:53:50 UTC,2020-03-09,16:53:50,+0000,59769395,niaidnews,NIAID News,,"@Farmgirl286 Thanks for your question. Adeno-associated viruses, like the one used in this study, do not cause disease in humans and have proven to be safe, well-tolerated vectors for gene therapy.",en,[],[],[],1,0,1,[],[],https://twitter.com/NIAIDNews/status/1237059027286163461,False,,0,,,,,,,,"[{'screen_name': 'Farmgirl286', 'name': ""Sittin' Pretty"", 'id': '812299267729719296'}]",,,,
1237048668064120834,1237048668064120834,2020-03-09 16:12:40 UTC,2020-03-09,16:12:40,+0000,59769395,niaidnews,NIAID News,,NEWS: A #DrugDelivery technology that uses a harmless virus to deliver an antibody gene into human cells led to sustained #HIV antibody production in a @NIAIDNews #ClinicalTrial. Such a strategy could be applied to other #InfectiousDiseases. #CROI2020  https://t.co/M0RaVehsSx,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['http://bit.ly/VRC603'],[],3,23,41,"['drugdelivery', 'hiv', 'clinicaltrial', 'infectiousdiseases', 'croi2020']",[],https://twitter.com/NIAIDNews/status/1237048668064120834,False,,0,,,,,,,,[],,,,
1236004733820624896,1236004733820624896,2020-03-06 19:04:27 UTC,2020-03-06,19:04:27,+0000,59769395,niaidnews,NIAID News,,"#HIV BLOG: Superior #AIDS-Kaposi‚Äôs sarcoma #cancer treatment improves outcomes in resource-limited settings, according to a NIAID- and @theNCI-funded study in @TheLancet. Read more on #NIAIDNow:  https://t.co/oM3ohFGAwT  https://t.co/woy1RvMXUK",en,"[{'screen_name': 'thenci', 'name': 'national cancer institute', 'id': '38530021'}, {'screen_name': 'thelancet', 'name': 'the lancet', 'id': '27013292'}]",['http://bit.ly/KSTreatmentNIAID'],['https://pbs.twimg.com/media/EScrkifUcAEFzPw.jpg'],3,7,17,"['hiv', 'aids', 'cancer', 'niaidnow']",[],https://twitter.com/NIAIDNews/status/1236004733820624896,False,,1,https://pbs.twimg.com/media/EScrkifUcAEFzPw.jpg,,,,,,,[],,,,
1234488356760948738,1234488356760948738,2020-03-02 14:38:54 UTC,2020-03-02,14:38:54,+0000,59769395,niaidnews,NIAID News,,"NEWS: NIAID scientists identify a gene involved in a subset of severe combined immunodeficiency (#SCID) cases. The gene, PAX1, is essential for the development of the #thymus, a gland where protective #Tcells mature:  https://t.co/EAU1wAYsGv  @SciImmunology   üì∏: @usairforce  https://t.co/0Zy6nyCC3l",en,"[{'screen_name': 'sciimmunology', 'name': 'science immunology', 'id': '4002598402'}, {'screen_name': 'usairforce', 'name': 'u.s. air force', 'id': '19611483'}]",['https://immunology.sciencemag.org/content/5/44/eaax1036'],['https://pbs.twimg.com/media/ESHIbWLUwAYmWaG.jpg'],2,6,19,"['scid', 'thymus', 'tcells']",[],https://twitter.com/NIAIDNews/status/1234488356760948738,False,,1,https://pbs.twimg.com/media/ESHIbWLUwAYmWaG.jpg,,,,,,,[],,,,
1233447523080998912,1233447523080998912,2020-02-28 17:43:00 UTC,2020-02-28,17:43:00,+0000,59769395,niaidnews,NIAID News,,#COVID19 NEWS: #NIAID Director Dr. Fauci and @CDCDirector Dr. Redfield comment on challenges in addressing novel #coronavirus in new @NEJM editorial.  https://t.co/57EeLijTGe  https://t.co/Q6ockEyza9,en,"[{'screen_name': 'cdcdirector', 'name': 'rochelle walensky, md, mph', 'id': '426909329'}, {'screen_name': 'nejm', 'name': 'nejm', 'id': '25950355'}]",['http://bit.ly/3cj7Mj1'],['https://pbs.twimg.com/media/ER4V9EHUUAA4I8m.jpg'],21,35,70,"['covid19', 'niaid', 'coronavirus']",[],https://twitter.com/NIAIDNews/status/1233447523080998912,False,,1,https://pbs.twimg.com/media/ER4V9EHUUAA4I8m.jpg,,,,,,,[],,,,
1233111782593417216,1233111704436957186,2020-02-27 19:28:53 UTC,2020-02-27,19:28:53,+0000,59769395,niaidnews,NIAID News,,@NatureMicrobiol Read more about how these researchers study the ever-growing ‚Äúvirome‚Äù‚Äîthe multitude of previously uncharacterized #viruses circulating in the life around us‚Äîin @NatureMicrobiol‚Äôs ‚ÄúBehind the Paper‚Äù blog:  https://t.co/Woe6xhhJcp,en,"[{'screen_name': 'naturemicrobiol', 'name': 'nature microbiology', 'id': '3061255931'}]",['http://bit.ly/BehindthePaperNIAIDCOVID19'],[],2,9,20,['viruses'],[],https://twitter.com/NIAIDNews/status/1233111782593417216,False,,0,,,,,,,,"[{'screen_name': 'NatureMicrobiol', 'name': 'Nature Microbiology', 'id': '3061255931'}]",,,,
1233111704436957186,1233111704436957186,2020-02-27 19:28:35 UTC,2020-02-27,19:28:35,+0000,59769395,niaidnews,NIAID News,,"NEWS: NIAID scientists describe a new approach that can rapidly identify receptor proteins that #coronaviruses‚Äîlike #SARSCoV2, the virus that causes #COVID19‚Äîuse to infect cells:  https://t.co/5Cq43sqS2v @NatureMicrobiol  https://t.co/Dlx5BSASiH",en,"[{'screen_name': 'naturemicrobiol', 'name': 'nature microbiology', 'id': '3061255931'}]",['http://bit.ly/NIAIDCOVID19Virome'],['https://pbs.twimg.com/media/ERzkcZYU8AAQyds.jpg'],3,58,97,"['coronaviruses', 'sarscov2', 'covid19']",[],https://twitter.com/NIAIDNews/status/1233111704436957186,False,,1,https://pbs.twimg.com/media/ERzkcZYU8AAQyds.jpg,,,,,,,[],,,,
1233027851743449089,1233027851743449089,2020-02-27 13:55:23 UTC,2020-02-27,13:55:23,+0000,59769395,niaidnews,NIAID News,,"COVID-19 NEWS: The disease spread by a novel #coronavirus is causing worldwide disruption. How did we get here, and can swift public health actions prevent a #pandemic? #NIAID scientists offer perspective:  https://t.co/jcMxplZLN8 #COVID19",en,[],['http://bit.ly/2HWYtHz'],[],8,32,59,"['coronavirus', 'pandemic', 'niaid', 'covid19']",[],https://twitter.com/NIAIDNews/status/1233027851743449089,False,,0,,,,,,,,[],,,,
1232342154556526594,1232342154556526594,2020-02-25 16:30:40 UTC,2020-02-25,16:30:40,+0000,59769395,niaidnews,NIAID News,,NEWS: NIH has begun a clinical trial to evaluate the safety and efficacy of the investigational antiviral #remdesivir in hospitalized adults diagnosed with #COVID19.   https://t.co/PkFNKkH934  https://t.co/f61cIHBVmo,en,[],['http://bit.ly/COVID19therapeuticstrial'],['https://pbs.twimg.com/media/ERookY2VUAIjiwT.jpg'],8,98,160,"['remdesivir', 'covid19']",[],https://twitter.com/NIAIDNews/status/1232342154556526594,False,,1,https://pbs.twimg.com/media/ERookY2VUAIjiwT.jpg,,,,,,,[],,,,
1232067171863298048,1230942575076360192,2020-02-24 22:17:59 UTC,2020-02-24,22:17:59,+0000,59769395,niaidnews,NIAID News,,@sharon_weston @US_FDA @ScottGottliebMD @CDCgov @NIH @CDCFlu @CDCGlobal The World Health Organization has provided guidance for the clinical management of people hospitalized with suspected COVID-19.  https://t.co/P2kOx6b7DA,en,[],['https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf?sfvrsn=bc7da517_2'],[],0,1,0,[],[],https://twitter.com/NIAIDNews/status/1232067171863298048,False,,0,,,,,,,,"[{'screen_name': 'sharon_weston', 'name': 'Sharon Weston', 'id': '1319030661932613634'}, {'screen_name': 'US_FDA', 'name': 'U.S. FDA', 'id': '208120290'}, {'screen_name': 'ScottGottliebMD', 'name': 'Scott Gottlieb, MD', 'id': '40156330'}, {'screen_name': 'CDCgov', 'name': 'CDC', 'id': '146569971'}, {'screen_name': 'NIH', 'name': 'NIH', 'id': '15134240'}, {'screen_name': 'CDCFlu', 'name': 'CDC Flu', 'id': '16616061'}, {'screen_name': 'CDCGlobal', 'name': 'CDC Global Health', 'id': '357648167'}]",,,,
1232048805681541122,1232048805681541122,2020-02-24 21:05:00 UTC,2020-02-24,21:05:00,+0000,59769395,niaidnews,NIAID News,,BLOG: NIAID scientists develop an integrated approach to characterize #AutoinflammatoryDiseases and discover three new #RareDiseases:  https://t.co/RP81qBRNmw #NIAIDNow #CareAboutRare #RareDiseaseDay  https://t.co/16V0yDaVES,en,[],['http://bit.ly/AutoinflamBlog'],['https://pbs.twimg.com/media/ERkXuzkUUAAqSZg.jpg'],0,3,8,"['autoinflammatorydiseases', 'rarediseases', 'niaidnow', 'careaboutrare', 'rarediseaseday']",[],https://twitter.com/NIAIDNews/status/1232048805681541122,False,,1,https://pbs.twimg.com/media/ERkXuzkUUAAqSZg.jpg,,,,,,,[],,,,
1232031161179766784,1228021580933918720,2020-02-24 19:54:53 UTC,2020-02-24,19:54:53,+0000,59769395,niaidnews,NIAID News,,@MeMicroscope Yes! @NIAIDNews images are in the public domain and free to use. Please credit NIAID-RML. See more #coronavirus images here:  https://t.co/tMQZTgRWVh,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['http://bit.ly/COVIDimagesNIAID'],[],1,1,3,['coronavirus'],[],https://twitter.com/NIAIDNews/status/1232031161179766784,False,,0,,,,,,,,"[{'screen_name': 'MeMicroscope', 'name': 'Microscope me up', 'id': '1196765811907682304'}]",,,,
1231975088062222336,1231975088062222336,2020-02-24 16:12:04 UTC,2020-02-24,16:12:04,+0000,59769395,niaidnews,NIAID News,,"BLOG: A person‚Äôs #immune system status can predict future immune responses, @NIAIDNews scientists explain in @NatureMedicine. Their findings could aid #vaccine development, as well as inform treatment of #autoimmune diseases.  https://t.co/Vvyn8b6wrD",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'naturemedicine', 'name': 'nature medicine', 'id': '26832834'}]",['http://bit.ly/ImmuneBaseline'],[],0,5,17,"['immune', 'vaccine', 'autoimmune']",[],https://twitter.com/NIAIDNews/status/1231975088062222336,False,,0,,,,,,,,[],,,,
1230945478008659968,1230945478008659968,2020-02-21 20:00:46 UTC,2020-02-21,20:00:46,+0000,59769395,niaidnews,NIAID News,,"We enjoyed participating in the #RareDiseaseDay chat! Learn more about NIAID‚Äôs #allergic, #immunologic &amp; #infectious disease research:  https://t.co/PjmgaRukho #NIHchat",en,[],['http://bit.ly/NIAIDNIH'],[],0,2,5,"['rarediseaseday', 'allergic', 'immunologic', 'infectious', 'nihchat']",[],https://twitter.com/NIAIDNews/status/1230945478008659968,False,https://twitter.com/NIH/status/1230945361138552832,0,,,,,,,,[],,,,
1230944708525883392,1230942575076360192,2020-02-21 19:57:43 UTC,2020-02-21,19:57:43,+0000,59769395,niaidnews,NIAID News,,"@docguayaco @US_FDA Yes, benralizumab. Learn more here:  https://t.co/sdVcx7kw93",en,[],['http://bit.ly/HESdrug2'],[],0,1,1,[],[],https://twitter.com/NIAIDNews/status/1230944708525883392,False,,0,,,,,,,,"[{'screen_name': 'docguayaco', 'name': 'Jose Luis Rivadeneira üá™üá®', 'id': '201440180'}, {'screen_name': 'US_FDA', 'name': 'U.S. FDA', 'id': '208120290'}]",,,,
1230944370410409984,1230944370410409984,2020-02-21 19:56:22 UTC,2020-02-21,19:56:22,+0000,59769395,niaidnews,NIAID News,,A8: #PrimaryImmune deficiency diseases (PIDDs) are #genetic. Illness can be inherited when one or both parents carries an abnormal #gene or result from a spontaneous mutation. Learn more:  https://t.co/qapoCnKB8N #genetics #NIHchat  https://t.co/aMeJj2QENq,en,[],['http://bit.ly/PIDDGenetics'],['https://pbs.twimg.com/media/ERUxUjAVAAA3pv8.jpg'],0,2,6,"['primaryimmune', 'genetic', 'gene', 'genetics', 'nihchat']",[],https://twitter.com/NIAIDNews/status/1230944370410409984,False,,1,https://pbs.twimg.com/media/ERUxUjAVAAA3pv8.jpg,,,,,,,[],,,,
1230943889613131776,1230943889613131776,2020-02-21 19:54:27 UTC,2020-02-21,19:54:27,+0000,59769395,niaidnews,NIAID News,,"A8: #NeglectedTropicalDiseases are prevalent in the developing world but rare in the US; travel causes most US cases of #NTDs. Read about some examples, like #elephantiasis and #hookworm, at  https://t.co/2HMhdcw4y0 #TravelMedicine #NIHchat",en,[],['http://bit.ly/NTDFacts'],[],0,2,4,"['neglectedtropicaldiseases', 'ntds', 'elephantiasis', 'hookworm', 'travelmedicine', 'nihchat']",[],https://twitter.com/NIAIDNews/status/1230943889613131776,False,,0,,,,,,,,[],,,,
1230942575076360192,1230942575076360192,2020-02-21 19:49:14 UTC,2020-02-21,19:49:14,+0000,59769395,niaidnews,NIAID News,,A7: An @US_FDA-approved #asthma drug dramatically improved the health of people with #rare chronic immune disorders called #hypereosinophilic syndromes.  https://t.co/sdVcx7kw93 #NIHchat  https://t.co/WHKxAhiTOz,en,"[{'screen_name': 'us_fda', 'name': 'u.s. fda', 'id': '208120290'}]",['http://bit.ly/HESdrug2'],['https://pbs.twimg.com/media/ERUvUUIUEAA0QEA.jpg'],3,5,11,"['asthma', 'rare', 'hypereosinophilic', 'nihchat']",[],https://twitter.com/NIAIDNews/status/1230942575076360192,False,,1,https://pbs.twimg.com/media/ERUvUUIUEAA0QEA.jpg,,,,,,,[],,,,
1230941640363102208,1230941544074473472,2020-02-21 19:45:31 UTC,2020-02-21,19:45:31,+0000,59769395,niaidnews,NIAID News,,A7: This #GeneTherapy also has improved the health &amp; quality of life of older kids &amp; young adults with #SCID who had complex medical problems after receiving live-saving bone marrow transplants to treat the condition.  https://t.co/XEl0e1ZLYQ #NIHchat,en,[],['http://j.mp/XSCID-Gene-Therapy'],[],0,1,3,"['genetherapy', 'scid', 'nihchat']",[],https://twitter.com/NIAIDNews/status/1230941640363102208,False,,0,,,,,,,,[],,,,
1230941544074473472,1230941544074473472,2020-02-21 19:45:08 UTC,2020-02-21,19:45:08,+0000,59769395,niaidnews,NIAID News,,"A7: An experimental #GeneTherapy restored immunity in infants with #SCID, a #rare immunodeficiency disease, researchers reported in spring 2019.  https://t.co/NwI4xvAtGj #NIHchat",en,[],['http://bit.ly/SCIDGeneTherapy'],[],1,1,4,"['genetherapy', 'scid', 'rare', 'nihchat']",[],https://twitter.com/NIAIDNews/status/1230941544074473472,False,,0,,,,,,,,[],,,,
1230940551240765440,1230940551240765440,2020-02-21 19:41:11 UTC,2020-02-21,19:41:11,+0000,59769395,niaidnews,NIAID News,,"A6: @NIAIDNews scientists &amp; volunteers at the @NIHClinicalCntr work together toward new treatments. In this video üìΩÔ∏è, a patient, his family &amp; his care team explain how they helped discover a medication for a rare inflammatory condition.  https://t.co/n0CxFHg4gB #NIHchat",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'nihclinicalcntr', 'name': 'nih clinical center', 'id': '20186316'}]",['http://youtu.be/ASep70b_qyE'],[],1,1,3,['nihchat'],[],https://twitter.com/NIAIDNews/status/1230940551240765440,False,,0,,,,,,,,[],,,,
1230940280754294784,1230940280754294784,2020-02-21 19:40:07 UTC,2020-02-21,19:40:07,+0000,59769395,niaidnews,NIAID News,,A6: Researchers continue to identify new #RareDiseases. #NewbornScreening aids discovery of novel #gene variants that cause #immune deficiency:  https://t.co/i4PmJh1Nc3 #NIHchat   üì∏: @usairforce  https://t.co/5DlU4OVJDy,en,"[{'screen_name': 'usairforce', 'name': 'u.s. air force', 'id': '19611483'}]",['http://j.mp/FOXN1Haploinsufficiency'],['https://pbs.twimg.com/media/ERUtnZzUYAAECXu.jpg'],0,1,1,"['rarediseases', 'newbornscreening', 'gene', 'immune', 'nihchat']",[],https://twitter.com/NIAIDNews/status/1230940280754294784,False,,1,https://pbs.twimg.com/media/ERUtnZzUYAAECXu.jpg,,,,,,,[],,,,
1230939824292368384,1230939824292368384,2020-02-21 19:38:18 UTC,2020-02-21,19:38:18,+0000,59769395,niaidnews,NIAID News,,"A5: Learn about #PrionDiseases, a related group of #rare, fatal brain diseases that affect animals and humans:  https://t.co/wp5V8vvyw1 #NIHchat  https://t.co/AY0OR3SIoN",en,[],['http://bit.ly/Prions'],['https://pbs.twimg.com/media/ERUtJtrUcAELf14.jpg'],0,4,3,"['priondiseases', 'rare', 'nihchat']",[],https://twitter.com/NIAIDNews/status/1230939824292368384,False,,1,https://pbs.twimg.com/media/ERUtJtrUcAELf14.jpg,,,,,,,[],,,,
1230939165094662144,1230939165094662144,2020-02-21 19:35:41 UTC,2020-02-21,19:35:41,+0000,59769395,niaidnews,NIAID News,,A5: Learn more about a new @NIH program that provides comprehensive treatment for inherited blood and immune diseases:  https://t.co/YSsTBx9rFM #NIHchat,en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}]",['http://j.mp/BID-CTP'],[],1,2,5,['nihchat'],[],https://twitter.com/NIAIDNews/status/1230939165094662144,False,,0,,,,,,,,[],,,,
1230938499336962048,1230938499336962048,2020-02-21 19:33:02 UTC,2020-02-21,19:33:02,+0000,59769395,niaidnews,NIAID News,,A5: Information about more than two dozen #PrimaryImmune deficiency diseases (PIDDs) is available on the @NIAIDNews website:  https://t.co/ZR8W4nI2bm #NIHchat,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['http://bit.ly/TypesOfPIDDs'],[],0,1,4,"['primaryimmune', 'nihchat']",[],https://twitter.com/NIAIDNews/status/1230938499336962048,False,,0,,,,,,,,[],,,,
1230938136189911040,1230938136189911040,2020-02-21 19:31:36 UTC,2020-02-21,19:31:36,+0000,59769395,niaidnews,NIAID News,,A5: Read about recent #NIAID #RareDisease research highlights &amp; resources on the #NIAIDNow blog ü¶ì:  https://t.co/6j8Q5r4FIF #RareDiseaseDay #RDD2020 #NIHchat  https://t.co/xoj6g1Km7W,en,[],['http://bit.ly/NIAIDRDD2020'],['https://pbs.twimg.com/media/ERUrqncU8AA3Ow3.jpg'],0,2,2,"['niaid', 'raredisease', 'niaidnow', 'rarediseaseday', 'rdd2020', 'nihchat']",[],https://twitter.com/NIAIDNews/status/1230938136189911040,False,,1,https://pbs.twimg.com/media/ERUrqncU8AA3Ow3.jpg,,,,,,,[],,,,
1230935773081300994,1230935773081300994,2020-02-21 19:22:12 UTC,2020-02-21,19:22:12,+0000,59769395,niaidnews,NIAID News,,A3: Research into a rare genetic mutation that results in increased susceptibility to rhinovirus infection yielded insights into the #CommonCold.  https://t.co/aEOYLsfPVt #NIHchat  https://t.co/7Ju8FXPUSD,en,[],['http://bit.ly/GeneticsCold'],['https://pbs.twimg.com/media/ERUpe36U4AAuMMV.jpg'],0,3,6,"['commoncold', 'nihchat']",[],https://twitter.com/NIAIDNews/status/1230935773081300994,False,https://twitter.com/NIH/status/1230935316988489728,1,https://pbs.twimg.com/media/ERUpe36U4AAuMMV.jpg,,,,,,,[],,,,
1230932062686724097,1230932062686724097,2020-02-21 19:07:28 UTC,2020-02-21,19:07:28,+0000,59769395,niaidnews,NIAID News,,A1: VIDEO üìΩÔ∏è: The first participant in a @NIAIDNews  #ClinicalTrial evaluating a #GeneTherapy for rare X-linked severe combined immunodeficiency (#SCID) discusses his experiences:  https://t.co/HNHG226RhB #NIHchat,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['http://youtu.be/yLqhEZKxsoo'],[],0,1,1,"['clinicaltrial', 'genetherapy', 'scid', 'nihchat']",[],https://twitter.com/NIAIDNews/status/1230932062686724097,False,,0,,,,,,,,[],,,,
1230931157929230336,1230931157929230336,2020-02-21 19:03:52 UTC,2020-02-21,19:03:52,+0000,59769395,niaidnews,NIAID News,,A1: VIDEOüìΩÔ∏è: 13-year-old Isaac talks about living with the rare #autoinflammatory disease CANDLE &amp; participating in a @NIAIDNews #ClinicalTrial:  https://t.co/n0CxFHg4gB #NIHchat,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['http://youtu.be/ASep70b_qyE'],[],0,3,3,"['autoinflammatory', 'clinicaltrial', 'nihchat']",[],https://twitter.com/NIAIDNews/status/1230931157929230336,False,,0,,,,,,,,[],,,,
1230930370041765888,1230930370041765888,2020-02-21 19:00:44 UTC,2020-02-21,19:00:44,+0000,59769395,niaidnews,NIAID News,,".@NIAIDNews hopes to share helpful info for #RareDiseaseDay #NIHchat! We support #allergic, #immunologic &amp; #infectious disease research  https://t.co/PjmgaRukho",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['http://bit.ly/NIAIDNIH'],[],0,1,1,"['rarediseaseday', 'nihchat', 'allergic', 'immunologic', 'infectious']",[],https://twitter.com/NIAIDNews/status/1230930370041765888,False,,0,,,,,,,,[],,,,
1230881111862992902,1230881111862992902,2020-02-21 15:45:00 UTC,2020-02-21,15:45:00,+0000,59769395,niaidnews,NIAID News,,.@NIAIDNews looks forward to participating in the #RareDiseaseDay #NIHchat today at 2 pm ET!,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",[],[],0,1,3,"['rarediseaseday', 'nihchat']",[],https://twitter.com/NIAIDNews/status/1230881111862992902,False,https://twitter.com/ncats_nih_gov/status/1230870133905727491,0,,,,,,,,[],,,,
1230526941221941248,1230526941221941248,2020-02-20 16:17:39 UTC,2020-02-20,16:17:39,+0000,59769395,niaidnews,NIAID News,,"BLOG: Each February, @NIH observes #RareDiseaseDay. Every day of the year, @NIAIDNews researchers work to better understand, diagnose &amp; treat #RareDiseases. Learn more about #GeneTherapy &amp; other recent research advances.  https://t.co/6j8Q5r4FIF #RDD2020 #CareAboutRare #RDDNIH  https://t.co/Z6OsaMaSZB",en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}, {'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['http://bit.ly/NIAIDRDD2020'],['https://pbs.twimg.com/media/ERO1l_jU0AEYJ_k.jpg'],0,0,1,"['rarediseaseday', 'rarediseases', 'genetherapy', 'rdd2020', 'careaboutrare', 'rddnih']",[],https://twitter.com/NIAIDNews/status/1230526941221941248,False,,1,https://pbs.twimg.com/media/ERO1l_jU0AEYJ_k.jpg,,,,,,,[],,,,
1230226299349680128,1230198799718477825,2020-02-19 20:23:00 UTC,2020-02-19,20:23:00,+0000,59769395,niaidnews,NIAID News,,"@qeastman @NIH @sciencemagazine Thank you for catching that! Yes, the new @sciencemagazine paper describes the atomic structure of a key novel coronavirus surface protein known as a spike.",en,"[{'screen_name': 'sciencemagazine', 'name': 'science magazine', 'id': '32372834'}]",[],[],1,1,4,[],[],https://twitter.com/NIAIDNews/status/1230226299349680128,False,,0,,,,,,,,"[{'screen_name': 'qeastman', 'name': 'Quinn Eastman', 'id': '240801472'}, {'screen_name': 'NIH', 'name': 'NIH', 'id': '15134240'}, {'screen_name': 'ScienceMagazine', 'name': 'Science Magazine', 'id': '32372834'}]",,,,
1230198799718477825,1230198799718477825,2020-02-19 18:33:44 UTC,2020-02-19,18:33:44,+0000,59769395,niaidnews,NIAID News,,"NEWS: @NIH scientists have identified the atomic structure of the novel #coronavirus (#SARSCoV2, formerly #2019nCoV). The findings appear in the peer-reviewed journal @ScienceMagazine &amp; may aid in the design of candidate vaccines, treatments for #COVID19:  https://t.co/VYGR3nHpH4  https://t.co/mN5c0ijKqE",en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}, {'screen_name': 'sciencemagazine', 'name': 'science magazine', 'id': '32372834'}]",['http://bit.ly/atomicSARSCoV2structure'],['https://pbs.twimg.com/media/ERKLHZtVAAAmrSt.jpg'],3,61,99,"['coronavirus', 'sarscov2', '2019ncov', 'covid19']",[],https://twitter.com/NIAIDNews/status/1230198799718477825,False,,1,https://pbs.twimg.com/media/ERKLHZtVAAAmrSt.jpg,,,,,,,[],,,,
1228364002163429377,1228364002163429377,2020-02-14 17:02:54 UTC,2020-02-14,17:02:54,+0000,59769395,niaidnews,NIAID News,,Today is #NationalDonorDay! Learn more about how people living with #HIV can also save lives through #OrganDonation to others with HIV:  https://t.co/zCLRSOLqw9 #NIAIDNow #DonateLife,en,[],['http://j.mp/HIVDonateLife'],[],1,5,9,"['nationaldonorday', 'hiv', 'organdonation', 'niaidnow', 'donatelife']",[],https://twitter.com/NIAIDNews/status/1228364002163429377,False,https://twitter.com/HHSGov/status/1228335593991671808,0,,,,,,,,[],,,,
1228021580933918720,1228021580933918720,2020-02-13 18:22:15 UTC,2020-02-13,18:22:15,+0000,59769395,niaidnews,NIAID News,,NEWS: NIAID labs have produced images of the #NovelCoronavirus SARS-CoV-2 üî¨ Check out more images on #NIAIDNow:  https://t.co/tMQZTgRWVh   #SARSCoV2 #COVID19 #coronavirus  https://t.co/WkI1p1Rf8Y,en,[],['http://bit.ly/COVIDimagesNIAID'],['https://pbs.twimg.com/media/EQrPDDzVUAEx50c.jpg'],7,142,189,"['novelcoronavirus', 'niaidnow', 'sarscov2', 'covid19', 'coronavirus']",[],https://twitter.com/NIAIDNews/status/1228021580933918720,False,,1,https://pbs.twimg.com/media/EQrPDDzVUAEx50c.jpg,,,,,,,[],,,,
1227257019805028352,1227257019805028352,2020-02-11 15:44:09 UTC,2020-02-11,15:44:09,+0000,59769395,niaidnews,NIAID News,,"TB NEWS: #NIAID officials describe 2019 as a banner year for #tuberculosis research advances and urge a collaborative effort by government, academia, industry, and civil society to achieve the end of #TB within a generation.  https://t.co/qrqw5SPYS0  https://t.co/JLYJhiPsIZ",en,[],['http://bit.ly/2tTcse4'],['https://pbs.twimg.com/media/EQgXwMIU4AEgGKs.jpg'],1,10,14,"['niaid', 'tuberculosis', 'tb']",[],https://twitter.com/NIAIDNews/status/1227257019805028352,False,,1,https://pbs.twimg.com/media/EQgXwMIU4AEgGKs.jpg,,,,,,,[],,,,
1227248610611322883,1227248610611322883,2020-02-11 15:10:44 UTC,2020-02-11,15:10:44,+0000,59769395,niaidnews,NIAID News,,NEWS: #Malaria-spreading mosquitoes use temperature-sensing receptor protein that helps non-blood-feeding flies avoid heat to detect nearby warm-blooded humans to bite. Research by #NIAID-funded scientists @BrandeisU appears in @Sciencemagazine.  https://t.co/6qdFbRVVIP  https://t.co/w9iIQ5gfQF,en,"[{'screen_name': 'brandeisu', 'name': 'brandeis university', 'id': '19546529'}, {'screen_name': 'sciencemagazine', 'name': 'science magazine', 'id': '32372834'}]",['http://bit.ly/2utjrdV'],['https://pbs.twimg.com/media/EQgQGsjUUAIvOuC.jpg'],0,5,6,"['malaria', 'niaid']",[],https://twitter.com/NIAIDNews/status/1227248610611322883,False,,1,https://pbs.twimg.com/media/EQgQGsjUUAIvOuC.jpg,,,,,,,[],,,,
1226906170691964928,1226906170691964928,2020-02-10 16:30:00 UTC,2020-02-10,16:30:00,+0000,59769395,niaidnews,NIAID News,,"#Cancer outcomes can be predicted from less #tumor #gene expression sequencing data than previously thought, reducing data collection costs, @NIAIDNews scientists report today in @NatureMedicine:  https://t.co/A3zW006agA #PrecisionMedicine #PrecisionOncology #genomics",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'naturemedicine', 'name': 'nature medicine', 'id': '26832834'}]",['http://bit.ly/tumor-RNAseq'],[],2,5,6,"['cancer', 'tumor', 'gene', 'precisionmedicine', 'precisiononcology', 'genomics']",[],https://twitter.com/NIAIDNews/status/1226906170691964928,False,,0,,,,,,,,[],,,,
1226888795347464193,1226888795347464193,2020-02-10 15:20:57 UTC,2020-02-10,15:20:57,+0000,59769395,niaidnews,NIAID News,,HIV NEWS: An #NIH-funded clinical trial specifically designed to test whether daily oral #PrEP and the monthly dapivirine #vaginalring are safe during pregnancy for women and their babies has begun in southern and eastern Africa:  https://t.co/IPXnY2S85U  #HIV #HIVprevention,en,[],['http://bit.ly/PrEP-Ring-in-Pregnancy'],[],0,5,7,"['nih', 'prep', 'vaginalring', 'hiv', 'hivprevention']",[],https://twitter.com/NIAIDNews/status/1226888795347464193,False,,0,,,,,,,,[],,,,
1225133237464256512,1225133237464256512,2020-02-05 19:05:00 UTC,2020-02-05,19:05:00,+0000,59769395,niaidnews,NIAID News,,"VIDEO üé•: In the latest #NIAIDVideoSNiP, #malaria researchers describe their efforts to track down the parasite‚Äôs genetic weaknesses. Read more about the new findings in @ScienceAdvances &amp; watch the video on #NIAIDNow:  https://t.co/dBIAirXElk  https://t.co/WIJMFcozBx",en,"[{'screen_name': 'scienceadvances', 'name': 'science advances', 'id': '2326120952'}]",['http://bit.ly/MalariaSNiP'],['https://pbs.twimg.com/media/EQBnz_QUwAIhFax.jpg'],1,1,4,"['niaidvideosnip', 'malaria', 'niaidnow']",[],https://twitter.com/NIAIDNews/status/1225133237464256512,False,,1,https://pbs.twimg.com/media/EQBnz_QUwAIhFax.jpg,,,,,,,[],,,,
1224365912762896385,1224365609510588416,2020-02-03 16:15:55 UTC,2020-02-03,16:15:55,+0000,59769395,niaidnews,NIAID News,,@CRForumUS @StanfordMed The @StanfordMed team found that few people with #PeanutAllergy tolerate #peanut after stopping oral #immunotherapy; continuing with a modest dose confers more protection. Results from this #NIAID-supported #ClinicalTrial appeared in @TheLancet. Read more:  https://t.co/T192REHcmX,en,"[{'screen_name': 'stanfordmed', 'name': 'stanford medicine', 'id': '56879674'}, {'screen_name': 'thelancet', 'name': 'the lancet', 'id': '27013292'}]",['http://j.mp/POISEDstudy'],[],2,0,1,"['peanutallergy', 'peanut', 'immunotherapy', 'niaid', 'clinicaltrial']",[],https://twitter.com/NIAIDNews/status/1224365912762896385,False,,0,,,,,,,,"[{'screen_name': 'CRForumUS', 'name': 'Clinical Research Forum', 'id': '782954815739527168'}, {'screen_name': 'StanfordMed', 'name': 'Stanford Medicine', 'id': '56879674'}]",,,,
1224365609510588416,1224365609510588416,2020-02-03 16:14:43 UTC,2020-02-03,16:14:43,+0000,59769395,niaidnews,NIAID News,,Congratulations to recipients of the 2020 Top 10 Clinical Research Achievement Awards from @CRForumUS! Awardees include @NIAIDNews-funded researchers from @StanfordMed for their work on oral #immunotherapy for #PeanutAllergyü•ú.  https://t.co/btYBqzCetq,en,"[{'screen_name': 'crforumus', 'name': 'clinical research forum', 'id': '782954815739527168'}, {'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'stanfordmed', 'name': 'stanford medicine', 'id': '56879674'}]",['http://bit.ly/37TZSdl'],[],2,1,0,"['immunotherapy', 'peanutallergy']",[],https://twitter.com/NIAIDNews/status/1224365609510588416,False,,0,,,,,,,,[],,,,
1224318047785107458,1224318047785107458,2020-02-03 13:05:43 UTC,2020-02-03,13:05:43,+0000,59769395,niaidnews,NIAID News,,HIV NEWS: An experimental vaccine regimen under study in South Africa was found to be ineffective in preventing HIV.  https://t.co/bbKp2Xp5lQ,en,[],['https://bit.ly/2RQyIya'],[],0,16,19,[],[],https://twitter.com/NIAIDNews/status/1224318047785107458,False,,0,,,,,,,,[],,,,
1223696290728620032,1223696290728620032,2020-02-01 19:55:05 UTC,2020-02-01,19:55:05,+0000,59769395,niaidnews,NIAID News,,"‚ù§Ô∏è February is #HeartMonth! People living with #HIV are up to 2x as likely to develop #HeartDisease, including #HeartAttack and #stroke, as people without HIV. Learn more about how @NIH and @reprievetrial hope to reverse this trend:  https://t.co/FqlxpMOepd  https://t.co/PuTVLiM7Pp",en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}, {'screen_name': 'reprievetrial', 'name': 'reprieve trial', 'id': '2863910194'}]",['http://bit.ly/NIAIDHeartMonth'],['https://pbs.twimg.com/media/EPtxSrGWkAAGznf.jpg'],2,8,6,"['heartmonth', 'hiv', 'heartdisease', 'heartattack', 'stroke']",[],https://twitter.com/NIAIDNews/status/1223696290728620032,False,,1,https://pbs.twimg.com/media/EPtxSrGWkAAGznf.jpg,,,,,,,[],,,,
1222964713501282305,1222964713501282305,2020-01-30 19:28:03 UTC,2020-01-30,19:28:03,+0000,59769395,niaidnews,NIAID News,,"BLOG: NIAID Now marks the first World Neglected Tropical Diseases (NTD) Day with a guest post by #NIAID scientist Dr. Shaden Kamhawi, who studies #leishmaniasis, an NTD spread by sand flies. #BeatNTDs #WorldNTDDday  https://t.co/hIvOTRTQgB  https://t.co/jlPQYp6md9",en,[],['http://bit.ly/2S64RAZ'],['https://pbs.twimg.com/media/EPjX60VVUAAqquQ.jpg'],1,7,11,"['niaid', 'leishmaniasis', 'beatntds', 'worldntddday']",[],https://twitter.com/NIAIDNews/status/1222964713501282305,False,,1,https://pbs.twimg.com/media/EPjX60VVUAAqquQ.jpg,,,,,,,[],,,,
1221836613174480896,1221836613174480896,2020-01-27 16:45:23 UTC,2020-01-27,16:45:23,+0000,59769395,niaidnews,NIAID News,,MALARIA NEWS: Trial of monoclonal antibody to prevent #malaria infection now open for volunteers at @NIHClinicalCntr. The antibody was developed by #NIAID scientists.  https://t.co/WQngRfEArX  https://t.co/AQnAuMYcQm,en,"[{'screen_name': 'nihclinicalcntr', 'name': 'nih clinical center', 'id': '20186316'}]",['http://bit.ly/2Ubtu1R'],['https://pbs.twimg.com/media/EPTV6qyU8Agf9jy.jpg'],2,5,9,"['malaria', 'niaid']",[],https://twitter.com/NIAIDNews/status/1221836613174480896,False,,1,https://pbs.twimg.com/media/EPTV6qyU8Agf9jy.jpg,,,,,,,[],,,,
1221831943890685952,1221831320407433217,2020-01-27 16:26:50 UTC,2020-01-27,16:26:50,+0000,59769395,niaidnews,NIAID News,,"@NatureMedicine The team includes researchers from @NIAIDNews, @UCLAstemcell, @BostonChildrens, @GreatOrmondSt &amp; other organizations. üé•Learn more about chronic #granulomatous disease (CGD) in a @NIAIDNews video:  https://t.co/qONzsstlV6",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'uclastemcell', 'name': 'ucla broad stem cell', 'id': '3235441782'}, {'screen_name': 'bostonchildrens', 'name': ""boston children's"", 'id': '48715988'}, {'screen_name': 'greatormondst', 'name': 'great ormond street hospital', 'id': '786227731167981568'}, {'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://youtu.be/roow1WZwByA'],[],2,0,5,['granulomatous'],[],https://twitter.com/NIAIDNews/status/1221831943890685952,False,,0,,,,,,,,"[{'screen_name': 'NatureMedicine', 'name': 'Nature Medicine', 'id': '26832834'}]",,,,
1221831320407433217,1221831320407433217,2020-01-27 16:24:21 UTC,2020-01-27,16:24:21,+0000,59769395,niaidnews,NIAID News,,"@#GeneTherapy shows promise for treating people with chronic granulomatous disease, a #genetic immunodeficiency characterized by susceptibility to bacterial &amp; fungal infections, a team of scientists report today in @NatureMedicine:  https://t.co/Cb1kag9g8r",en,"[{'screen_name': 'naturemedicine', 'name': 'nature medicine', 'id': '26832834'}]",['http://bit.ly/XCGD-gene-therapy'],[],2,2,11,"['genetherapy', 'genetic']",[],https://twitter.com/NIAIDNews/status/1221831320407433217,False,,0,,,,,,,,[],,,,
1220838637547319297,1220838637547319297,2020-01-24 22:39:47 UTC,2020-01-24,22:39:47,+0000,59769395,niaidnews,NIAID News,,NIAID scientists review factors that will affect our ability to contain the #2019nCoV in new perspective article. #coronavirus  https://t.co/nnSqbAbchV  https://t.co/jL93Q0Eayh,en,[],['https://bit.ly/2TV6EeI'],['https://pbs.twimg.com/media/EPFKQ67U8AA4Eb5.jpg'],1,17,23,"['2019ncov', 'coronavirus']",[],https://twitter.com/NIAIDNews/status/1220838637547319297,False,,1,https://pbs.twimg.com/media/EPFKQ67U8AA4Eb5.jpg,,,,,,,[],,,,
1220726100193697793,1220726100193697793,2020-01-24 15:12:36 UTC,2020-01-24,15:12:36,+0000,59769395,niaidnews,NIAID News,,HIV NEWS: @NIAIDNews has launched the first clinical trial to test the combination of a broadly neutralizing #antibody plus an #antiretroviral drug as long-acting #HIVtreatment:  https://t.co/SfCiS3l4kD  #NIH #HIV #bnAbs @NUFeinbergMed @Penn @actgnetwork  https://t.co/dxTdD0qNLX,en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}, {'screen_name': 'nufeinbergmed', 'name': 'northwestern feinberg school of medicine', 'id': '68506542'}, {'screen_name': 'penn', 'name': 'penn', 'id': '24894213'}, {'screen_name': 'actgnetwork', 'name': 'actg network', 'id': '361405892'}]",['http://bit.ly/bnAb-ARV-Tx'],['https://pbs.twimg.com/media/EPDj6LsWoAAnMG9.jpg'],3,13,22,"['antibody', 'antiretroviral', 'hivtreatment', 'nih', 'hiv', 'bnabs']",[],https://twitter.com/NIAIDNews/status/1220726100193697793,False,,1,https://pbs.twimg.com/media/EPDj6LsWoAAnMG9.jpg,,,,,,,[],,,,
1220440548969938945,1220440548969938945,2020-01-23 20:17:56 UTC,2020-01-23,20:17:56,+0000,59769395,niaidnews,NIAID News,,NIAID scientists at Rocky Mountain Laboratories rapidly identified human ACE2 as receptor #2019nCoV uses to infect human cells. #coronavirus  https://t.co/0SA29NXFn6,en,[],['https://bit.ly/2RMwLlh'],[],0,27,55,"['2019ncov', 'coronavirus']",[],https://twitter.com/NIAIDNews/status/1220440548969938945,False,,0,,,,,,,,[],,,,
1220045358488645632,1220045358488645632,2020-01-22 18:07:35 UTC,2020-01-22,18:07:35,+0000,59769395,niaidnews,NIAID News,,"HIV NEWS: In progress toward an #HIVcure, @NIH-supported scientists reactivated resting immune cells that were latently infected with #HIV or its monkey relative in cells in blood and a variety of tissues in animals:  https://t.co/BrAJzIVK42  @UNC @EmoryUniversity  https://t.co/Hao60DZVGu",en,"[{'screen_name': 'nih', 'name': 'nih', 'id': '15134240'}, {'screen_name': 'unc', 'name': 'unc-chapel hill', 'id': '20683724'}, {'screen_name': 'emoryuniversity', 'name': 'emory university', 'id': '16438655'}]",['http://bit.ly/HIVLatencyReversal'],['https://pbs.twimg.com/media/EO54x1MVAAADVtK.jpg'],2,26,40,"['hivcure', 'hiv']",[],https://twitter.com/NIAIDNews/status/1220045358488645632,False,,1,https://pbs.twimg.com/media/EO54x1MVAAADVtK.jpg,,,,,,,[],,,,
1217240245630119936,1217240245630119936,2020-01-15 00:21:04 UTC,2020-01-15,00:21:04,+0000,59769395,niaidnews,NIAID News,,üë©‚Äç‚öïÔ∏è Resolving to stay healthy in 2020? Routine #HIV and #STI testing helps ensure you have the care you need. Locate a testing site near you today with the @HIVgov HIV services locator:  https://t.co/o3emT7Eevk  #NIHHealthy2020 #TipTuesday #GetTested  https://t.co/dLU8jsLjp5,en,"[{'screen_name': 'hivgov', 'name': 'hiv.gov', 'id': '15368404'}]",['http://bit.ly/HIVTestingBasics'],['https://pbs.twimg.com/media/EOSBjZWWoAAEs8e.jpg'],2,9,15,"['hiv', 'sti', 'nihhealthy2020', 'tiptuesday', 'gettested']",[],https://twitter.com/NIAIDNews/status/1217240245630119936,False,,1,https://pbs.twimg.com/media/EOSBjZWWoAAEs8e.jpg,,,,,,,[],,,,
1216766482878627845,1216766482878627845,2020-01-13 16:58:30 UTC,2020-01-13,16:58:30,+0000,59769395,niaidnews,NIAID News,,"EBOLA NEWS: NIAID-supported Partnership for Research on Ebola Vaccination extends study of three #Ebola #vaccine regimens in Liberia, Guinea, Sierra Leone and Mali. #PREVAC  https://t.co/2IqqtYeT8U  https://t.co/ssI2c3M8QX",en,[],['http://bit.ly/InsermPressRoomPREVAC-UP'],['https://pbs.twimg.com/media/EOLSqMxUwAA3PZi.jpg'],1,4,5,"['ebola', 'vaccine', 'prevac']",[],https://twitter.com/NIAIDNews/status/1216766482878627845,False,,1,https://pbs.twimg.com/media/EOLSqMxUwAA3PZi.jpg,,,,,,,[],,,,
1215740308266209282,1215740308266209282,2020-01-10 21:00:51 UTC,2020-01-10,21:00:51,+0000,59769395,niaidnews,NIAID News,,"NEWS: NIAID-funded #MERS #coronavirus study in mice shows promise of anti-viral drug #remdesivir as treatment; NIAID scientists also exploring remdesivir as a treatment for Ebola, Nipah and other viruses.  https://t.co/1R94W5syV1  https://t.co/TfWmLgovFZ",en,[],['https://go.nature.com/2TaSiX5'],['https://pbs.twimg.com/media/EN8tXBoU0AEI684.jpg'],2,15,22,"['mers', 'coronavirus', 'remdesivir']",[],https://twitter.com/NIAIDNews/status/1215740308266209282,False,,1,https://pbs.twimg.com/media/EN8tXBoU0AEI684.jpg,,,,,,,[],,,,
1214690959033872384,1214690959033872384,2020-01-07 23:31:07 UTC,2020-01-07,23:31:07,+0000,59769395,niaidnews,NIAID News,,"üëã Resolving to stay healthy in 2020? #Handwashing with soap is vital to preventing the spread of infectious diseases in hospitals, schools, at home and in the community. #NIHHealthy2020 #TipTuesday  https://t.co/HcQ5pxIDDO",en,[],[],['https://pbs.twimg.com/media/ENty_WcW4AcYbES.jpg'],1,8,21,"['handwashing', 'nihhealthy2020', 'tiptuesday']",[],https://twitter.com/NIAIDNews/status/1214690959033872384,False,,1,https://pbs.twimg.com/media/ENty_WcW4AcYbES.jpg,,,,,,,[],,,,
1214581125688938496,1214581125688938496,2020-01-07 16:14:40 UTC,2020-01-07,16:14:40,+0000,59769395,niaidnews,NIAID News,,NEWS: The first clinical trial to formally compare autologous hematopoietic stem cell transplantation to the best available biologic drugs for treating severe forms of relapsing #MultipleSclerosis has begun:  https://t.co/BVxjcYPEpe   #MS #AHSCT #autoimmune  https://t.co/U2q9fnvZn2,en,[],['http://bit.ly/BEAT-MS'],['https://pbs.twimg.com/media/ENsPFtnUUAAQXRQ.jpg'],1,3,6,"['multiplesclerosis', 'ms', 'ahsct', 'autoimmune']",[],https://twitter.com/NIAIDNews/status/1214581125688938496,False,,1,https://pbs.twimg.com/media/ENsPFtnUUAAQXRQ.jpg,,,,,,,[],,,,
1214567799143534593,1214567799143534593,2020-01-07 15:21:43 UTC,2020-01-07,15:21:43,+0000,59769395,niaidnews,NIAID News,,Congrats to NIAID‚Äôs Eli Boritz on becoming part of the Earl Stadtman Tenure-Track Investigator Program! Dr. Boritz is chief of the Virus Persistence and Dynamics Section in NIAID‚Äôs Vaccine Research Center.  https://t.co/MBrNRjAb0a,en,[],['https://irp.nih.gov/catalyst/v28i1/getting-to-know-11-stadtmans'],[],1,3,9,[],[],https://twitter.com/NIAIDNews/status/1214567799143534593,False,,0,,,,,,,,[],,,,
1212868443357233154,1212868443357233154,2020-01-02 22:49:05 UTC,2020-01-02,22:49:05,+0000,59769395,niaidnews,NIAID News,,"VIDEO üé•: Though #FluSeason is upon us, it‚Äôs not too late to get your #FluShot if you haven‚Äôt already. In this video from October, @NIAIDNews Director Dr. Anthony Fauci explains why he never misses his #flu vaccine. #NIHHealthy2020  https://t.co/eGo8YUq6zb",en,"[{'screen_name': 'niaidnews', 'name': 'niaid news', 'id': '59769395'}]",['https://youtu.be/nZj9eY5lC98'],[],2,7,11,"['fluseason', 'flushot', 'flu', 'nihhealthy2020']",[],https://twitter.com/NIAIDNews/status/1212868443357233154,False,,0,,,,,,,,[],,,,
1212803241408372738,1212803241408372738,2020-01-02 18:30:00 UTC,2020-01-02,18:30:00,+0000,59769395,niaidnews,NIAID News,,#STI NEWS: Learn how a unique NIAID-supported study led to FDA-approved tests for #gonorrhea and #chlamydia. #STD,en,[],[],[],0,1,3,"['sti', 'gonorrhea', 'chlamydia', 'std']",[],https://twitter.com/NIAIDNews/status/1212803241408372738,False,https://twitter.com/ARLGnetwork/status/1211746599317061633,0,,,,,,,,[],,,,
1212787522599669760,1212787522599669760,2020-01-02 17:27:32 UTC,2020-01-02,17:27:32,+0000,59769395,niaidnews,NIAID News,,TB NEWS: Changing the route of immunization dramatically improves protective power of century-old #TuberculosisVaccine. Studies in animals by #NIAID scientists published in @Nature.  https://t.co/Z5eOIFlpZ3  https://t.co/f8k1hbhivQ,en,"[{'screen_name': 'nature', 'name': 'nature', 'id': '15862891'}]",['http://bit.ly/39xzjvE'],['https://pbs.twimg.com/media/ENSv0ZGU0AAp3Lj.jpg'],3,21,30,"['tuberculosisvaccine', 'niaid']",[],https://twitter.com/NIAIDNews/status/1212787522599669760,False,,1,https://pbs.twimg.com/media/ENSv0ZGU0AAp3Lj.jpg,,,,,,,[],,,,
1212750397070356486,1212750397070356486,2020-01-02 15:00:01 UTC,2020-01-02,15:00:01,+0000,59769395,niaidnews,NIAID News,,"#ScienceHighlights2019: #HappyNewYear üéâ! As 2020 begins, #NIAID looks back at a productive 2019:  https://t.co/aEhT3prpv3 üß¨üß™üë©üèø‚Äçüî¨  https://t.co/0cO8JXPld0",en,[],['http://j.mp/NIAID2019Highlights'],['https://pbs.twimg.com/tweet_video_thumb/EMzUV2JVUAYrYWJ.jpg'],0,2,5,"['sciencehighlights2019', 'happynewyear', 'niaid']",[],https://twitter.com/NIAIDNews/status/1212750397070356486,False,,1,https://pbs.twimg.com/tweet_video_thumb/EMzUV2JVUAYrYWJ.jpg,,,,,,,[],,,,
1212447686055661568,1212447686055661568,2020-01-01 18:57:09 UTC,2020-01-01,18:57:09,+0000,59769395,niaidnews,NIAID News,,üé® #DYK NIAID has an extensive Flickr library of #PublicDomain photos and video b-roll? Check it out here:  https://t.co/Aw4Ui9mZs2 #PublicDomainDay #SciComm #SciArt  https://t.co/QN3tcoEBrs,en,[],['http://bit.ly/NIAIDFlickr'],['https://pbs.twimg.com/media/ENN6vprWsAU_jej.jpg'],0,1,4,"['dyk', 'publicdomain', 'publicdomainday', 'scicomm', 'sciart']",[],https://twitter.com/NIAIDNews/status/1212447686055661568,False,,1,https://pbs.twimg.com/media/ENN6vprWsAU_jej.jpg,,,,,,,[],,,,
